Date: 2021-03-25 Category: Extra Ordinary State: Union Government Country: India

Government of India in the Ministry of Chemicals and Fertilizers the National Pharmaceutical Pricing Authority

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

                    Okay, I will analyze the provided policy text and generate a report following the requested structure.

**Report on National Pharmaceutical Pricing Authority (NPPA) Orders of March 25, 2021**

**1. Executive Summary:**

This report analyzes three orders (S.O. 1328(E), S.O. 1329(E), S.O. 1330) issued by the National Pharmaceutical Pricing Authority (NPPA) on March 25, 2021, based on the provided Gazette of India excerpts. The orders primarily pertain to the price regulation of pharmaceutical products in India under the Drugs Prices Control Order (DPCO) 2013. S.O. 1328(E) fixes the retail prices of specified formulations. S.O. 1329(E) sets the ceiling price for a scheduled formulation. S.O. 1330 (E) establishes ceiling prices for a list of additional scheduled formulations. The key findings are the specific prices fixed for a range of drugs, along with the responsibilities and compliance measures imposed on manufacturers, retailers, and dealers.

**2. Introduction:**

This report aims to provide an informative overview and analysis of the pharmaceutical pricing orders issued by the National Pharmaceutical Pricing Authority (NPPA) on March 25, 2021, as published in the Gazette of India. The analysis is based solely on the provided policy text and focuses on the key provisions, target audience, and implementation aspects discernible from the document.

**3. Policy Overview:**

*   This policy operates under the framework of the Drugs Prices Control Order (DPCO), 2013, read with related notifications (S.O. 1394(E) dated May 30, 2013 and S.O. 701(E) dated March 10, 2016).

*   **Core Objective(s) (as inferred from the text):**
    *   To regulate the prices of essential medicines to ensure affordability and availability.
    *   To fix retail prices for specific pharmaceutical formulations, as indicated in S.O. 1328(E).
    *   To set ceiling prices for scheduled formulations, as indicated in S.O. 1329(E) and S.O. 1330.
    *   To ensure compliance with the price regulations by manufacturers, retailers, and dealers.

**4. Background and Rationale:**

*   **Rationale (as inferred from the text):** The NPPA issues these orders to exercise its authority under the DPCO, 2013, to control the prices of drugs. Price controls are often implemented to address market failures, ensure fair pricing, and prevent profiteering, thereby making essential medicines accessible to the public. The orders appear to be part of an ongoing effort to manage pharmaceutical pricing across a wide range of formulations.

**5. Key Provisions / Changes:**

The core provision of these orders is the specification of prices for various pharmaceutical products.

*   **S.O. 1328(E):** This order *fixes the retail prices* of the listed formulations. The price is specified in column 6 of the table, exclusive of goods and services tax (GST). It covers a wide range of formulations, including combinations of drugs and different dosage forms. The retail price applies to the manufacturer/marketer listed in the table and who applied for price fixation/revision. The provided text contains a table listing 35 new formulations and their retail prices.

*   **S.O. 1329(E):** This order *fixes the ceiling price* for Povidone Iodine Scrub 7.5% at Rs. 1.60 per ml, exclusive of GST. It applies to all manufacturers of the scheduled formulation, selling branded or generic versions at a price higher than the ceiling price, requiring them to revise prices downward. It also states manufacturers with MRPs lower than the ceiling price must maintain their existing MRP.

*   **S.O. 1330(E):** This order *fixes the ceiling prices* of a list of additional scheduled formulations, providing the Name of the Scheduled Formulation, Dosage Form, Strength, Unit and Ceiling Price in Rupees.

    The provided text contains a table listing 861 formulations and their ceiling prices.

    These formulations include different medicines, vaccines, injections, and tablets.

**6. Target Audience and Stakeholders:**

The primary target audience and stakeholders are:

*   Pharmaceutical manufacturers and marketing companies: They must comply with the fixed retail/ceiling prices and related regulations.
*   Retailers and dealers: They are required to display price lists and supplementary price lists conspicuously.
*   Consumers: They are the ultimate beneficiaries of price regulation as it aims to ensure affordability.
*   State Drug Controllers: They receive copies of the price lists.
*   The National Pharmaceutical Pricing Authority (NPPA) : Responsible for implementation and monitoring

**7. Implementation Aspects (Inferred):**

*   **Responsible agency:** The National Pharmaceutical Pricing Authority (NPPA) is the primary body responsible for implementing and monitoring compliance with these orders.
*   **Timelines and procedures:** Manufacturers are required to:
    *   Issue a price list in Form V from the date of notification.
    *   Submit the price list to the NPPA through IPDMS (Integrated Pharmaceutical Database Management System).
    *   Provide a copy of the price list to the State Drug Controller and dealers.
    *   Furnish quarterly returns to the NPPA, in respect of production, import and sale of scheduled formulations in FormIII of ScheduleII of the DPCO, 2013 through IPDMS.
    *   Furnish information to the NPPA, in respect of discontinuation of production and or import of scheduled formulation in FormIV of ScheduleII of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
*   Retailers and dealers must display price lists conspicuously.
*   In case the retail/ceiling price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
*   Existing price orders for the specified formulations are superseded by these notifications.
*   Where an existing manufacturer of scheduled formulation with dosage or strength or both launches a new drug as per paragraph 2 u of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under ScheduleII of the DPCO, 2013.

**8. Expected Outcomes / Impact of Changes:**

*   **Likely intended outcomes:**
    *   Reduced prices for specific pharmaceutical formulations, making them more affordable.
    *   Increased compliance with price regulations within the pharmaceutical industry.
    *   Greater transparency in pharmaceutical pricing for consumers and stakeholders.
    *   Ensuring a level playing field for manufacturers regarding price competition.
    *   The maintenance of existing lower MRPs, benefiting consumers.

**9. Conclusion:**

The NPPA orders of March 25, 2021, represent a continuation of the government's efforts to regulate pharmaceutical prices under the DPCO, 2013. The orders fix both retail and ceiling prices for a variety of drugs, which will likely impact manufacturers, retailers, and ultimately, consumers. The implementation of these orders necessitates adherence to specific guidelines regarding price lists, reporting, and compliance, as outlined in the document. These actions reinforce the NPPA's commitment to ensure affordability and availability of essential medicines in India.
                

Key Entities Referenced

Drugs Prices Control Order, 2013: A legal instrument under the Essential Commodities Act, 1955 that empowers the government to regulate the prices of drugs. Essential Commodities Act, 1955: An act of the Parliament of India that seeks to regulate the production, supply and distribution of essential commodities in order to ensure their availability to consumers at fair prices. Ministry of Chemicals and Fertilizers: A ministry in the Government of India. Department of Pharmaceuticals: A department under the Ministry of Chemicals and Fertilizers, Government of India. National Pharmaceutical Pricing Authority: A regulatory agency of the Government of India that fixes, revises, and monitors the prices of pharmaceutical products. New Delhi: The capital of India, where the order was issued. State Drug Controller: The drug controlling authority for each state in India.

Official Source Record View Original Source →

See Full Document Text

                रजजस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
xxxGIDHxxx
सी.जी.-डी.एxलx.x-GअID.-E2xx6x0 32021-226134
CG-DL-E-26032021-226134
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 1230] नई ददल्ली, बृहस्ट्प जतर्ार, माच व25, 2021/चत्रै 4, 1943
No. 1230] NEW DELHI, THURSDAY, MARCH 25, 2021/CHAITRA 4, 1943
रसायन और उर्वरक मत्रं ालय
(औषध जर्भाग)
(राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण)
आदिे
नई ददल्ली, 25 माच,व 2021
का.आ. 1328(अ).—भारत सरकार के रसायन और उर्वरक मंत्रालय द्वारा जारी का.आ. 1394 (अ) तारीख 30 मई, 2013
और का.आ. 701(अ) तारीख 10 माचव, 2016 के साथ पठठत औषध (कीमत जनयंत्रण) आदिे , 2013 के पैरा 5,11 और 15 द्वारा प्रदत्त
िजियों का प्रयोग करते हुए, राष्ट्रीय औषध मूल्य जनधावरण प्राजधकरण(जजसको संजिप्त रूप में एनपीपीए कहा जाता ह)ै नीचे की सारणी
के स्ट्तंभ (6) में जर्जनर्ददष्ट खुदरा मूल्य को उि सारणी के स्ट्तंभ(3),(4) और (5) में तत्सस्ट्थानी प्रजर्जष्टयों में जर्जनर्ददष्ट प्रबलता, इकाई
(यूजनट) और जर्जनमावता और जर्पणन कंपजनयों के नाम सजहत स्ट्तंभ(2) में की तत्सस्ट्थानी प्रजर्जष्ट में स ेप्रत्सयेक की,र्स्ट्तु एर्ं सेर्ा कर, यदद
कोई ह,ै को छोड़कर अजधकतम खुदरा मूल्य के रूप में जनयत करती है
सारणी
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
1. प्रत्सयेक जमलीलीटर में िाजमल ह:ैं मैसस वएक्सा पेरेंटरल्स जलजमटेड / 1.69
जसप्रोफ्लोक्साजसन +
जसप्रोफ्लोक्साजसन हाइड्रोक्लोराइड 1 जमली. मैससव सन फामावस्ट्यूठटकल्स
डेक्सामेथासोन आई ड्रॉप्स
आईपी सेप्रोफ्लोक्साजसन 0.3% डब्लू/र्ी इंडस्ट्रीज जलजमटेड
1809 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
के बराबर,
डेक्सामेथासोन 0.1% डब्लू/र्ी,
2. प्रत्सयेक हाडव जजलेठटन कैप्सूल में: 6.00
इसोमेप्राजोल मैग्नीजियम राइहाइड्रेट
इसोमेप्राजोल मैसस वप्योर एंड क्योर हल्े थकेयर
आईपी इसोमेप्राजोल 40 जम.ग्रा के
और सस्ट्टेन्ड ठरलीज 1 कैप्सूल प्रा. जलजमटेड / मैसस वएलेजम्बक
बराबर (एंटठरक कोटेड पेलेट्स के रूप में)
डॉम्पठरडोन कैप्सूल फामावस्ट्यूठटकल्स जलजमटेड
डॉम्पठरडोन आईपी 30 जम.ग्रा (सस्ट्टेन्ड
ठरलीज पेलेट्स के रूप में)
3. प्रत्सयेक 100 जमलीलीटर में: 91.56
लेर्ेटीरसेटम इन्फ्यूिन मैसस वअकुम्स ड्रग्स एंड
लेर्ेटीरसेटम आईपी 500 जम.ग्रा प्रत्सयेक
500 जमलीग्राम / 100 फामावस्ट्यूठटकल्स जलजमटेड / मैससव
सोजडयम क्लोराइड आईपी 820 जम.ग्रा पैक
जमली एबॉट हल्े थकेयर प्रा. जलजमटेड
इंजेक्िन के जलए आईपी क्यू. एस. पानी
4. प्रत्सयेक 100 जमलीलीटर में: 148.72
लेर्ेटीरसेटम इन्फ्यूिन मैसस वअकुम्स ड्रग्स एंड
लेर्ेटीरसेटम आईपी 1000 जम.ग्रा प्रत्सयेक
1000 जमलीग्राम / 100 फामावस्ट्यूठटकल्स जलजमटेड / मैससव
सोजडयम क्लोराइड आईपी 750 जम.ग्रा पैक
जमली एबॉट हल्े थकेयर प्रा. जलजमटेड
इंजेक्िन के जलए आईपी क्यू. एस. पानी
5. प्रत्सयेक दफल्म जलजपत बाईलेयर गोली में: 11.96
टेजल्मसटवन + टेजल्मसटवन आईपी 40 जम.ग्रा,
मैसस वरेर्ेनभेल हल्े थकेयर प्रा.
जसलजनडीपाईन + जसलजनडीपाईन आईपी 10 जम.ग्रा
1 गोली जलजमटेड / मैसस वमैनकाइंड फामाव
मेटोप्रोलोल (ईआर) गोली मेटोप्रोलोल सक्सीनेट आईपी 47.50
जलजमटेड
जम.ग्रा मेटोप्रोलोल टारेरेट (एक्स्ट्टेंडेड
ठरलीज रूप में) 50 जम.ग्रा
6. प्रत्सयेक दफल्म जलजपत बाईलेयर गोली में: 9.64
टेजल्मसटवन + टेजल्मसटवन आईपी 40 जम.ग्रा,
मैसस वरेर्ेनभेल हल्े थकेयर प्रा.
जसलजनडीपाईन + जसलजनडीपाईन आईपी 10 जम.ग्रा
1 गोली जलजमटेड / मैसस वमैनकाइंड फामाव
मेटोप्रोलोल (ईआर) गोली मेटोप्रोलोल सक्सीनेट आईपी 23.75
जलजमटेड
जम.ग्रा मेटोप्रोलोल टारेरेट (एक्स्ट्टेंडेड
ठरलीज रूप में) 25 जम.ग्रा
7. प्रत्सयेक दफल्म जलजपत गोली में: 22.38
मैसस वप्योर एंड क्योर हल्े थकेयर
लैबेटलॉल हाइड्रोक्लोराइड आईपी 200
लेबेटलॉल गोली 1 गोली प्रा. जलजमटेड / मैसस वसन फामाव
जम.ग्रा
लेबोरेटरीज जलजमटेड
8. प्रत्सयेक हाडव जजलेठटन कैप्सूल में: 9.11
रेबेप्राजोल सोजडयम आईपी 20 जम.ग्रा मैसस वथेओन फामावस्ट्युठटकल्स
रेबेप्राजोल + डॉम्पठरडोन
(एंटेठरक जलजपत पेलेटस के रूप में) 1 कैप्सूल जलजमटेड / मैससव एठरस हल्े थकेयर
कैप्सूल
डॉम्पठरडोन आईपी 30 जम.ग्रा (सस्ट्टेंड प्राइर्ेट जलजमटेड
ठरलीज़ पेलेटस के रूप में)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 3
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
9. प्रत्सयेक अजलजपत गोली में: मैसस वजिर्ाजलक रेमेडीज प्रा। जल. 3.98
पेराजसटामोल +
पेराजसटामोल आईपी 325 जम.ग्रा, 1 गोली / मैसस वएठरस हल्े थकेयर प्राइर्ेट
जनमेसुलाइड गोली
जनमेसुलाइड बीपी 100 जम.ग्रा जलजमटेड
10. टेजल्मसटवन + क्लोथवजलडोन प्रत्सयेक अजलजपत गोली में: 8.63
गोली टेजल्मसटवन आईपी 40 जम.ग्रा, मेसस वमैकलोड्स फामावस्ट्यूठटकल्स
1 गोली
(टेलमीडयूस सी एच और क्लोथवजलडोन आईपी 6.25 जम.ग्रा जलजमटेड
मैकसटव सी एच 6.25)
11. प्रत्सयेक दफल्म जलजपत गोली में: 18.02
कैजल्ियम काबोनेट आईपी 1250 जम.ग्रा,
कैजल्ियम काबोनेट + जर्टाजमन डी 3 आईपी 2000 आईयू,
जर्टाजमन डी 3 + मेजथलकोबालाजमन आईपी 1500
मैसस वजतरुपजत मेजडकेयर जलजमटेड
मेजथलकोबालाजमन + एल- एमसीजी,,
1 गोली / मैससव इंटास फामावस्ट्यूठटकल्स
जमथाइलफोलेट कैजल्ियम + कैजल्ियम एल-5-
जलजमटेड
पाइठरडोक्सल -5- फॉस्ट्फेट जमथाइलटेराहाइड्रोफोलोलेट (एल-
गोली जमथाइलोफोलेट कैजल्ियम) यूएसपी 1
जम.ग्रा पाइठरडोक्सल -5- फॉस्ट्फेट 20
जम.ग्रा
12. प्रत्सयेक अजलजपत बाईलेयर गोली में: 6.58
जर्ल्डाजग्लजप्टन+
जर्ल्डाजग्लजप्टन 50 जम.ग्रा, मैसस वएजक्ज़मेड फामावस्ट्यूठटकल्स /
मेटफॉर्ममन हाइड्रोक्लोराइ 1 गोली
मेटफॉर्ममन हाइड्रोक्लोराइ आईपी 500 मैसस वमैनकाइंड फामाव जल.
(सस्ट्टेंड ठरलीज) गोली
जम.ग्रा (सस्ट्टेंड ठरलीज के रूप में)
13. प्रत्सयेक अजलजपत बाईलेयर गोली में: 7.07
जर्ल्डाजग्लजप्टन +
जर्ल्डाजग्लजप्टन 50 जम.ग्रा, मैसस वएजक्ज़मेड फामावस्ट्यूठटकल्स /
मेटफॉर्ममन हाइड्रोक्लोराइ 1 गोली
मेटफॉर्ममन हाइड्रोक्लोराइ आईपी 1000 मैसस वमैनकाइंड फामाव जल.
(सस्ट्टेंड ठरलीज) गोली
जम.ग्रा (सस्ट्टेंड ठरलीज के रूप में)
14. प्रत्सयेक दफल्म-जलजपत गोली में: 11.81
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न + मोनोहाइड्रेट डापाजग्लफ्लोजज़न 10 जम.ग्रा
मैसस वएजक्ज़मेड फामावस्ट्यूठटकल्स /
मेटफॉर्ममन हाइड्रोक्लोराइड के बराबर, 1 गोली
मैसस वज़ाइडस हल्े थकेयर जलजमटेड
(ईआर) गोली मेटफॉर्ममन हाइड्रोक्लोराइड आईपी
1000 जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के
रूप में)
15. प्रत्सयेक दफल्म-जलजपत गोली में: 10.22
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न +
मोनोहाइड्रेट डापाजग्लफ्लोजज़न 10 जम.ग्रा मैसस वएजक्ज़मेड फामावस्ट्यूठटकल्स /
मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली
के बराबर, मैसस वज़ाइडस हल्े थकेयर जलजमटेड
(ईआर) गोली
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी 500
जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के रूप में)4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
16. प्रत्सयेक दफल्म-जलजपत बाईलेयर गोली में: 6.74
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न +
मोनोहाइड्रेट डापाजग्लफ्लोजज़न 5 जम.ग्रा मैसस वअलकेम हल्े थसाइंस / मैससव
मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली
के बराबर, अल्केम लेबोरेटरीज जल.
(एक्स्ट्टेंडेड ठरलीज़) गोली
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी 500
जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के रूप में)
17. प्रत्सयेक दफल्म-जलजपत बाईलेयर गोली में: 1 गोली 8.12
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न + मोनोहाइड्रेट डापाजग्लफ्लोजज़न 5 जम.ग्रा
मैससव अलकेम हल्े थसाइंस / मैससव
मेटफॉर्ममन हाइड्रोक्लोराइड के बराबर,
अल्केम लेबोरेटरीज जल.
(एक्स्ट्टेंडेड ठरलीज़) गोली मेटफॉर्ममन हाइड्रोक्लोराइड आईपी
1000 जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के
रूप में)
18. प्रत्सयेक दफल्म-जलजपत बाईलेयर गोली में: 1 गोली 10.22
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न +
मोनोहाइड्रेट डापाजग्लफ्लोजज़न 10 जम.ग्रा मैसस वअलकेम हल्े थसाइंस / मैससव
मेटफॉर्ममन हाइड्रोक्लोराइड
के बराबर, अल्केम लेबोरेटरीज जल.
(एक्स्ट्टेंडेड ठरलीज़) गोली
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी 500
जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के रूप में)
19. प्रत्सयेक दफल्म-जलजपत बाईलेयर गोली में: 1 गोली 11.81
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न + मोनोहाइड्रेट डापाजग्लफ्लोजज़न 10 जम.ग्रा
मैसस वअलकेम हल्े थसाइंस / मैससव
मेटफॉर्ममन हाइड्रोक्लोराइड के बराबर,
अल्केम लेबोरेटरीज जल.
(एक्स्ट्टेंडेड ठरलीज़) गोली मेटफॉर्ममन हाइड्रोक्लोराइड आईपी
1000 जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के
रूप में)
20. प्रत्सयेक दफल्म जलजपत गोली में: 1 गोली 5.90
जर्ल्डाजग्लजप्टन + मैसस वप्योर एंड क्योर हल्े थकेयर
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी 500
मेटफॉर्ममन हाइड्रोक्लोराइ प्रा. जल। / मैसस वब्लू क्रॉस
जम.ग्रा
गोली लेबोरेटरीज प्रा. जलजमटेड
जर्ल्डाजग्लजप्टन 50 जम.ग्रा,
21. प्रत्सयेक दफल्म जलजपत गोली में: 1 गोली 6.90
जर्ल्डाजग्लजप्टन + मैसस वप्योर एंड क्योर हल्े थकेयर
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी
मेटफॉर्ममन हाइड्रोक्लोराइ प्रा. जल। / मैसस वब्लू क्रॉस
1000 जम.ग्रा
गोली लेबोरेटरीज प्रा. जलजमटेड
जर्ल्डाजग्लजप्टन 50 जम.ग्रा,
22. डापाजग्लफ्लोजज़न + प्रत्सयेक दफल्म-जलजपत गोली में: मैसस वएमएसएन लेबोरेटरीज प्रा. 11.81
मेटफॉर्ममन हाइड्रोक्लोराइड डापाजग्लफ्लोजज़न 10 जम.ग्रा, 1 गोली जलजमटेड / मैसस वयूएसर्ी प्रा.
एक्स्ट्टेंडेड ठरलीज गोली जलजमटेड
मेटफॉर्ममन हाइड्रोक्लोराइड[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 5
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
आईपी/यूएसपी 1000 जम.ग्रा (एक्स्ट्टेंडडे
ठरलीज़ फॉमव के रूप में)
23. प्रत्सयेक दफल्म-जलजपत गोली में: 10.22
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 10 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जलजमटेड / मैसस वयूएसर्ी प्रा.
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 500 जम.ग्रा (एक्स्ट्टेंडेड जलजमटेड
ठरलीज़ फॉमव के रूप में)
24. प्रत्सयेक दफल्म-जलजपत गोली में: 6.74
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 5 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जलजमटेड / मैससव इंटास
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 500 जम.ग्रा (एक्स्ट्टेंडेड फामावस्ट्यूठटकल्स जलजमटेड
ठरलीज़ फॉमव के रूप में)
25. प्रत्सयेक दफल्म-जलजपत गोली में: 8.12
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 5 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जलजमटेड / मैससव इंटास
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 1000 जम.ग्रा (एक्स्ट्टेंडडे फामावस्ट्यूठटकल्स जलजमटेड
ठरलीज़ फॉमव के रूप में)
26. प्रत्सयेक दफल्म-जलजपत गोली में: 11.81
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 10 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जलजमटेड / मैससव इंटास
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 1000 जम.ग्रा (एक्स्ट्टेंडडे फामावस्ट्यूठटकल्स जलजमटेड
ठरलीज़ फॉमव के रूप में)
27. प्रत्सयेक दफल्म-जलजपत गोली में: 10.22
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 10 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जलजमटेड / मैससव इंटास
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 500 जम.ग्रा (एक्स्ट्टेंडेड फामावस्ट्यूठटकल्स जलजमटेड
ठरलीज़ फॉमव के रूप में)
28. प्रत्सयेक दफल्म-जलजपत गोली में: 6.74
डापाजग्लफ्लोजज़न प्रोपेनेजडओल
डापाजग्लफ्लोजज़न +
मोनोहाइड्रेट डापाजग्लफ्लोजज़न 5 जम.ग्रा मैसस वएजक्ज़मेड फामावस्ट्यूठटकल /
मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली
के बराबर, मैसस वज़ाइडस हल्े थकेयर जलजमटेड
(एक्स्ट्टेंडेड ठरलीज) गोली
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी 500
जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के रूप में)
29. प्रत्सयेक दफल्म-जलजपत गोली में: 8.12
डापाजग्लफ्लोजज़न +
डापाजग्लफ्लोजज़न प्रोपेनेजडओल मैसस वएजक्ज़मेड फामावस्ट्यूठटकल /
मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली
मोनोहाइड्रेट डापाजग्लफ्लोजज़न 5 जम.ग्रा मैसस वज़ाइडस हल्े थकेयर जलजमटेड
(एक्स्ट्टेंडेड ठरलीज) गोली
के बराबर,6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
क्रं स ं जर्जनर्ममजत का नाम/ब्ाडं का प्रबलता इकाई जर्जनमातव ा और जर्पणन कंपनी खदु रा मल्ू य
नाम (रु.)
(1) (2) (3) (4) (5) (6)
मेटफॉर्ममन हाइड्रोक्लोराइड आईपी
1000 जम.ग्रा (एक्स्ट्टेंडेड ठरलीज़ फॉमव के
रूप में)
30. प्रत्सयेक दफल्म-जलजपत गोली में: 6.74
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 5 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जल. / मैसस वएठरस लाइफसाइंस
एक्स्ट्टेंडेड ठरलीज गोली जलजमटेड
आईपी/यूएसपी 500 जम.ग्रा (एक्स्ट्टेंडेड
ठरलीज़ फॉमव के रूप में)
31. प्रत्सयेक दफल्म-जलजपत गोली में: 8.12
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 5 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जल. / मैसस वएठरस लाइफसाइंस
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 1000 जम.ग्रा (एक्स्ट्टेंडडे जलजमटेड
ठरलीज़ फॉमव के रूप में)
32. प्रत्सयेक दफल्म-जलजपत गोली में: 10.22
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 10 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जल. / मैसस वएठरस लाइफसाइंस
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 500 जम.ग्रा (एक्स्ट्टेंडेड जलजमटेड
ठरलीज़ फॉमव के रूप में)
33. प्रत्सयेक दफल्म-जलजपत गोली में: 11.81
डापाजग्लफ्लोजज़न + डापाजग्लफ्लोजज़न 10 जम.ग्रा, मैसस वएमएसएन लेबोरेटरीज प्रा.
मेटफॉर्ममन हाइड्रोक्लोराइड मेटफॉर्ममन हाइड्रोक्लोराइड 1 गोली जल. / मैसस वएठरस लाइफसाइंस
एक्स्ट्टेंडेड ठरलीज गोली आईपी/यूएसपी 1000 जम.ग्रा (एक्स्ट्टेंडडे जलजमटेड
ठरलीज़ फॉमव के रूप में)
34. प्रत्सयेक हाडव जजलेठटन कैप्सूल में: 20.22
एटोरर्ास्ट्टेठटन कैजल्ियम आईपी
एटोरर्ास्ट्टेठटन और
एटोरर्ास्ट्टेठटन 40 जमलीग्राम के बराबर, 1 कैप्सूल मैसस वयूएसर्ी प्राइर्ेट जलजमटेड.
एजस्ट्पठरन कैप्सूल
एजस्ट्पठरन आईपी 75 जमलीग्राम (गैस्ट्रो-
प्रजतरोधी गोली आईपी के रूप में)
35. प्रत्सयेक दफल्म जलजपत गोली में: 15.18
ऐसक्लोफेनाक + मैसस वसायनोकेम फामावस्ट्युठटकल्स
ऐसक्लोफेनाक आईपी 100 जम.ग्रा.,
पैराजसटामोल + 1 गोली जलजमटेड / मैसस वमायलन
पैराजसटामोल आईपी 325 जम.ग्रा
जथयोकोलीकोसाइड गोली फामावस्ट्यूठटकल्स प्राइर्ेट जलजमटेड
जथयोकोलीकोसाइड आईपी 4 जम.ग्रा
(6)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 7
V
(4)
I
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदेिक
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 25th March, 2021
S.O. 1328(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control)
Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the
Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority
(hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail
price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in
column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in
the corresponding entries in columns (3), (4) and (5) thereof;
TABLE
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Brand Marketing Company Price
Name (Rs.)
(1) (2) (3) (4) (5) (6)
1. Each ml Contains: M/s AXA Parenterals 1.69
Ciprofloxacin +
Ciprofloxacin Hydrochloride IP Eq. Ltd. /M/s Sun
Dexamethasone Eye 1 ML
to Ciprofloxacin 0.3% w/v, Pharmaceutical
Drops
Dexamethasone 0.1% w/v, Industries Limited
2. Each hard Gelatin Capsule Contains: 6.00
M/s Pure & Cure
Esomeprazole Magnesium
Esomeprazole & Healthcare Pvt. Ltd. /
Trihydrate IP eq. to Esomeprazole 1
sustained release M/s Alembic
40mg (as enteric coated pellets) Capsule
Domperidone Capsule Pharmaceuticals
Domperidone IP 30mg (as sustained
Limited
release pellets)
3. Levetiracetam Infusion Each 100ml contains: Each M/s Akums Drugs & 91.56
500mg/100ml Levetiracetam IP 500mg Pack Pharmaceuticals8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Brand Marketing Company Price
Name (Rs.)
(1) (2) (3) (4) (5) (6)
Sodium Chloride IP 820mg Limited / M/s Abbott
Water for Injections IP q. s. Healthcare Pvt. Ltd.
4. Each 100ml contains: M/s Akums Drugs & 148.72
Levetiracetam Infusion Levetiracetam IP 1000mg Each Pharmaceuticals
1000mg/100ml Sodium Chloride IP 750mg Pack Limited / M/s Abbott
Water for Injections IP q. s. Healthcare Pvt. Ltd.
5. Each film coated bilayered tablet 11.96
contains:
M/s Ravenbhel
Telmisartan + Telmisartan IP 40mg,
Healthcare Pvt. Ltd. /
Cilnidipine + Cilnidipine IP 10mg 1 Tablet
M/s Mankind Pharma
Metoprolol (ER) Tablet Metoprolol Succinate IP 47.50mg
Limited
eq. to Metoprolol Tartrate (as
extended release) 50mg
6. Each film coated bilayered tablet 9.64
contains:
M/s Ravenbhel
Telmisartan + Telmisartan IP 40mg,
Healthcare Pvt. Ltd. /
Cilnidipine + Cilnidipine IP 10mg 1 Tablet
M/s Mankind Pharma
Metoprolol (ER) Tablet Metoprolol Succinate IP 23.75mg
Limited
eq. to Metoprolol Tartrate (as
extended release) 25mg
7. Each film coated tablet contains: M/s Pure and Cure 22.38
Labetalol Hydrochloride IP 200mg Healthcare Pvt. Ltd. /
Labetalol Tablet 1 Tablet
M/s Sun Pharma
Laboratories Limited
8. Each hard gelatine capsule contains: 9.11
M/s Theon
Rabeprazole Sodium IP 20mg (as
Rabeprazole + 1 Pharmaceuticals Ltd.
enteric coated pellets)
Domperidone capsule Capsule / M/s Eris Healthcare
Domperidone IP 30mg (As
Private Limited
sustained release pellets)
9. Each uncoated tablet contains: M/s Shivalik 3.98
Paracetamol + Paracetamol IP 325mg, Remedies Pvt. Ltd. /
1 Tablet
Nimesulide Tablet Nimesulide BP 100mg M/s Eris Healthcare
Private Limited
10. Telmisartan + Each uncoated tablet contains: 8.63
M/s Macleods
Chlorthalidone Tablet Telmisartan IP 40mg,
1 Tablet Pharmaceuticals
(TELMIDUCE CH & Chlorthalidone IP 6.25mg
Limited
MACSART CH 6.25)
11. Each Film coated tablet contains: 18.02
Calcium Carbonate +
Calcium Carbonate IP 1250mg,
Vitamin D3 +
Vitamin D3 IP 2000 IU, M/s Tirupati Medicare
Methylcobalamin + L-
Methylcobalamin IP 1500mcg, 1 Tablet Limited / M/s Intas
Methylfolate Calcium
Calcium L-5-Methyltetrahydrofolate Pharmaceuticals Ltd.
+ Pyridoxal -5-
(L-Methylfolate Calcium) USP 1mg
Phosphate Tablets
Pyridoxal -5- Phosphate 20mg
12. Vildagliptin + Each uncoated bilayered tablet 6.58
Metformin contains: M/s Exemed
Hydrochloride Vildagliptin 50mg, 1 Tablet Pharmaceuticals / M/s
(sustained release) Metformin Hydrochloride IP Mankind Pharma Ltd.
Tablet 500mg (As sustained release form)
13. Vildagliptin + Each uncoated bilayered tablet M/s Exemed 7.07
1 Tablet
Metformin contains: Pharmaceuticals / M/s[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 9
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Brand Marketing Company Price
Name (Rs.)
(1) (2) (3) (4) (5) (6)
Hydrochloride Vildagliptin 50mg, Mankind Pharma Ltd.
(sustained release) Metformin Hydrochloride IP
Tablet 1000mg (As sustained release form)
14. Each film-coated tablet contains: 11.81
Dapagliflozin +
Dapagliflozin Propanediol M/s Exemed
Metformin
monohydrate eq. to Dapagliflozin Pharmaceutical / M/s
Hydrochloride 1 Tablet
10mg, Zydus Healthcare
Extended Release
Metformin Hydrochloride IP Limited
Tablet
1000mg (As Extended release form)
15. Each film-coated tablet contains: 10.22
Dapagliflozin +
Dapagliflozin Propanediol M/s Exemed
Metformin
monohydrate eq. to Dapagliflozin Pharmaceutical / M/s
Hydrochloride 1 Tablet
10mg, Zydus Healthcare
Extended Release
Metformin Hydrochloride IP 500mg Limited
Tablet
(As Extended release form)
16. Each film-coated bilayered tablet 6.74
Dapagliflozin + contains:
M/s Alkem
Metformin Dapagliflozin Propanediol
Healthscience /M/s
Hydrochloride monohydrate eq. to Dapagliflozin 1 Tablet
Alkem Laboratories
Extended Release 5mg,
Ltd.
Tablet Metformin Hydrochloride IP 500mg
(As Extended release form)
17. Each film-coated bilayered tablet 1 Tablet 8.12
Dapagliflozin + contains:
M/s Alkem
Metformin Dapagliflozin Propanediol
Healthscience /M/s
Hydrochloride monohydrate eq. to Dapagliflozin
Alkem Laboratories
Extended Release 5mg,
Ltd.
Tablet Metformin Hydrochloride IP
1000mg (As Extended release form)
18. Each film-coated bilayered tablet 1 Tablet 10.22
Dapagliflozin + contains:
M/s Alkem
Metformin Dapagliflozin Propanediol
Healthscience /M/s
Hydrochloride monohydrate eq. to Dapagliflozin
Alkem Laboratories
Extended Release 10mg,
Ltd.
Tablet Metformin Hydrochloride IP 500mg
(As Extended release form)
19. Each film-coated bilayered tablet 1 Tablet 11.81
Dapagliflozin + contains:
M/s Alkem
Metformin Dapagliflozin Propanediol
Healthscience /M/s
Hydrochloride monohydrate eq. to Dapagliflozin
Alkem Laboratories
Extended Release 10mg,
Ltd.
Tablet Metformin Hydrochloride IP
1000mg (As Extended release form)
20. Vildagliptin + Each film coated tablet contains: 1 Tablet M/s Pure & Cure 5.90
Metformin Metformin Hydrochloride IP 500mg Healthcare Pvt. Ltd. /
Hydrochloride Tablet Vildagliptin 50mg, M/s Blue Cross
Laboratories Pvt. Ltd.
21. Vildagliptin + Each film coated tablet contains: 1 Tablet M/s Pure & Cure 6.90
Metformin Metformin Hydrochloride IP Healthcare Pvt. Ltd. /
Hydrochloride Tablet 1000mg M/s Blue Cross
Vildagliptin 50mg, Laboratories Pvt. Ltd.
22. Dapagliflozin + Each film-coated tablet contains: 1 Tablet M/s MSN 11.8110 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Brand Marketing Company Price
Name (Rs.)
(1) (2) (3) (4) (5) (6)
Metformin Dapagliflozin 10mg, Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP / M/s USV Pvt.
Extended Release 1000mg (As Extended release form) Limited
Tablet
23. Dapagliflozin + Each film-coated tablet contains: 10.22
M/s MSN
Metformin Dapagliflozin 10mg,
Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet
/ M/s USV Pvt.
Extended Release 500mg (As Extended release form)
Limited
Tablet
24. Dapagliflozin + Each film-coated tablet contains: M/s MSN 6.74
Metformin Dapagliflozin 5mg, Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet / M/s Intas
Extended Release 500mg (As Extended release form) Pharmaceuticals
Tablet Limited
25. Dapagliflozin + Each film-coated tablet contains: M/s MSN 8.12
Metformin Dapagliflozin 5mg, Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet / M/s Intas
Extended Release 1000mg (As Extended release form) Pharmaceuticals
Tablet Limited
26. Dapagliflozin + Each film-coated tablet contains: M/s MSN 11.81
Metformin Dapagliflozin 10mg, Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet / M/s Intas
Extended Release 1000mg (As Extended release form) Pharmaceuticals
Tablet Limited
27. Dapagliflozin + Each film-coated tablet contains: M/s MSN 10.22
Metformin Dapagliflozin 10mg, Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet / M/s Intas
Extended Release 500mg (As Extended release form) Pharmaceuticals
Tablet Limited
28. Dapagliflozin + Each film-coated tablet contains: 6.74
Metformin Dapagliflozin Propanediol M/s Exemed
Hydrochloride monohydrate eq. to Dapagliflozin Pharmaceutical / M/s
1 Tablet
(Extended Release) 5mg, Zydus Healthcare
Tablet Metformin Hydrochloride IP 500mg Limited
(As Extended release form)
29. Dapagliflozin + Each film-coated tablet contains: 8.12
Metformin Dapagliflozin Propanediol M/s Exemed
Hydrochloride monohydrate eq. to Dapagliflozin Pharmaceutical / M/s
1 Tablet
(Extended 5mg, Zydus Healthcare
Release)Tablet Metformin Hydrochloride IP Limited
1000mg (As Extended release form)
30. Dapagliflozin + Each film-coated tablet contains: 6.74
M/s MSN
Metformin Dapagliflozin 5mg,
Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet
/ M/s Eris
Extended Release 500mg (As Extended release form)
Lifesciences Limited
Tablet
31. Dapagliflozin + Each film-coated tablet contains: 8.12
M/s MSN
Metformin Dapagliflozin 5mg,
Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet
/ M/s Eris
Extended Release 1000mg (As Extended release form)
Lifesciences Limited
Tablet[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 11
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Brand Marketing Company Price
Name (Rs.)
(1) (2) (3) (4) (5) (6)
32. Dapagliflozin + Each film-coated tablet contains: 10.22
M/s MSN
Metformin Dapagliflozin 10mg,
Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP / USP 1 Tablet
/ M/s Eris
Extended Release 500mg (As Extended release form)
Lifesciences Limited
Tablet
33. Dapagliflozin + Each film-coated tablet contains: 11.81
M/s MSN
Metformin Dapagliflozin 10mg,
Laboratories Pvt. Ltd.
Hydrochloride Metformin Hydrochloride IP 1 Tablet
/ M/s Eris
Extended Release 1000mg (As Extended release form)
Lifesciences Limited
Tablet
34. Each Hard gelatine capsule contains: 20.22
Atorvastatin calcium IP eq. to
Atorvastatin and 1 M/s USV Private
Atorvastatin 40mg,
Aspirin Capsule Capsule Limited.
Aspirin IP 75mg (As Gastro-
resistant tablet IP)
35. Each film coated tablet contains: M/s Synokem 15.18
Aceclofenac +
Aceclofenac IP 100mg, Pharmaceuticals Ltd.
Paracetamol +
Paracetamol IP 325mg 1 Tablet /M/s Mylan
Thiocolchicoside
Thiocolchicoside IP 4mg Pharmaceuticals
Tablet
Private Limited.
Note:
(a) The manufacturer of above mentioned formulations i.e. ―new drug‖ under paragraph 2(u) of the DPCO, 2013
shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the
Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in
accordance with the retail price specified in column (6) of the above table as per provisions contained in
paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of
Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State
Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on
business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned
above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated
under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the
Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent
Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned
manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price
notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be
liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO,
2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in
this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of
notification, stand(s) superseded.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director12 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
आदेि
नई ददल्ली, 25 माचव, 2021
का.आ. 1329(अ).—
4, 6, 10, 11, 14, 16,
(1) (2) (3) (4) (5)
1. पोजर्डोन आयोडीन स्ट्क्रब 7.5% 1 जमली. 1.60
(5)
(2)
(5)
V
(4)
II I
II III
II
IV[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 13
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदेिक
ORDER
New Delhi, the 25th March, 2021
S.O. 1329(E).—In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the
Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated
10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National
Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of
the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the
Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form &
strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
Sl. No. Name of the Scheduled Formulation Dosage form & Strength Unit Ceiling
Price (Rs.)
(1) (2) (3) (4) (5)
1. Povidone Iodine Scrub 7.5% 1 ml 1.60
Note:
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled
formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and
notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling
price specified in column (5) in the above table plus goods and services tax as applicable, if any.
(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling
price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue
to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the
Government on the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in
accordance with the ceiling price specified in column (5) of the above table as per provisions contained in
paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V
from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy
to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price
list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business
in a manner so as to be easily accessible to any person wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the
above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall
apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the
DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect
of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013
through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation14 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled
formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control)
Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this
notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of
notification, stand(s) superseded.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
आदिे
नई ददल्ली, 25 माच,व 2021
का.आ. 1330(अ).—
4, 6, 10, 11,
14, 16, 17 18
a b
@ (0.53638%)
0.53638%
(1) (2) (3) (4) (5) 6(a) 6(b)
1 5&,feukslsyhflfyd ,flM lqIiksftVªh 500 fexzk- fjVsu'ku ,fuek 1 lqIiksftVªh 16.95 1213(अ) 25.03.2020
2 5&,feukslsyhflfyd ,flM xksyh 400 fexzk- 1 xksyh 7.49 1213(अ) 25.03.2020
3 5&¶ywjksjkfly batSD'ku 250 fexzk-@5 fefy- 1 fefy- 2.34 1213(अ) 25.03.2020
4 6&eds sZiVkWI;wfju xksyh 50 fexzk- 1 xksyh 6.47 1213(अ) 25.03.2020
5 ,cdkohj xksyh 300 fexzk- 1 xksyh 47.27 1213(अ) 25.03.2020
6 ,cdkohj ¼,½ $ ysfeoqMhu xksyh 60 fexzk- ¼,½ $ 30 fexzk- ¼ch½ 1 xksyh 20.13 1213(अ) 25.03.2020
¼ch½
7 ,cdkohj ¼,½ $ ysfeoqMhu xksyh 600 fexzk-¼,½$300 fexzk- ¼ch½ 1 xksyh 91.35 1213(अ) 25.03.2020
¼ch½
8 ,flVktksykekbM dSIlwy 250 fexzk- 1 dSIlwy 4.53 1213(अ) 25.03.2020
9 ,flVktksykekbM xksyh 250 fexzk- 1 xksyh 3.67 1213(अ) 25.03.2020
10 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xksyh 0.18 1213(अ) 25.03.2020
dksfVM xksyh 100 fexzk-
11 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xksyh 1.21 1213(अ) 25.03.2020
dksfVM xksyh 150 fexzk-[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 15
12 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xksyh 1.23 1213(अ) 25.03.2020
dksfVM xksyh 75 fexzk-
13 ,lhVkbylSyhflfyd ,flM xksyh 100 fexzk- 1 xksyh 0.17 1213(अ) 25.03.2020
14 ,lhVkbylSyhflfyd ,flM xksyh 150 fexzk- 1 xksyh 0.41 1213(अ) 25.03.2020
15 ,lhVkbylSyhflfyd ,flM xksyh 325 fexzk- 1 xksyh 0.55 1213(अ) 25.03.2020
16 ,lhVkbylSyhflfyd ,flM xksyh 350 fexzk- 1 xksyh 0.31 1213(अ) 25.03.2020
17 ,lhVkbylSyhflfyd ,flM xksyh 75 fexzk- 1 xksyh 0.31 1213(अ) 25.03.2020
18 ,fDVuksekbflu Mh batSD'ku ds fy, ikmMj 0-5 fexzk- izfr iSd 317.90 1213(अ) 25.03.2020
19 ,flDyksohj vksbVa esaV 3% 1 xzke 10.44 1213(अ) 25.03.2020
20 ,flDyksohj vksjy fyD;wbZM 400 fexzk-@5 fefy- 1 fefy- 1.27 1213(अ) 25.03.2020
21 ,flDyksohj xksyh 200 fexzk- 1 xksyh 6.79 1213(अ) 25.03.2020
22 ,flDyksohj xksyh 400 fexzk- 1 xksyh 12.34 1213(अ) 25.03.2020
23 ,flDyksohj batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 356.17 1213(अ) 25.03.2020
24 ,flDyksohj batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 460.03 1213(अ) 25.03.2020
25 ,Msukslkbu batSD'ku 3 fexzk-@fefy- 1 fefy- 98.70 1213(अ) 25.03.2020
26 ,Mªsukykbu batSD'ku 1 fexzk-@fefy- 1 fefy- 15.69 1213(अ) 25.03.2020
27 ,ycsMa ktksy vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 1.60 1213(अ) 25.03.2020
28 ,ycsMa ktksy xksyh 400 fexzk- 1 xksyh 7.72 1213(अ) 25.03.2020
29 ,yksI;wfjuksy xksyh 100 fexzk- 1 xksyh 1.91 1213(अ) 25.03.2020
30 ,yksI;wfjuksy xksyh 300 fexzk- 1 xksyh 7.50 1213(अ) 25.03.2020
31 vkWy&Vªkal jsVhukWbd ,flM dSIlwy 10 fexzk- 1 dSIlwy 82.00 1213(अ) 25.03.2020
32 ,yizksLVkfMy batSD'ku 0-5 fexzk-@fefy- 1 fefy- 5676.93 1213(अ) 25.03.2020
33 ,YVsIyl batSD'ku ds fy, ikmMj 20 fexzk- izfr iSd 19040.03 1213(अ) 25.03.2020
34 ,YVsIyl batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 39753.72 1213(अ) 25.03.2020
35 ,fe;ksMsjksu batSD'ku 50 fexzk-@fefy- 1 fefy- 22.36 1213(अ) 25.03.2020
36 ,fe;ksMsjksu xksyh 100 fexzk- 1 xksyh 5.73 1213(अ) 25.03.2020
37 ,fe;ksMsjksu xksyh 200 fexzk- 1 xksyh 11.35 1213(अ) 25.03.2020
38 ,fefVªfIVykbu xksyh 10 fexzk- 1 xksyh 2.29 1213(अ) 25.03.2020
39 ,fefVªfIVykbu xksyh 25 fexzk- 1 xksyh 2.26 1213(अ) 25.03.2020
40 ,fefVªfIVykbu xksyh 50 fexzk- 1 xksyh 5.82 1213(अ) 25.03.2020
41 ,fefVªfIVykbu xksyh 75 fexzk- 1 xksyh 5.62 1213(अ) 25.03.2020
42 ,EyksfMikbu xksyh 10 fexzk- 1 xksyh 5.08 1213(अ) 25.03.2020
43 ,EyksfMikbu xksyh 2-5 fexzk- 1 xksyh 1.66 1213(अ) 25.03.2020
44 ,EyksfMikbu xksyh 5 fexzk- 1 xksyh 2.61 1213(अ) 25.03.2020
45 ,eksDlhflfyu dSIlwy 250 fexzk- 1 dSIlwy 2.21 1213(अ) 25.03.2020
46 ,eksDlhflfyu vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 1.35 1213(अ) 25.03.2020
47 ,eksDlhflfyu dSIlwy 500 fexzk- 1 dSIlwy 6.47 1213(अ) 25.03.2020
48 ,eksDlhflfyu ¼,½ $ MªkbZ flji 125 fexzk- ¼,½ $ 31-25 1 fefy- 2.17 1213(अ) 25.03.2020
Dykoqykfud ,flM ¼ch½ fexzk-¼ch½@5 fefy-
49 ,eksDlhflfyu ¼,½ $ vksjy fyD;wbZM 200 fexzzk-¼,½ $ 28- 1 fefy- 1.81 1213(अ) 25.03.2020
Dykoqykfud ,flM ¼ch½ 5 fexzk-¼ch½@5 fefy-16 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
50 ,eksDlhflfyu ¼,½ $ batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 90.24 1213(अ) 25.03.2020
Dykoqykfud ,flM ¼ch½ ¼,½ $ 100 fexzk- ¼ch½
51 ,eksDlhflfyu ¼,½ $ xksyh 500 fexzk- ¼,½ $ 125 fexzk- 1 xksyh 18.01 1213(अ) 25.03.2020
Dykoqykfud ,flM ¼ch½ ¼ch½
52 ,eksDlhflfyu ¼,½ $ batSD'ku ds fy, ikmMj 1 xzke ¼,½ izfr iSd 125.89 1213(अ) 25.03.2020
Dykoqykfud ,flM ¼ch½ $ 200 fexzk- ¼ch½
53 ,EQksVsfjflu ch ¼fyfiM½ batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 3213.07 1213(अ) 25.03.2020
54 ,EQksVsfjflu ch batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 7484.24 1213(अ) 25.03.2020
¼fyikslksey½
55 ,EQksVsfjflu batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 310.48 1213(अ) 25.03.2020
ch&dkWuosu'kuy
56 ,Eihflfyu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 21.39 1213(अ) 25.03.2020
57 ,Eihflfyu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 13.18 1213(अ) 25.03.2020
58 ,aVh&Mh bEequksXykscfqyu batSD'ku 300 ,elhth izfr iSd 2139.67 1213(अ) 25.03.2020
59 ,aVh&Mh bEequksXykscfqyu batSD'ku 150 ,elhth izfr ok;y 1667.80 1213(अ) 25.03.2020
60 ,aVh&jscht bEeuq ksXykscqfyu batSD'ku 150 vkbZ;w@fefy- 1 fefy- 2781.05 1213(अ) 25.03.2020
61 ,aVh&jscht bEeuq ksXykscqfyu batSD'ku 300 vkbZ;w@fefy- 1 fefy- 98.04 1213(अ) 25.03.2020
62 ,aVh&VsVul 250 vkbZ;w izfr iSd 1113.99 1213(अ) 25.03.2020
bEequksXykscqfyu
63 vlsfZud VªhvkWDlkbM batSD'ku 1 fexzk-@fefy- 1 fefy- 54.43 1213(अ) 25.03.2020
64 vVseZ Fs kj ¼,½ $yqesQkVªhu vksjy fyD;wbZM 80 fexzzk-¼,½ $ 480 1 fefy- 4.04 1213(अ) 25.03.2020
¼ch½ fexzk-¼ch½@5 fefy-
65 vVseZ Fs kj ¼,½ $yqesQkVªhu xksyh 20 fexzk- ¼,½ $ 120 fexzk- 1 xksyh 12.55 1213(अ) 25.03.2020
¼ch½ ¼ch½
66 vVseZ Fs kj ¼,½ $yqesQkVªhu xksyh 40 fexzk- ¼,½ $ 240 fexzk- 1 xksyh 16.18 1213(अ) 25.03.2020
¼ch½ ¼ch½
67 vVseZ Fs kj ¼,½ $yqesQkVªhu xksyh 80 fexzk- ¼,½ $ 480 fexzk- 1 xksyh 23.22 1213(अ) 25.03.2020
¼ch½ ¼ch½
68 vVslZ quVs batSD'ku ds fy, ikmMj 120 fexzk- izfr iSd 417.13 1213(अ) 25.03.2020
69 vVslZ quVs batSD'ku ds fy, ikmMj 60 fexzk- izfr iSd 219.10 1213(अ) 25.03.2020
70 vVslZ quVs ¼,½ $ xksyh 100 fexzk- ¼,½ $ 1 xksyh ¼750 dksEch iSd 29.57 1213(अ) 25.03.2020
lYQkMkWDlhu & fexzk- $ 37-5 fexzk-½ ¼ch½
fifjeFs kkekbu ¼ch½
71 vVslZ quVs ¼,½ $ xksyh 150 fexzk- ¼,½ $ 2 xksyh ¼500 dksEch iSd 40.14 1213(अ) 25.03.2020
lYQkMkWDlhu & fexzk- $ 25 fexzk-½ ¼ch½
fifjeFs kkekbu ¼ch½
72 vVslZ quVs ¼,½ $ xksyh 200 fexzk- ¼,½ $ 2 xksyh ¼750 dksEch iSd 36.60 1213(अ) 25.03.2020
lYQkMkWDlhu & fexzk- $ 37-5 fexzk-½ ¼ch½
fifjeFs kkekbu ¼ch½
73 vVslZ quVs ¼,½ $ xksyh 25 fexzk- ¼,½ $ 1 xksyh ¼250 dksEch iSd 19.71 1213(अ) 25.03.2020
lYQkMkWDlhu & fexzk- $ 12-5 fexzk-½ ¼ch½
fifjeFs kkekbu ¼ch½
74 vVslZ quVs ¼,½ $ 1 xksyh 50 fexzk- ¼,½ $ 1 xksyh dksEch iSd 21.27 1213(अ) 25.03.2020
lYQkMkWDlhu & ¼500 fexzk $ 25 fexzk-½ ¼ch½
fifjeFs kkekbu ¼ch½
75 ,LdksfZcd ,flM ¼foVkfeu xksyh 100 fexzk- 1 xksyh 0.19 1213(अ) 25.03.2020
lh½
76 ,LdksfZcd ,flM ¼foVkfeu xksyh 500 fexzk- 1 xksyh 1.38 1213(अ) 25.03.2020
lh½
77 ,Vktsukohj ¼,½$fjVksusohj xksyh 300 fexzk- ¼,½ $ 100 fexzk- 1 xksyh 98.96 1213(अ) 25.03.2020
¼ch½ ¼ch½
78 ,Vsuksykys xksyh 100 fexzk- 1 xksyh 3.49 1213(अ) 25.03.2020
79 ,Vsuksykys xksyh 50 fexzk- 1 xksyh 1.79 1213(अ) 25.03.2020
80 ,VksjokLVkfVu xksyh 10 fexzk- 1 xksyh 5.50 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 17
81 ,VksjokLVkfVu xksyh 20 fexzk- 1 xksyh 13.32 1213(अ) 25.03.2020
82 ,VksjokLVkfVu xksyh 40 fexzk- 1 xksyh 19.34 1213(अ) 25.03.2020
83 ,VªkD;wfj;e batSD'ku 10 fexzk-@fefy- izfr iSd 52.55 1213(अ) 25.03.2020
84 ,Vªksikbu vksbVa esaV 1% 1 xzke 3.79 1213(अ) 25.03.2020
85 ,Vªksikbu batSD'ku 0-6 fexzk-@fefy- 1 fefy- 4.20 1213(अ) 25.03.2020
86 ,Vªksikbu MªksIl 1% 1 fefy- 3.44 1213(अ) 25.03.2020
87 ,tkfFk;ksihzu xksyh 50 fexzk- 1 xksyh 10.17 1213(अ) 25.03.2020
88 ,ftFkzksekblhu dSIlwy 250 fexzk- 1 dSIlwy 10.53 1213(अ) 25.03.2020
89 ,ftFkzksekblhu dSIlwy 500 fexzk- 1 dSIlwy 16.62 1213(अ) 25.03.2020
90 ,ftFkzksekblhu vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 3.09 1213(अ) 25.03.2020
91 ,ftFkzksekblhu xksyh 250 fexzk- 1 xksyh 10.58 1213(अ) 25.03.2020
92 ,ftFkzksekblhu xksyh 500 fexzk- 1 xksyh 21.34 1213(अ) 25.03.2020
93 ,ftFkzksekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 192.73 1213(अ) 25.03.2020
94 cSDyksQus xksyh 10 fexzk- 1 xksyh 10.78 1213(अ) 25.03.2020
95 cSDyksQus xksyh 20 fexzk- 1 xksyh 14.83 1213(अ) 25.03.2020
96 cSDyksQus xksyh 5 fexzk- 1 xksyh 5.55 1213(अ) 25.03.2020
97 chlhth oSDlhu izfr Mkst 8.96 1213(अ) 25.03.2020
98 cSatkfFku batSD'ku ds fy, ikmMj 12 yk[k izfr iSd 18.28 1213(अ) 25.03.2020
cSutkbZyisfuflfyu ;wfuV
99 cSatkfFku batSD'ku ds fy, ikmMj 6 yk[k izfr iSd 12.09 1213(अ) 25.03.2020
cSutkbZyisfuflfyu ;wfuV
100 csutks,y isjkDlkbM Øhe 2-5% 1 xzke 2.34 1213(अ) 25.03.2020
101 csutks,y isjkDlkbM tSy 2-5% 1 xzke 3.76 1213(अ) 25.03.2020
102 csutkby isfuflfyu batSD'ku ds fy, ikmMj 10 yk[k izfr iSd 7.82 1213(अ) 25.03.2020
;wfuV
103 chVkesFklksu Øhe 0-05% 1 xzke 0.58 1213(अ) 25.03.2020
104 chVkesFklksu Øhe 0-1% 1 xzke 0.84 1213(अ) 25.03.2020
105 chVkesFklksu tSy 0-05% 1 xzke 0.53 1213(अ) 25.03.2020
106 chVkesFklksu yks'ku 0-1% 1 fefy- 0.82 1213(अ) 25.03.2020
107 chVkesFklksu yks'ku 0-5% 1 fefy- 0.53 1213(अ) 25.03.2020
108 chVkesFklksu batSD'ku 4 fexzk-@fefy- 1 fefy- 4.21 1213(अ) 25.03.2020
109 fcdkyqVkekbM xksyh 50 fexzk- 1 xksyh 68.78 1213(अ) 25.03.2020
110 fclkdkWfMy lqIiksftVªh 5 fexzk- 1 lqIiksftVªh 8.46 1213(अ) 25.03.2020
111 fclkdkWfMy xksyh 5 fexzk- 1 xksyh 1.01 1213(अ) 25.03.2020
112 cys;ksekbflu batSD'ku ds fy, ikmMj 15 ;wfuV izfr iSd 622.26 1213(अ) 25.03.2020
113 cksVstZ kfec batSD'ku ds fy, ikmMj 2 fexzk- izfr iSd 12328.88 1213(अ) 25.03.2020
114 cqMslksukbM usty Lizs 100 ,elhth@Mkst 1 Mkst 0.91 1213(अ) 25.03.2020
115 cqMslksukbM usty Lizs 50 ,elhth@Mkst 1 Mkst 1.02 1213(अ) 25.03.202018 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
116 cqMslksukbM jslfijsVkWjh lksyq'ku QkWj ;wt bu 1 fefy- 10.74 1213(अ) 25.03.2020
uscqykbtj 0-5 fexzk-@fefy-
117 cqMslksukbM jslfijsVkWjh lksyq'ku QkWj ;wt bu 1 fefy- 12.95 1213(अ) 25.03.2020
uscqykbtj 1 fexzk-@fefy-
118 cqMslksukbM bugsys'ku ¼,eMhvkbZ½ 100 1.27 1213(अ) 25.03.2020
,elhth@Mkst
119 cqMslksukbM bugsys'ku ¼,eMhvkbZ½ 200 1.77 2292(अ) 10.07.2020
,elhth@Mkst
120 cqMslksukbM bugsys'ku ¼MhihvkbZ½ 100 2.00 1213(अ) 25.03.2020
,elhth@Mkst
121 cqMslksukbM bugsys'ku ¼MhihvkbZ½ 200 2.90 1213(अ) 25.03.2020
,elhth@Mkst
122 cqMslksukbM ¼,½ $ bugsys'ku ¼,eMhvkbZ½ 100 ,elhth 1.89 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
123 cqMslksukbM ¼,½ $ bugsys'ku ¼,eMhvkbZ½ 200 ,elhth 2.68 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
124 cqMslksukbM ¼,½ $ bugsys'ku ¼,eMhvkbZ½ 400 ,elhth 3.06 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
125 cqMslksukbM ¼,½ $ bugsys'ku ¼MhihvkbZ½ 100 ,elhth 3.80 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
126 cqMslksukbM ¼,½ $ bugsys'ku ¼MhihvkbZ½ 200 ,elhth 5.05 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
127 cqMslksukbM ¼,½ $ bugsys'ku ¼MhihvkbZ½ 400 ,elhth 6.45 1213(अ) 25.03.2020
QkseksVZ sjksy ¼ch½ ¼,½ $ 6 ,elhth ¼ch½
128 cqfiokdsu batSD'ku 0-25% 1 fefy- 2.46 1213(अ) 25.03.2020
129 cqfiokdsu batSD'ku 0-5% ds lkFk 7-5% 1 fefy- 6.22 1213(अ) 25.03.2020
Xywdkst
130 cqfiokdsu batSD'ku 0-50% 1 fefy- 3.93 1213(अ) 25.03.2020
131 dSQhu batSD'ku 20 fexzk-@fefy- 1 fefy- 251.61 1213(अ) 25.03.2020
132 dSQhu vksjy fyD;wbZM 20 fexzk-@fefy- 1 fefy- 213.70 1213(अ) 25.03.2020
133 dSykekbu yks'ku ¼vkbZih ds vuqlkj½ 1 fefy- 0.85 1213(अ) 25.03.2020
134 dSfY‖k;e dkWcksZusV Xksyh 500 fexzk- 1 xksyh 1.73 1213(अ) 25.03.2020
135 dSfY'k;e QkWyhusV xksyh 15 fexzk- 1 xksyh 40.89 1213(अ) 25.03.2020
136 dSfY'k;e XyqdksuVs batSD'ku 100 fexzk-@fefy- 1 fefy- 0.55 1213(अ) 25.03.2020
137 dSisflVkckbu xksyh 500 fexzk- 1 xksyh 126.69 1213(अ) 25.03.2020
138 dSizs;ksekbflu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 347.22 1213(अ) 25.03.2020
139 dkckZektkikbu vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.19 1213(अ) 25.03.2020
140 dkckZektkikbu lhvkj xksyh 200 fexzk- 1 xksyh 1.56 1213(अ) 25.03.2020
141 dkckZektkikbu lhvkj xksyh 400 fexzk- 1 xksyh 3.07 1213(अ) 25.03.2020
142 dkckZektkikbu xksyh 100 fexzk- 1 xksyh 0.68 1213(अ) 25.03.2020
143 dkckZektkikbu xksyh 200 fexzk- 1 xksyh 1.40 1213(अ) 25.03.2020
144 dkckZektkikbu xksyh 400 fexzk- 1 xksyh 3.31 1213(अ) 25.03.2020
145 dkfcZektksy xksyh 10 fexzk- 1 xksyh 3.71 1213(अ) 25.03.2020
146 dkfcZektksy xksyh 5 fexzk- 1 xksyh 1.91 1213(अ) 25.03.2020
147 dkcksZIykfVu batSD'ku 10 fexzk-@fefy- 1 fefy- 53.34 1213(अ) 25.03.2020
148 dkcksZDlhesFkhylsykykst MªksIl 0-5% 1 fefy- 12.81 1213(अ) 25.03.2020
149 dkcksZDlhesFkhylsykykst MªksIl 1% 1 fefy- 17.75 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 19
150 lsQkMªksDlhy dSIlwy 500 fexzk- 1 dSIlwy 7.17 1213(अ) 25.03.2020
151 lsQkMªksDlhy vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 0.63 1213(अ) 25.03.2020
152 lsQkMªksDlhy xksyh 1 xzke 1 xksyh 6.30 1213(अ) 25.03.2020
153 lsQkMªksDlhy xksyh 500 fexzk- 1 xksyh 4.04 1213(अ) 25.03.2020
154 lsQktksfyu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 24.61 1213(अ) 25.03.2020
155 lsQktksfyu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 15.60 1213(अ) 25.03.2020
156 lsfQDlhe dSIlwy 200 fexzk- 1 dSIlwy 14.47 1213(अ) 25.03.2020
157 lsfQDlhe dSIlwy 400 fexzk- 1 dSIlwy 29.31 1213(अ) 25.03.2020
158 lsfQDlhe vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 2.16 1213(अ) 25.03.2020
159 lsfQDlhe vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 1.46 1213(अ) 25.03.2020
160 lsfQDlhe xksyh 400 fexzk- 1 xksyh 22.12 1213(अ) 25.03.2020
161 lsfQDlhe xksyh 200 fexzk- 1 xksyh 9.62 1213(अ) 25.03.2020
162 lsQksVsDlkbe batSD'ku ds fy, ikmMj 1 xzke izfr iSd 34.40 1213(अ) 25.03.2020
163 lsQksVsDlkbe batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 15.64 1213(अ) 25.03.2020
164 lsQksVsDlkbe batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 20.57 1213(अ) 25.03.2020
165 lsQVkftMkbe batSD'ku ds fy, ikmMj 1 xzke izfr iSd 209.80 1213(अ) 25.03.2020
166 lsQVkftMkbe batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 65.25 1213(अ) 25.03.2020
167 lsQVªh;kDlksu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 54.04 1213(अ) 25.03.2020
168 lsQVªh;kDlksu batSD'ku ds fy, ikmMj 2 xzke izfr iSd 128.46 1213(अ) 25.03.2020
169 lsQVªh;kDlksu batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 24.74 1213(अ) 25.03.2020
170 lsQVªh;kDlksu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 45.19 1213(अ) 25.03.2020
171 lsfVªftu dSIlwy 10 fexzk- 1 dSIlwy 2.38 1213(अ) 25.03.2020
172 lsfVªftu vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.59 1213(अ) 25.03.2020
173 lsfVªftu xksyh 10 fexzk- 1 xksyh 1.66 1213(अ) 25.03.2020
174 lsfVªekbM lksy'q ku 20% ¼da'kuVªsV QkWj 1 fefy- 0.32 1213(अ) 25.03.2020
fMyq'ku½
175 Dyksjkecfqly xksyh 2 fexzk- 1 xksyh 37.00 1213(अ) 25.03.2020
176 Dyksjkecfqly xksyh 5 fexzk- 1 xksyh 83.14 1213(अ) 25.03.2020
177 DyksjgsDlkMhu lksy'q ku 5% ¼da'kuVªsV QkWj 1 fefy- 0.15 1213(अ) 25.03.2020
fMyq'ku½
178 DyksjksDohu vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 0.30 1213(अ) 25.03.2020
179 DyksjksDohu xksyh 150 fexzk- 1 xksyh 1.19 1213(अ) 25.03.2020
180 DyksjQsuhjkekbu xksyh 4 fexzk- 1 xksyh 0.09 1213(अ) 25.03.2020
181 dkWysdfsYlQsjksy dSIlwy 1000 vkbZ;w 1 dSIlwy 4.79 1213(अ) 25.03.2020
182 dkWysdfsYlQsjksy dSIlwy 60000 vkbZ;w 1 dSIlwy 29.60 1213(अ) 25.03.2020
183 dkWysdfsYlQsjksy vksjy fyD;wbZM 400 vkbZ;w@fefy- 1 fefy- 2.35 1213(अ) 25.03.2020
184 dkWysdfsYlQsjksy xksyh 1000 vkbZ;w 1 xksyh 3.76 1213(अ) 25.03.2020
185 dkWysdfsYlQsjksy xksyh 60000 vkbZ;w 1 xksyh 24.31 1213(अ) 25.03.2020
186 flizks¶yksDlkflu vksbVa esaV 0-3% 1 xzke 1.14 1213(अ) 25.03.2020
187 flizks¶yksDlkflu MªksIl 0-30% 1 fefy- 1.53 1213(अ) 25.03.202020 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
188 flizks¶yksDlkflu batSD'ku 200 fexzk-@100 fefy- 1 fefy- 0.17 1213(अ) 25.03.2020
189 flizks¶yksDlkflu vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.63 1213(अ) 25.03.2020
190 flizks¶yksDlkflu xksyh 250 fexzk- 1 xksyh 2.08 1213(अ) 25.03.2020
191 flizks¶yksDlkflu xksyh 500 fexzk- 1 xksyh 3.66 1213(अ) 25.03.2020
192 fllIysfVu batSD'ku 1 fexzk-@fefy- 1 fefy- 6.91 1213(अ) 25.03.2020
193 DysjhFkzksekblhu vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 4.32 1213(अ) 25.03.2020
194 DysjhFkzksekblhu xksyh 250 fexzk- 1 xksyh 28.07 1213(अ) 25.03.2020
195 DysjhFkzksekblhu xksyh 500 fexzk- 1 xksyh 49.47 1213(अ) 25.03.2020
196 DyhuMkekblhu dSIlwy 150 fexzk- 1 dSIlwy 14.51 1213(अ) 25.03.2020
197 DyhuMkekblhu dSIlwy 300 fexzk- 1 dSIlwy 23.69 1213(अ) 25.03.2020
198 DyhuMkekblhu xksyh 300 fexzk- 1 xksyh 15.28 1213(अ) 25.03.2020
199 Dykscktse xksyh 10 fexzk- 1 xksyh 9.06 1213(अ) 25.03.2020
200 Dykscktse xksyh 5 fexzk- 1 xksyh 5.15 1213(अ) 25.03.2020
201 DyksQkftekbu dSIlwy 100 fexzk- 1 dSIlwy 3.72 1213(अ) 25.03.2020
202 DyksQkftekbu dSIlwy 50 fexzk- 1 dSIlwy 2.18 1213(अ) 25.03.2020
203 DyksfeQsu dSIlwy 100 fexzk- 1 dSIlwy 55.80 1213(अ) 25.03.2020
204 DyksfeQsu dSIlwy 50 fexzk- 1 dSIlwy 30.69 1213(अ) 25.03.2020
205 DyksfeQsu xksyh 100 fexzk- 1 xksyh 12.25 1213(अ) 25.03.2020
206 DyksfeQsu xksyh 50 fexzk- 1 xksyh 8.34 1213(अ) 25.03.2020
207 Dyksehizkekbu xksyh 10 fexzk- 1 xksyh 2.52 1213(अ) 25.03.2020
208 Dyksehizkekbu xksyh 25 fexzk- 1 xksyh 5.56 1213(अ) 25.03.2020
209 Dyksehizkekbu xksyh 75 fexzk- 1 xksyh 14.38 1213(अ) 25.03.2020
210 Dyksuktsike xksyh 0-25 fexzk- 1 xksyh 1.83 1213(अ) 25.03.2020
211 Dyksuktsike xksyh 0-5 fexzk- 1 xksyh 3.12 1213(अ) 25.03.2020
212 Dyksuktsike xksyh 1 fexzk- 1 xksyh 4.24 1213(अ) 25.03.2020
213 DyksfiMksxzsy xksyh 75 fexzk- 1 xksyh 6.97 1213(अ) 25.03.2020
214 DyksfVªektksy Øhe 1% 1 xzke 2.92 1213(अ) 25.03.2020
215 DyksfVªektksy MªksIl 1% 1 fefy- 3.04 1213(अ) 25.03.2020
216 DyksfVªektksy yks'ku 1% 1 fefy- 3.59 1213(अ) 25.03.2020
217 DyksfVªektksy isljh 100 fexzk- 1 isljh 8.71 1213(अ) 25.03.2020
218 DyksDlkflfyu dSIlwy 250 fexzk- 1 dSIlwy 1.14 1213(अ) 25.03.2020
219 DyksDlkflfyu dSIlwy 500 fexzk- 1 dSIlwy 1.91 1213(अ) 25.03.2020
220 DyksDlkflfyu xksyh 250 fexzk- 1 xksyh 1.73 1213(अ) 25.03.2020
221 DyksDlkflfyu batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 4.45 1213(अ) 25.03.2020
222 Dykstkikbu xksyh 100 fexzk- 1 xksyh 7.76 1213(अ) 25.03.2020
223 Dykstkikbu xksyh 25 fexzk- 1 xksyh 2.52 1213(अ) 25.03.2020
224 Dykstkikbu xksyh 50 fexzk- 1 xksyh 4.82 1213(अ) 25.03.2020
225 dksxqys'ku QSDVj IX batSD'ku ds fy, ikmMj 600 vkbZ;w izfr iSd 12350.88 1213(अ) 25.03.2020
226 dksxs qys'ku QSDVj VIII batSD'ku ds fy, ikmMj 250 vkbZ;w izfr iSd 3744.09 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 21
227 dksxqys'ku QSDVj VIII batSD'ku ds fy, ikmMj 500 vkbZ;w izfr iSd 9187.72 1213(अ) 25.03.2020
228 dksyphflu xksyh 0-5 fexzk- 1 xksyh 3.12 1213(अ) 25.03.2020
229 dks&Vªk;eksDlktksy vksjy fyD;wbZM 200 fexzzk-¼,½ $ 40 1 fefy- 0.33 1213(अ) 25.03.2020
[lYQkesFkkWDlklsy fexzk- ¼ch½@5 fefy-
¼,½$VªheFs kksizhe ¼ch½]]
230 dks&Vªk;eksDlktksy xksyh 400 fexzk- ¼,½ $ 80 fexzk- 1 xksyh 0.78 1213(अ) 25.03.2020
[lYQkesFkkWDlklsy ¼ch½
¼,½$VªheFs kksizhe ¼ch½]]
231 dks&Vªk;eksDlktksy xksyh 800 fexzk- ¼,½ $ 160 fexzk- 1 xksyh 2.03 1213(अ) 25.03.2020
[lYQkesFkkWDlklsy ¼ch½
¼,½$VªheFs kksizhe ¼ch½]]
232 lkbDyksQkslQkekbM xksyh 50 fexzk- 1 xksyh 4.06 1213(अ) 25.03.2020
233 lkbDyksQkslQkekbM batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 80.01 1213(अ) 25.03.2020
234 lkbDykslfsju dSIlwy 250 fexzk- 1 dSIlwy 54.42 1213(अ) 25.03.2020
235 lkbDykslfsju xksyh 250 fexzk- 1 xksyh 46.79 1213(अ) 25.03.2020
236 lkbDyksLiksfju dSIlwy 100 fexzk- 1 dSIlwy 102.75 1213(अ) 25.03.2020
237 lkbDyksLiksfju dSIlwy 25 fexzk- 1 dSIlwy 27.58 1213(अ) 25.03.2020
238 lkbDyksLiksfju dSIlwy 50 fexzk- 1 dSIlwy 52.77 1213(अ) 25.03.2020
239 lkbDyksLiksfju batSD'ku 50 fexzk-@fefy- 1 fefy- 270.37 1213(अ) 25.03.2020
240 lkbDyksLiksfju vksjy fyD;wbZM 100 fexzk-@fefy- 1 fefy- 94.75 1213(अ) 25.03.2020
241 lkbVksflu vfcZukslkbM batSD'ku 100 fexzk-@fefy- izfr iSd 199.15 1213(अ) 25.03.2020
242 lkbVksflu vfcZukslkbM batSD'ku ds fy, ikmMj 1000 fexzk- izfr iSd 1074.14 1213(अ) 25.03.2020
243 lkbVksflu vfcZukslkbM batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 513.39 1213(अ) 25.03.2020
244 MkdkckZftu batSD'ku ds fy, ikmMj 200 fexzk- izfr iSd 440.38 1213(अ) 25.03.2020
245 MkdkckZftu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 993.45 1213(अ) 25.03.2020
246 Msilksu xksyh 100 fexzk- 1 xksyh 0.36 1213(अ) 25.03.2020
247 Mk:ukohj xksyh 600 fexzk- 1 xksyh 167.32 1213(अ) 25.03.2020
248 MkSuk:fclhu I.V. batSD'ku ds fy, ikmMj 20 izfr iSd 243.77 1213(अ) 25.03.2020
fexzk- ¼5 fexzk-@fefy-½
249 MslQsjhvksDlkekbu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 161.20 1213(अ) 25.03.2020
250 MsDlkesFkklksu xksyh 0-5 fexzk- 1 xksyh 0.19 1213(अ) 25.03.2020
251 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 13.80 1213(अ) 25.03.2020
¼10 fefy-½
252 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 9.34 1213(अ) 25.03.2020
¼2 fefy-½
253 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 26.46 1213(अ) 25.03.2020
¼20 fefy-½
254 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 35.36 1213(अ) 25.03.2020
¼30 fefy-½
255 MsDlkVªku&40 batSD'ku 10% 1 fefy- 0.85 1213(अ) 25.03.2020
256 Mk;tsike batSD'ku 5 fexzk-@fefy- 1 fefy- 6.07 1213(अ) 25.03.2020
257 Mk;tsike vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 2.74 1213(अ) 25.03.2020
258 Mk;tsike lqIiksftVªh 5 fexzk- 1 lqIiksftVªh 5.99 1213(अ) 25.03.2020
259 Mk;tsike xksyh 2 fexzk- 1 xksyh 1.51 1213(अ) 25.03.2020
260 Mk;tsike xksyh 5 fexzk- 1 xksyh 1.43 1213(अ) 25.03.202022 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
261 fMDyksQus d dSIlwy 50 fexzk- 1 dSIlwy 0.61 1213(अ) 25.03.2020
262 fMDyksQus d batSD'ku 25 fexzk-@fefy- 1 fefy- 1.47 1213(अ) 25.03.2020
263 fMDyksQus d xksyh 50 fexzk- 1 xksyh 1.92 1213(अ) 25.03.2020
264 fMlkbDyksekbu batSD'ku 10 fexzk-@fefy-¼10 fefy- 1 fefy- 2.06 1213(अ) 25.03.2020
,aM 30 fefy- iSd½
265 fMlkbDyksekbu batSD'ku 10 fexzk-@fefy-¼1fefy- ,aM 1 fefy- 3.20 1213(अ) 25.03.2020
2 fefy- iSd½
266 fMlkbDyksekbu vksjy lksyq'ku 10 fexzk-@5 fefy- 1 fefy- 0.16 1213(अ) 25.03.2020
267 fMlkbDyksekbu xksyh 10 fexzk- 1 xksyh 0.11 1213(अ) 25.03.2020
268 MkbZbFkk;ydkckZestkbu vksjy fyD;wbZM 120 fexzk-@5 fefy- 1 fefy- 0.49 1213(अ) 25.03.2020
269 MkbZbFkk;ydkckZestkbu xksyh 100 fexzk- 1 xksyh 1.42 1213(अ) 25.03.2020
270 MkbZbFkk;ydkckZestkbu xksyh 50 fexzk- 1 xksyh 0.56 1213(अ) 25.03.2020
271 MkbxksfDlu batSD'ku 0-25 fexzk-@fefy- 1 fefy- 3.34 1213(अ) 25.03.2020
272 MkbxksfDlu vksjy fyD;wbZM 0-05 fexzk-@ fefy- 1 fefy- 1.27 1213(अ) 25.03.2020
273 MkbxksfDlu xksyh 0-25 fexzk- 1 xksyh 1.20 1213(अ) 25.03.2020
274 MkbyksDlkukbM Qwjks,V xksyh 500 fexzk- 1 xksyh 1.06 1213(अ) 25.03.2020
275 MkbyfV;ktse dSIlwy 90 fexzk- 1 dSIlwy 9.63 1213(अ) 25.03.2020
276 MkbyfV;ktse batSD'ku 5 fexzk-@fefy- 1 fefy- 3.17 1213(अ) 25.03.2020
277 MkbyfV;ktse ,lvkj xksyh 90 fexzk- 1 xksyh 9.35 1213(अ) 25.03.2020
278 MkbyfV;ktse xksyh 30 fexzk- 1 xksyh 2.40 1213(अ) 25.03.2020
279 MkbyfV;ktse xksyh 60 fexzk- 1 xksyh 4.90 1213(अ) 25.03.2020
280 fMejs dkizksy batSD'ku 50 fexzk-@fefy- 1 fefy- 200.62 1213(अ) 25.03.2020
281 MkbuksizksLVksu tSy 0-5 fexzk- 1 xzke 81.26 1213(अ) 25.03.2020
282 MkbuksizksLVkus xksyh 0-5 fexzk- 1 xksyh 50.17 1213(अ) 25.03.2020
283 MkbQFksfj;k ,VhaVksDlhu 10000 vkbZ;w izfr iSd 1313.77 1213(अ) 25.03.2020
284 MkscqVkekbu batSD'ku 50 fexzk-@fefy- izfr iSd 37.59 1213(अ) 25.03.2020
285 MkslsVkDlsy batSD'ku ds fy, ikmMj 20 fexzk- izfr iSd 3000.60 1213(अ) 25.03.2020
286 MkslsVkDlsy batSD'ku ds fy, ikmMj 80 fexzk- izfr iSd 11408.49 1213(अ) 25.03.2020
287 MkseisfjMksu vksjy fyD;wbZM 1 fexzk-@fefy- 1 fefy- 1.08 1213(अ) 25.03.2020
288 MkseisfjMksu xksyh 10 fexzk- 1 xksyh 2.42 1213(अ) 25.03.2020
289 Mksusits kby xksyh 10 fexzk- 1 xksyh 16.09 1213(अ) 25.03.2020
290 Mksusits kby xksyh 5 fexzk- 1 xksyh 11.27 1213(अ) 25.03.2020
291 Mksikekbu batSD'ku 40 fexzk-@fefy- 1 fefy- 5.66 1213(अ) 25.03.2020
292 MksDlks:fclhu batSD'ku 2 fexzk-@fefy- 1 fefy- 35.99 1213(अ) 25.03.2020
293 MksDlhlkblyhu dSIlwy 100 fexzk- 1 dSIlwy 2.51 1213(अ) 25.03.2020
294 MksDlhlkblyhu xksyh 100 fexzk- 1 xksyh 0.98 1213(अ) 25.03.2020
295 MhihVh$fgc$gsi ch oSDlhu izfr 0-1 80.51 1213(अ) 25.03.2020
fefy-
296 MhihVh oSDlhu izfr 0-5 14.20 1213(अ) 25.03.2020
fefy-
297 bQkohjsta dSIlwy 200 fexzk- 1 dSIlwy 24.13 1213(अ) 25.03.2020
298 bQkohjsta dSIlwy 600 fexzk- 1 dSIlwy 62.88 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 23
299 bQkohjsta xksyh 200 fexzk- 1 xksyh 22.73 1213(अ) 25.03.2020
300 bQkohjsta xksyh 600 fexzk- 1 xksyh 71.19 1213(अ) 25.03.2020
301 bukykizhy xksyh 2-5 fexzk- 1 xksyh 1.94 1213(अ) 25.03.2020
302 bukykizhy xksyh 5 fexzk- 1 xksyh 3.22 1213(अ) 25.03.2020
303 buksDlkikfju batSD'ku 40 fexzk-@0-4 fefy- 0-1 fefy- 101.89 1213(अ) 25.03.2020
304 buksDlkikfju batSD'ku 60 fexzk-@0-6 fefy- 0-1 fefy- 101.89 1213(अ) 25.03.2020
305 buVsdkohj xksyh 0-5 fexzk- 1 xksyh 79.98 1213(अ) 25.03.2020
306 buVsdkohj xksyh 1 fexzk- 1 xksyh 127.08 1213(अ) 25.03.2020
307 ,fjFkzksiksbVhu batSD'ku 10000 vkbZ;w@fefy- izfr iSd 2607.78 1213(अ) 25.03.2020
308 ,fjFkzksiksbVhu batSD'ku 2000 vkbZ;w@fefy- izfr iSd 617.66 1213(अ) 25.03.2020
309 blhVkyksikze xksyh 10 fexzk- 1 xksyh 8.12 1213(अ) 25.03.2020
310 blhVkyksikze xksyh 20 fexzk- 1 xksyh 12.83 1213(अ) 25.03.2020
311 blhVkyksikze xksyh 5 fexzk- 1 xksyh 4.57 1213(अ) 25.03.2020
312 bleksyksy batSD'ku 10 fexzk-@fefy- 1 fefy- 21.72 1213(अ) 25.03.2020
313 bFkkecqVksy xksyh 200 fexzk- 1 xksyh 1.06 1213(अ) 25.03.2020
314 bFkkecqVksy xksyh 400 fexzk- 1 xksyh 2.40 1213(अ) 25.03.2020
315 bFkkecqVksy xksyh 600 fexzk- 1 xksyh 3.55 1213(अ) 25.03.2020
316 bFkkecqVksy xksyh 800 fexzk- 1 xksyh 4.24 1213(अ) 25.03.2020
317 bFkhuysLVkMhvksy xksyh 0-01 fexzk- 1 xksyh 2.35 1213(अ) 25.03.2020
318 bFkhuysLVkMhvksy xksyh 0-05 fexzk- 1 xksyh 3.76 1213(अ) 25.03.2020
319 bFkhuysLVkMhvksy xksyh 0-03 fexzk- ¼,½ $ 0-15 fexzk 1 xksyh 3.46 1213(अ) 25.03.2020
¼,½$ysoksuksxLsZ Vªsy ¼ch½ ¼ch½
320 bFkhukekbM xksyh 250 fexzk- 1 xksyh 15.82 1213(अ) 25.03.2020
321 bFkkbZy ,Ydksgy lksY;q'ku 70 izfr'kr 1 fefy- 0.42 1213(अ) 25.03.2020
¼MhuspjM½
322 bVksikslkbM dSIlwy 50 fexzk- 1 dSIlwy 54.50 1213(अ) 25.03.2020
323 bVksikslkbM batSD'ku 20 fexzk-@fefy- 1 fefy- 35.94 1213(अ) 25.03.2020
324 QsuVkukby batSD'ku 50 ,elhth@fefy- 1 fefy- 22.76 1213(अ) 25.03.2020
325 Qsjl lkYV ¼,½ $ Qksfyd Xkksyh 100 fexzk- byhesuVy vk;ju 1 xksyh 0.23 1213(अ) 25.03.2020
,flM ¼ch½ ¼,½ $ 500 ,elhth ¼ch½
326 fQyxkzLVhe batSD'ku 300 ,elhth izfr iSd 1375.63 1213(अ) 25.03.2020
327 ¶ywdksuktksy dSIlwy 100 fexzk- 1 dSIlwy 25.33 1213(अ) 25.03.2020
328 ¶ywdksuktksy dSIlwy 150 fexzk- 1 dSIlwy 18.59 1213(अ) 25.03.2020
329 ¶ywdksuktksy dSIlwy 200 fexzk- 1 dSIlwy 36.60 1213(अ) 25.03.2020
330 ¶ywdksuktksy vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 2.62 1213(अ) 25.03.2020
331 ¶ywdksuktksy xksyh 100 fexzk- 1 xksyh 8.00 1213(अ) 25.03.2020
332 ¶ywdksuktksy xksyh 150 fexzk- 1 xksyh 11.87 1213(अ) 25.03.2020
333 ¶ywdksuktksy xksyh 200 fexzk- 1 xksyh 18.83 1213(अ) 25.03.2020
334 ¶ywdksuktksy xksyh 400 fexzk- 1 xksyh 31.32 1213(अ) 25.03.2020
335 ¶ywdksuktksy batSD'ku 200 fexzk-@100 fefy- izfr iSd 106.68 1213(अ) 25.03.2020
336 ¶ywukfjtkbu xksyh 10 fexzk- 1 xksyh 4.75 1213(अ) 25.03.202024 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
337 ¶ywukfjtkbu xksyh 5 fexzk- 1 xksyh 2.76 1213(अ) 25.03.2020
338 ¶ywDlsVkbu dSIlwy 10 fexzk- 1 dSIlwy 2.98 1213(अ) 25.03.2020
339 ¶ywDlsVkbu dSIlwy 20 fexzk- 1 dSIlwy 3.66 1213(अ) 25.03.2020
340 ¶ywDlsVkbu dSIlwy 40 fexzk- 1 dSIlwy 5.55 1213(अ) 25.03.2020
341 ¶ywDlsVkbu dSIlwy 60 fexzk- 1 dSIlwy 9.81 1213(अ) 25.03.2020
342 ¶ywDlsVkbu xksyh 10 fexzk- 1 xksyh 2.50 1213(अ) 25.03.2020
343 ¶ywDlsVkbu xksyh 20 fexzk- 1 xksyh 3.97 1213(अ) 25.03.2020
344 ¶ywDlsVkbu xksyh 40 fexzk- 1 xksyh 5.35 1213(अ) 25.03.2020
345 ¶ywDlsVkbu xksyh 60 fexzk- 1 xksyh 7.42 1213(अ) 25.03.2020
346 ¶ywQsuktkbu fMiksV batSD'ku 25 fexzk-@fefy- 1 fefy- 50.15 1213(अ) 25.03.2020
347 Qksfyd ,flM dSIlwy 5 fexzk- 1 dSIlwy 5.65 1213(अ) 25.03.2020
348 Qksfyd ,flM xksyh 5 fexzk- 1 xksyh 1.40 1213(अ) 25.03.2020
349 Qqjksles kbM vksjy fyD;wbZM 10 fexzk-@fefy- 1 fefy- 2.77 1213(अ) 25.03.2020
350 Qqjksles kbM xksyh 40 fexzk- 1 xksyh 0.75 1213(अ) 25.03.2020
351 Qqjksles kbM batSD'ku 10 fexzk-@fefy- 1 fefy- 2.49 1213(अ) 25.03.2020
352 QqflfMd ,flM Øhe 2% 1 xzke 9.15 1213(अ) 25.03.2020
353 xkMkscsusV batSD'ku 529 fexzk-@fefy- 1 fefy- 109.25 1213(अ) 25.03.2020
354 xkulhDyksohj dSIlwy 250 fexzk- 1 dSIlwy 120.51 1213(अ) 25.03.2020
355 xkulhDyksohj batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 1691.68 1213(अ) 25.03.2020
356 tsfQfVfuc xksyh 250 fexzk- 1 xksyh 429.64 1213(अ) 25.03.2020
357 tseflVkckbu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 5318.10 1213(अ) 25.03.2020
358 tseflVkckbu batSD'ku ds fy, ikmMj 200 fexzk- izfr iSd 1174.50 1213(अ) 25.03.2020
359 tsVa kekbflu MªksIl 0-3% 1 fefy- 0.91 1213(अ) 25.03.2020
360 tsVa kekbflu batSD'ku 10 fexzk-@fefy- 1 fefy- 3.19 1213(अ) 25.03.2020
361 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 18.01 1213(अ) 25.03.2020
¼10 fefy-½
362 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 8.44 1213(अ) 25.03.2020
¼2 fefy-½
363 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 27.30 1213(अ) 25.03.2020
¼20 fefy-½
364 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 29.88 1213(अ) 25.03.2020
¼30 fefy-½
365 XyhehfijkbM xksyh 1 fexzk- 1 xksyh 3.60 1213(अ) 25.03.2020
366 XyhehfijkbM xksyh 2 fexzk- 1 xksyh 5.72 1213(अ) 25.03.2020
367 Xywdkst batSD'ku 25% 1 fefy- 0.17 1213(अ) 25.03.2020
368 Xywdkst batSD'ku 50% 1 fefy- 0.49 1213(अ) 25.03.2020
369 Xywdkst batSD'ku 5% 1000 fefy- 64.38 1213(अ) 25.03.2020
Xykl
370 Xywdkst batSD'ku 5% 1000 fefy- 51.97 1213(अ) 25.03.2020
ukWu Xykl
371 Xywdkst batSD'ku 5% 100 fefy- 18.07 1213(अ) 25.03.2020
Xykl
372 Xywdkst batSD'ku 5% 100 fefy- 16.36 1213(अ) 25.03.2020
ukWu Xykl
373 Xywdkst batSD'ku 5% 250 fefy- 24.97 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 25
Xykl
374 Xywdkst batSD'ku 5% 250 fefy- 22.56 1213(अ) 25.03.2020
ukWu Xykl
375 Xywdkst batSD'ku 5% 500 fefy- 35.44 1213(अ) 25.03.2020
Xykl
376 Xywdkst batSD'ku 5% 500 fefy- 30.58 1213(अ) 25.03.2020
ukWu Xykl
377 Xywdkst batSD'ku 10% izfr iSd 25.89 1213(अ) 25.03.2020
¼1000 fefy-
½
378 Xywdkst batSD'ku 10% izfr iSd 28.16 1213(अ) 25.03.2020
¼500 fefy-½
379 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- 64.80 1213(अ) 25.03.2020
DyksjkbM ¼ch½ Xykl
380 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- 52.36 1213(अ) 25.03.2020
DyksjkbM ¼ch½ ukWu Xykl
381 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- 18.12 1213(अ) 25.03.2020
DyksjkbM ¼ch½ Xykl
382 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- 16.38 1213(अ) 25.03.2020
DyksjkbM ¼ch½ ukWu Xykl
383 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 250 fefy- 25.07 1213(अ) 25.03.2020
DyksjkbM ¼ch½ Xykl
384 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9%¼ch½ 250 fefy- 22.64 1213(अ) 25.03.2020
DyksjkbM ¼ch½ ukWu Xykl
385 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- 35.62 1213(अ) 25.03.2020
DyksjkbM ¼ch½ Xykl
386 Xywdkst ¼,½ $ lksfM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- 30.77 1213(अ) 25.03.2020
DyksjkbM ¼ch½ ukWu Xykl
387 XywVkjkyMsgkbM lksy'q ku 2% 1 fefy- 0.06 1213(अ) 25.03.2020
388 fXyljhu vkjs y fyD;wbZM 1 fefy- 0.15 1213(अ) 25.03.2020
389 fXyljkby VªkbZfuVªsV batSD'ku 5 fexzk-@fefy- 1 fefy- 6.58 1213(अ) 25.03.2020
390 fXyljkby VªkbZfuVªsV lcfyaxq,y xksyh 0-5 fexzk- 1 xksyh 1.81 1213(अ) 25.03.2020
391 XykbdksikbjksyVs batSD'ku 0-2 fexzk-@fefy- 1 fefy- 12.32 1213(अ) 25.03.2020
392 xzhlksQqyfou xksyh 125 fexzk- 1 xksyh 0.82 1213(अ) 25.03.2020
393 xzhlksQqyfou xksyh 250 fexzk- 1 xksyh 1.60 1213(अ) 25.03.2020
394 xzhlksQqyfou xksyh 375 fexzk- 1 xksyh 4.31 1213(अ) 25.03.2020
395 gseksMk;ylhl ¶ywM ykblsal ds vuqlkj 1 fefy- 0.04 1213(अ) 25.03.2020
396 gsyksisfjMksy batSD'ku 5 fexzk-@fefy- 1 fefy- 5.84 1213(अ) 25.03.2020
397 gsyksisfjMksy vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 2.06 1213(अ) 25.03.2020
398 gsyksisfjMksy xksyh 1-5 fexzk- 1 xksyh 1.66 1213(अ) 25.03.2020
399 gsyksisfjMksy xksyh 10 fexzk- 1 xksyh 4.42 1213(अ) 25.03.2020
400 gsyksisfjMksy xksyh 20 fexzk- 1 xksyh 4.94 1213(अ) 25.03.2020
401 gsyksisfjMksy xksyh 5 fexzk- 1 xksyh 3.45 1213(अ) 25.03.2020
402 gsyksFksu bugsy's ku 1 fefy- 5.87 1213(अ) 25.03.2020
403 gsikfju batSD'ku 1000 vkbZ;w@fefy- 1 fefy- 16.35 1213(अ) 25.03.2020
404 gsikfju batSD'ku 5000 vkbZ;w@fefy- 1 fefy- 40.58 1213(अ) 25.03.2020
405 gsikVkbfVl ch izfr iSd 5521.66 1213(अ) 25.03.2020
bEequksXykscqfyu
406 gSikVkbfVl ch oSDlhu 1 fefy- 78.50 1213(अ) 25.03.2020
407 gksekVªksikbu MªksIl 2% 1 fefy- 6.22 1213(अ) 25.03.202026 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
408 gkeksZu fjfyftax vkbZ;wMh bleas 52 fexzk- ysoksuksxsZLVsªy 'kkfey 1 vkbZ;wMh 3877.55 1213(अ) 25.03.2020
gS
409 g~;qeu dksfjvksfud batSD'ku 1000 vkbZ;w izfr iSd 213.04 1213(अ) 25.03.2020
xksukMksVªksfiu
410 g~;qeu dksfjvksfud batSD'ku 5000 vkbZ;w izfr iSd 418.37 1213(अ) 25.03.2020
xksukMksVªksfiu
411 g~;qeu ukWeZy lksyq'ku QkWj buQ~;wtu 5 izfr'kr 1 fefy- 154.65 1213(अ) 25.03.2020
bEequksXykscqfyu
412 g~;qeu ukWeZy lksyq'ku QkWj buQ~;wtu 10 1 fefy- 209.38 1213(अ) 25.03.2020
bEequksXykscqfyu izfr‖kr
413 g~;qeu ukWeZy lksyq'ku QkWj buQ~;wtu 16.5 1 fefy- 381.87 1241(अ) 03.04.2020
bEequksXykscqfyu izfr'kr
414 gkbMªksDyksjksFkkbtkbM xksyh 12-5 fexzk- 1 xksyh 0.99 1213(अ) 25.03.2020
415 gkbMªksDyksjksFkkbtkbM xksyh 25 fexzk- 1 xksyh 1.69 1213(अ) 25.03.2020
416 gkbMªksDyksjksFkkbtkbM xksyh 50 fexzk- 1 xksyh 0.08 1213(अ) 25.03.2020
417 gkbMªksdksVhZlksu xksyh 10 fexzk- 1 xksyh 5.90 1213(अ) 25.03.2020
418 gkbMªksdksVhZlksu xksyh 5 fexzk- 1 xksyh 3.04 1213(अ) 25.03.2020
419 gkbMªksdksVhZlksu batSD'ku 100 fexzk- izfr iSd 39.01 1213(अ) 25.03.2020
420 gkbMªksdksVhZlksu batSD'ku 200 fexzk- izfr iSd 60.14 1213(अ) 25.03.2020
421 gkbMªksdksVhZlksu batSD'ku ds fy, ikmMj 100 fexzk- izfr iSd 39.01 1213(अ) 25.03.2020
422 gkbMªkstu isjksDlkbM lksy'q ku 6% 1 fefy- 0.04 1213(अ) 25.03.2020
423 gkbMªksDlhDyksjksDohu xksyh 200 fexzk- 1 xksyh 5.94 1213(अ) 25.03.2020
424 gkbMªksDlhDyksjksDohu xksyh 400 fexzk- 1 xksyh 11.97 1213(अ) 25.03.2020
425 gkbMªksDlhizksikby batSD'ku 2% 1 fefy- 37.59 1213(अ) 25.03.2020
eFs kkbylsyqykst
426 gkbMªksDlh;wfj;k dSIlwy 500 fexzk- 1 dSIlwy 12.85 1213(अ) 25.03.2020
427 gk;kslhu cqVhyczksekbM batSD'ku 20 fexzk-@fefy- 1 fefy- 10.46 1213(अ) 25.03.2020
428 gk;kslhu cqVhyczksekbM xksyh 10 fexzk- 1 xksyh 2.98 1213(अ) 25.03.2020
429 vkbZcqizksQuq dSIlwy 400 fexzk- 1 dSIlwy 1.06 1213(अ) 25.03.2020
430 vkbZcqizksQuq dSIlwy 200 fexzk- 1 lkWQ~V 2.68 1213(अ) 25.03.2020
tsyVs kbu
dSIlwy
431 vkbZcqizksQuq xksyh 200 fexzk- 1 xksyh 0.39 1213(अ) 25.03.2020
432 vkbZcqizksQuq xksyh 400 fexzk- 1 xksyh 0.69 1213(अ) 25.03.2020
433 vkbZcqizksQuq vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.19 1213(अ) 25.03.2020
434 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 1 xzke izfr iSd 362.72 1213(अ) 25.03.2020
435 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 2 xzke izfr iSd 952.09 1213(अ) 25.03.2020
436 befsVuhc dSIlwy 100 fexzk- 1 dSIlwy 77.82 1213(अ) 25.03.2020
437 befsVuhc dSIlwy 400 fexzk- 1 dSIlwy 256.04 1213(अ) 25.03.2020
438 befsVuhc xksyh 100 fexzk- 1 xksyh 79.61 1213(अ) 25.03.2020
439 befsVuhc xksyh 400 fexzk- 1 xksyh 230.47 1213(अ) 25.03.2020
440 balqfyu ¼lksycq y½ batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.09 1213(अ) 25.03.2020
441 baVjesfM,V ,fDVax batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.09 1213(अ) 25.03.2020
¼,uih,p½ balqfyu
442 bvksgsDlksy batSD'ku 300 fexzk- vk;ksfMu@fefy- 1 fefy- 16.67 1213(अ) 25.03.2020
443 vkbZizkVªksfi;e bugsy's ku ¼,eMhvkbZ@MhihvkbZ½ 20 1 Mkst 0.61 1213(अ) 25.03.2020
,elhth@Mkst[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 27
444 vkbZizkVªksfi;e jslfijsVkWjh lksyq'ku QkWj ;wt bu 1 fefy- 2.54 1213(अ) 25.03.2020
uscqykbtj 250 ,elhth@fefy-
445 vk;ju lqØkst batSD'ku 20 fexzk-@fefy- 1 fefy- 53.88 1213(अ) 25.03.2020
446 vkbZlks¶yjq su bugsy's ku 1 fefy- 10.48 1213(अ) 25.03.2020
447 vkbZlksfuftM xksyh 100 fexzk- 1 xksyh 0.68 1213(अ) 25.03.2020
448 vkbZlksfuftM xksyh 300 fexzk- 1 xksyh 1.20 1213(अ) 25.03.2020
449 vkbZlkslksfcZM 5 eksuksuhVªsV xksyh 20 fexzk- 1 xksyh 3.29 1213(अ) 25.03.2020
450 vkbZlkslksfcZM fMfuVªsV xksyh 10 fexzk- 1 xksyh 0.73 1213(अ) 25.03.2020
451 vkbZlkslksfcZM fMfuVªsV xksyh 5 fexzk- 1 xksyh 0.75 1213(अ) 25.03.2020
452 vkbZlkslksfcZM 5 & ,lvkj dSIlwy 30 fexzk- 1 dSIlwy 3.51 1213(अ) 25.03.2020
eksuksuhVªsV
453 vkbZlkslksfcZM 5 & ,lvkj dSIlwy 60 fexzk- 1 dSIlwy 3.49 1213(अ) 25.03.2020
eksuksuhVªsV
454 vkbZlkslksfcZM 5 & ,lvkj xksyh 30 fexzk- 1 xksyh 4.91 1213(अ) 25.03.2020
eksuksuhVªsV
455 vkbZlkslksfcZM 5 & ,lvkj xksyh 60 fexzk- 1 xksyh 6.40 1213(अ) 25.03.2020
eksuksuhVªsV
456 vkbZlkslksfcZM 5 & xksyh 10 fexzk- 1 xksyh 1.97 1213(अ) 25.03.2020
eksuksuhVªsV
457 bLik?kqyk xzsU;wyl@gLd@ikmMj 1 xzke 0.77 1213(अ) 25.03.2020
458 vkbZ;wMh daVsfauax dkWij ykblsal ds :i esa 1 vkbZ;wMh 288.19 1213(अ) 25.03.2020
459 tkiuht bulsQkfyfVl 4 ,elhth ls 6 ,elhth izfr iSd 699.24 1213(अ) 25.03.2020
oSDlhu
460 tkiuht bulsQkfyfVl 3 ,elhth rd izfr iSd 532.72 1213(अ) 25.03.2020
oSDlhu
461 dSukekblhu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 39.20 1213(अ) 25.03.2020
462 dSukekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 21.38 1213(अ) 25.03.2020
463 dSukekblhu batSD'ku ds fy, ikmMj 750 fexzk- izfr iSd 36.53 1213(अ) 25.03.2020
464 dSVkekbu batSD'ku 10 fexzk-@fefy- 1 fefy- 10.62 1213(अ) 25.03.2020
465 dSVkekbu batSD'ku 50 fexzk-@fefy- 1 fefy- 10.48 1213(अ) 25.03.2020
466 yscVs kyksy batSD'ku 5 fexzk-@fefy- 1 fefy- 50.81 1213(अ) 25.03.2020
467 ySDVksykst vksjy fyD;wbZM 10 xzke@15 fefy- 1 fefy- 1.10 1213(अ) 25.03.2020
468 ysfeoqMkbu ¼,½ xksyh 150 fexzk- ¼,½ $ 200 fexzk- 1 xksyh 15.64 1213(अ) 25.03.2020
$usfojkikbu ¼ch½ ¼ch½ $ 30 fexzk- ¼lh½
$LVkoqMkbu ¼lh½
469 ysfeoqMkbu ¼,½ $ xksyh 150 fexzk- ¼,½ $ 300 fexzk- 1 xksyh 20.11 1213(अ) 25.03.2020
ftMkscqMkbu ¼ch½ ¼ch½
470 ysfeoqMkbu ¼,½ fMLizsflcy xksyh 30 fexzk- ¼,½ $ 1 xksyh 4.96 1213(अ) 25.03.2020
$usfojkikbu ¼ch½ 50 fexzk-¼ch½ $ 6 fexzk- ¼lh½
$LVkoqMkbu ¼lh½
471 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj 10000 ds;w izfr iSd 1609.22 1213(अ) 25.03.2020
472 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj 5000 ds;w izfr iSd 1038.73 1213(अ) 25.03.2020
473 ys¶yquksekbM xksyh 10 fexzk- 1 xksyh 10.03 1213(अ) 25.03.2020
474 ys¶yquksekbM xksyh 20 fexzk- 1 xksyh 19.58 1213(अ) 25.03.2020
475 ysVªkstksy xksyh 2-5 fexzk- 1 xksyh 40.87 1213(अ) 25.03.2020
476 ysofsVjklsVe batSD'ku 100 fexzk-@fefy- 1 fefy- 21.87 1213(अ) 25.03.2020
477 ysofsVjklsVe bZvkj xksyh 750 fexzk- 1 xksyh 17.43 1213(अ) 25.03.2020
478 ysofsVjklsVe xksyh 250 fexzk- 1 xksyh 5.86 1213(अ) 25.03.202028 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
479 ysofsVjklsVe xksyh 500 fexzk- 1 xksyh 11.85 1213(अ) 25.03.2020
480 ysofsVjklsVe xksyh 750 fexzk- 1 xksyh 18.23 1213(अ) 25.03.2020
481 ysofsVjklsVe vksjy fyD;wbZM 100 fexzk-@fefy- 1 fefy- 3.66 1213(अ) 25.03.2020
482 ysoksMksik ¼,½ $dkfcZMksik lhvkj xksyh 100 fexzk-¼,½ $ 25 1 xksyh 3.34 1213(अ) 25.03.2020
¼ch½ fexzk- ¼ch½
483 ysoksMksik ¼,½ $dkfcZMksik xksyh 100 fexzk- ¼,½ $ 10 fexzk- 1 xksyh 1.56 1213(अ) 25.03.2020
¼ch½ ¼ch½
484 ysoksMksik ¼,½ $dkfcZMksik xksyh 100 fexzk- ¼,½ $ 25 fexzk- 1 xksyh 2.26 1213(अ) 25.03.2020
¼ch½ ¼ch½
485 ysoksMksik ¼,½ $dkfcZMksik xksyh 250 fexzk- ¼,½ $ 25 fexzk- 1 xksyh 3.75 1213(अ) 25.03.2020
¼ch½ ¼ch½
486 ysoksMksik ¼,½ $dkfcZMksik lhvkj xksyh 200 fexzk-¼,½ $ 50 1 xksyh 4.12 1213(अ) 25.03.2020
¼ch½ fexzk- ¼ch½
487 ysoks¶yksDlklhu xksyh 250 fexzk- 1 xksyh 4.42 1213(अ) 25.03.2020
488 ysoks¶yksDlklhu xksyh 750 fexzk- 1 xksyh 10.96 1213(अ) 25.03.2020
489 ysoks¶yksDlklhu xksyh 500 fexzk- 1 xksyh 8.08 1213(अ) 25.03.2020
490 ysoksuksxsLZ Vªsy xksyh 0-75 fexzk- 1 xksyh 23.07 1213(अ) 25.03.2020
491 ysoksFkkbjksDlhu xksyh 100 ,elhth 1 xksyh 1.20 1213(अ) 25.03.2020
492 ysoksFkkbjksDlhu xksyh 112 ,elhth 1 xksyh 1.44 1213(अ) 25.03.2020
493 ysoksFkkbjksDlhu xksyh 12-5 ,elhth 1 xksyh 1.35 1213(अ) 25.03.2020
494 ysoksFkkbjksDlhu xksyh 125 ,elhth 1 xksyh 1.54 1213(अ) 25.03.2020
495 ysoksFkkbjksDlhu xksyh 150 ,elhth 1 xksyh 1.55 1213(अ) 25.03.2020
496 ysoksFkkbjksDlhu xksyh 25 ,elhth 1 xksyh 1.31 1213(अ) 25.03.2020
497 ysoksFkkbjksDlhu xksyh 50 ,elhth 1 xksyh 0.99 1213(अ) 25.03.2020
498 ysoksFkkbjksDlhu xksyh 62-5 ,elhth 1 xksyh 1.41 1213(अ) 25.03.2020
499 ysoksFkkbjksDlhu xksyh 75 ,elhth 1 xksyh 1.30 1213(अ) 25.03.2020
500 ysoksFkkbjksDlhu xksyh 88 ,elhth 1 xksyh 1.54 1213(अ) 25.03.2020
501 fyXuksdus batSD'ku 2% 1 fefy- 0.99 1213(अ) 25.03.2020
502 fyXuksdus batSD'ku 2% ¼izstjosfVo Qzh QkWj 1 fefy- 0.98 1213(अ) 25.03.2020
IV ;wt
503 fyXuksdus batSD'ku 1% izfr iSd 7.96 1213(अ) 25.03.2020
504 fyXuksdus VkWfidy QkWeZ 2&5% 1 xzke vkSj 1.08 1213(अ) 25.03.2020
1 fefy-
505 fyXuksdus batSD'ku 5% Xywdkst 7-5% ds 1 fefy- 3.69 1213(अ) 25.03.2020
lkFk
506 fyXuksdus ¼,½ $ batSD'ku 1%¼,½ $ 1%200000¼5 1 fefy- 0.45 1213(अ) 25.03.2020
,Mªsukykbu ¼ch½ ,elhth@fefy-½ ¼ch½
507 fyXuksdus ¼,½ $ batSD'ku 2% ¼,½ $ 1%200000 ¼5 1 fefy- 0.92 1213(अ) 25.03.2020
,Mªsukykbu ¼ch½ ,elhth@fefy-½ ¼ch½
508 ykbutksfyM xksyh 600 fexzk- 1 xksyh 33.12 1213(अ) 25.03.2020
509 fyfFk;e xksyh 300 fexzk- 1 xksyh 1.47 1213(अ) 25.03.2020
510 ysijs kekbM dSIlwy 2 fexzk- 1 dSIlwy 3.59 1213(अ) 25.03.2020
511 ysijs kekbM xksyh 2 fexzk- 1 xksyh 1.98 1213(अ) 25.03.2020
512 yksfiukohj ¼,½ $fjVksukohj xksyh 100 fexzk- ¼,½ $ 25 fexzk- 1 xksyh 23.57 1213(अ) 25.03.2020
¼ch½ ¼ch½
513 yksfiukohj ¼,½ $fjVksukohj xksyh 200 fexzk- ¼,½ $ 50 fexzk- 1 xksyh 45.67 1213(अ) 25.03.2020
¼ch½ ¼ch½[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 29
514 yksjktsike batSD'ku 2 fexzk-@fefy- 1 fefy- 7.79 1213(अ) 25.03.2020
515 yksjktsike xksyh 1 fexzk- 1 xksyh 2.07 1213(अ) 25.03.2020
516 yksjktsike xksyh 2 fexzk- 1 xksyh 2.52 1213(अ) 25.03.2020
517 eaSxfuf'k;e lYQsV batSD'ku 500 fexzk-@fefy- 1 fefy- 4.79 1213(अ) 25.03.2020
518 efsuVksy batSD'ku 10% 1 fefy- 0.16 1213(अ) 25.03.2020
519 efsuVksy batSD'ku 20% 1 fefy- 0.30 1213(अ) 25.03.2020
520 fetyl :csyk oSDlhu izfr iSd 88.62 1213(अ) 25.03.2020
¼0-5 fefy-½
521 fetyl oSDlhu oSDlhu izfr iSd 51.11 1213(अ) 25.03.2020
¼0-5 fefy-½
522 eos suMktksy vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.77 1213(अ) 25.03.2020
523 eos suMktksy xksyh 100 fexzk- 1 xksyh 2.94 1213(अ) 25.03.2020
524 eMs ªksDlh izksxsLVsjksu ,lsVVs xksyh 10 fexzk- 1 xksyh 5.40 1213(अ) 25.03.2020
525 eQs sukfed ,flM vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.52 1213(अ) 25.03.2020
526 eQs susfed ,flM xksyh 250 fexzk- 1 xksyh 1.94 1213(अ) 25.03.2020
527 eQs susfed ,flM xksyh 500 fexzk- 1 xksyh 2.46 1213(अ) 25.03.2020
528 e¶s yksDohu xksyh 250 fexzk- 1 xksyh 51.10 1213(अ) 25.03.2020
529 eXsyqekbu MkbVªhtks,V batSD'ku 60% MCY;w@oh 1 fefy- 8.28 1213(अ) 25.03.2020
530 eXsyqekbu MkbVªhtks,V batSD'ku 76% MCY;w@oh 1 fefy- 9.57 1213(अ) 25.03.2020
531 eys Qkyku xksyh 2 fexzk- 1 xksyh 98.34 1213(अ) 25.03.2020
532 eys Qkyku xksyh 5 fexzk- 1 xksyh 168.67 1213(अ) 25.03.2020
533 els uk batSD'ku 100 fexzk-@fefy- 1 fefy- 16.81 1213(अ) 25.03.2020
534 eVs QkWfeZu bEesMsV fjfyt xksyh 500 fexzk- 1 xksyh 1.51 1213(अ) 25.03.2020
535 eVs QkWfeZu daVªksyM fjfyt xksyh 1000 fexzk- 1 xksyh 3.66 1213(अ) 25.03.2020
536 eVs QkWfeZu daVªksyM fjfyt xksyh 500 fexzk- 1 xksyh 1.92 1213(अ) 25.03.2020
537 eVs QkWfeZu daVªksyM fjfyt xksyh 750 fexzk- 1 xksyh 2.40 1213(अ) 25.03.2020
538 eVs QkWfeZu bEesMsV fjfyt xksyh 1000 fexzk- 1 xksyh 3.61 1213(अ) 25.03.2020
539 eVs QkWfeZu bEesMsV fjfyt xksyh 750 fexzk- 1 xksyh 3.05 1213(अ) 25.03.2020
540 eFs kksVªsDlsV batSD'ku 25 fexzk-@fefy- 1 fefy- 48.22 1213(अ) 25.03.2020
541 eFs kksVªsDlsV batSD'ku 50 fexzk-@fefy- 1 fefy- 40.15 1213(अ) 25.03.2020
542 eFs kksVªsDlsV xksyh 10 fexzk- 1 xksyh 12.17 1213(अ) 25.03.2020
543 eFs kksVªsDlsV xksyh 2-5 fexzk- 1 xksyh 4.80 1213(अ) 25.03.2020
544 eFs kksVªsDlsV xksyh 7-5 fexzk- 1 xksyh 11.61 1213(अ) 25.03.2020
545 eFs kksVªsDlsV xksyh 5 fexzk- 1 xksyh 8.39 1213(अ) 25.03.2020
546 efSFkyMksik xksyh 250 fexzk- 1 xksyh 2.45 1213(अ) 25.03.2020
547 efSFkyMksik xksyh 500 fexzk- 1 xksyh 4.70 1213(अ) 25.03.2020
548 efSFkysxksZeVs ªhu batSD'ku 0-2 fexzk-@fefy- 1 fefy- 14.31 1213(अ) 25.03.2020
549 efSFkysxksZeVs ªhu xksyh 0-125 fexzk- 1 xksyh 7.94 1213(अ) 25.03.2020
550 efSFkyizsMuhlksykus xksyh 16 fexzk- 1 xksyh 8.94 1213(अ) 25.03.2020
551 efSFkyizsMuhlksyksu xksyh 8 fexzk- 1 xksyh 5.11 1213(अ) 25.03.202030 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
552 efSFkyizsMuhlksykus batSD'ku 40 fexzk-@fefy- 1 fefy- 54.10 1213(अ) 25.03.2020
553 जमथाईलरोसाजनजलजनयम पैंन्ट 1% 1 fefy- 0.08549 4334(अ) 03.12.2020
क्लोरईड (जेंजसया र्ाइलटे )
554 eVs ksDyksizkekbM batSD'ku 5 fexzk-@fefy- ¼10 fefy- 1 fefy- 1.43 1213(अ) 25.03.2020
iSd½
555 eVs ksDyksizkekbM batSD'ku 5 fexzk-@fefy- ¼2 fefy- 1 fefy- 2.34 1213(अ) 25.03.2020
iSd½
556 eVs ksDyksizkekbM vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.44 1213(अ) 25.03.2020
557 esVksDyksizkekbM xksyh 10 fexzk- 1 xksyh 1.17 1213(अ) 25.03.2020
558 eVs ksikzsyksy dSIlwy 25 fexzk- 1 dSIlwy 4.24 1213(अ) 25.03.2020
559 eVs ksikzsyksy dSIlwy 50 fexzk- 1 dSIlwy 6.46 1213(अ) 25.03.2020
560 eVs ksikzsyksy ,lvkj xksyh 25 fexzk- 1 xksyh 4.04 1213(अ) 25.03.2020
561 eVs ksikzsyksy ,lvkj xksyh 50 fexzk- 1 xksyh 5.79 1213(अ) 25.03.2020
562 eVs ksikzsyksy xksyh 25 fexzk- 1 xksyh 3.12 1213(अ) 25.03.2020
563 eVs ksikzsyksy xksyh 50 fexzk- 1 xksyh 4.73 1213(अ) 25.03.2020
564 eVs ªksfuMktksy batSD'ku 500 fexzk-@100 fefy- 1 fefy- 0.20 1213(अ) 25.03.2020
565 eVs ªksfuMktksy vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 0.45 1213(अ) 25.03.2020
566 eVs ªksfuMktksy xksyh 200 fexzk- 1 xksyh 0.69 1213(अ) 25.03.2020
567 eVs ªksfuMktksy xksyh 400 fexzk- 1 xksyh 1.28 1213(अ) 25.03.2020
568 feMktksye batSD'ku 1 fexzk-@fefy- 1 fefy- 5.92 1213(अ) 25.03.2020
569 feMktksye batSD'ku 5 fexzk-@fefy- 1 fefy- 14.55 1213(अ) 25.03.2020
570 feMktksye xksyh 7-5 fexzk- 1 xksyh 22.50 1213(अ) 25.03.2020
571 feQsihzLVksu xksyh 200 fexzk- 1 xksyh 322.49 1213(अ) 25.03.2020
572 felksizksLVksy xksyh 100 ,elhth 1 xksyh 8.73 1213(अ) 25.03.2020
573 felksizksLVksy xksyh 200 ,elhth 1 xksyh 16.74 1213(अ) 25.03.2020
574 eksQhZu batSD'ku 10 fexzk-@fefy- 1 fefy- 23.81 1213(अ) 25.03.2020
575 eksQhZu batSD'ku 15 fexzk-@fefy- 1 fefy- 29.71 1213(अ) 25.03.2020
576 eksQhZu ,lvkj xksyh 30 fexzk- 1 xksyh 5.46 1213(अ) 25.03.2020
577 eksQhZu xksyh 10 fexzk- 1 xksyh 5.34 1213(अ) 25.03.2020
578 eksDlh¶yksDlklhu xksyh 400 fexzk- 1 xksyh 25.40 1213(अ) 25.03.2020
579 ekbZdksQus ksyVs eksQsfVy xksyh 250 fexzk- 1 xksyh 41.62 1213(अ) 25.03.2020
580 ekbZdksQus ksyVs eksQsfVy xksyh 500 fexzk- 1 xksyh 82.33 1213(अ) 25.03.2020
581 ,u&,flVkbyflLVsu batSD'ku 200 fexzk-@fefy- 1 fefy- 22.46 1213(अ) 25.03.2020
582 ,u&,flVkbyflLVsu lpsV 200 fexzk- 1 xzke 9.02 1213(अ) 25.03.2020
583 ukyksDlksu batSD'ku 0-4 fexzk-@fefy- 1 fefy- 86.96 1213(अ) 25.03.2020
584 ukVkekblhu MªksIl 5% 1 fefy- 22.86 1213(अ) 25.03.2020
585 fuvksLVhtekbu batSD'ku 0-5 fexzk-@fefy- 1 fefy- 4.36 1213(अ) 25.03.2020
586 fuvksLVhtekbu xksyh 15 fexzk- 1 xksyh 4.68 1213(अ) 25.03.2020
587 usohjkikbu vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 0.84 1213(अ) 25.03.2020
588 usohjkikbu xksyh 200 fexzk- 1 xksyh 14.35 1213(अ) 25.03.2020
589 fuQsfMikbu dSIlwy 10 fexzk- 1 dSIlwy 0.86 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 31
590 fuQsfMikbu xksyh 10 fexzk- 1 xksyh 1.24 1213(अ) 25.03.2020
591 जनVªksQjq uटोइन vksjy fyD;wbZM 25 fexzk-@5 fefy- 1 fefy- 0.82 1213(अ) 25.03.2020
592 जनVªksQjq uटोइन xksyh 100 fexzk- 1 xksyh 7.25 1213(अ) 25.03.2020
593 जनVªksQjq uटोइन dSIlwy 100 fexzk- 1 dSIlwy 7.87 1213(अ) 25.03.2020
594 ukbZVªl vkWDlkbM ?ku ehVj 234.21 1213(अ) 25.03.2020
595 uksjkMªsukykbu batSD'ku 2 fexzk-@fefy- 1 fefy- 25.83 1213(अ) 25.03.2020
596 uksjfsFkLVsjksu xksyh 5 fexzk- 1 xksyh 5.12 1213(अ) 25.03.2020
597 vksesikztksy dSIlwy 10 fexzk- 1 dSIlwy 2.12 1213(अ) 25.03.2020
598 vksesikztksy dSIlwy 20 fexzk- 1 dSIlwy 2.50 1213(अ) 25.03.2020
599 vksesikztksy dSIlwy 40 fexzk- 1 dSIlwy 4.95 1213(अ) 25.03.2020
600 vksesikztksy vksjy fyD;wbZM ds fy, ikmMj 20 1 xzke 1.23 1213(अ) 25.03.2020
fexzk-
601 vksesikztksy xksyh 10 fexzk- 1 xksyh 4.44 1213(अ) 25.03.2020
602 vksesikztksy xksyh 20 fexzk- 1 xksyh 4.94 1213(अ) 25.03.2020
603 vksesikztksy xksyh 40 fexzk- 1 xksyh 8.35 1213(अ) 25.03.2020
604 vksuMulsVªksu batSD'ku 2 fexzk-@fefy- 1 fefy- 5.86 1213(अ) 25.03.2020
605 vksuMulsVªksu vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 1.14 1213(अ) 25.03.2020
606 vksuMulsVªksu xksyh 4 fexzk- 1 xksyh 4.72 1213(अ) 25.03.2020
607 vksuMulsVªksu xksyh 8 fexzk- 1 xksyh 9.78 1213(अ) 25.03.2020
608 ओरल पोजलओमाईजलठटस 1 fefy- 102.79 4335(अ) 03.12.2020
र्ेक्सीन
609 vksjy fjgkbMªs'ku lkYVl ykblsal ds :i esa 1 xzke 0.89 1213(अ) 25.03.2020
610 vksjy fjgkbMªs'ku lkYVl ykblsal ds :i esa 1 fefy- 0.14 1213(अ) 25.03.2020
611 vksDlkyhIykVhu batSD'ku 100 fexzk-¼ykblsal ds :i izfr iSd 4479.80 1213(अ) 25.03.2020
es½a
612 vksDlkyhIykVhu batSD'ku 50 fexzk-¼ykblsal ds :i izfr iSd 2605.35 1213(अ) 25.03.2020
es½a
613 vkWDlhVkslhu batSD'ku 10 vkbZ;w@fefy- 1 fefy- 39.49 1213(अ) 25.03.2020
614 vkWDlhVkslhu batSD'ku 5 vkbZ;w@fefy- 1 fefy- 17.69 1213(अ) 25.03.2020
615 isdyhVsDlsy batSD'ku 100 fexzk-@16-7 fefy- 1 fefy- 206.14 1242(अ) 03.04.2020
616 isdyhVsDlsy batSD'ku 30 fexzk-@5 fefy- 1 fefy- 206.14 1242(अ) 03.04.2020
617 isuVksikztksy batSD'ku 40 fexzk- izfr iSd 44.63 1213(अ) 25.03.2020
618 ikjk&,feukslkfyflfyd xzsU;wyl ¼ykblsla ds :i es½a 1 xzke 2.85 1213(अ) 25.03.2020
,flM
619 isjkflVkeksy vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.51 1213(अ) 25.03.2020
620 isjkflVkeksy vksjy fyD;wbZM 120 fexzk-@5 fefy- 1 fefy- 0.53 1213(अ) 25.03.2020
621 isjkflVkeksy vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 0.34 1213(अ) 25.03.2020
622 isjkflVkeksy vksjy fyD;wbZM 150 fexzk-@5 fefy- 1 fefy- 0.58 1213(अ) 25.03.2020
623 isjkflVkeksy vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.60 1213(अ) 25.03.2020
624 isjkflVkeksy vksjy fyD;wbZM 500 fexzk-@5 fefy- 1 fefy- 0.64 1213(अ) 25.03.2020
625 isjkflVkeksy vksjy fyD;wbZM 650 fexzk-@5 fefy- 1 fefy- 0.52 1213(अ) 25.03.2020
626 isjkflVkeksy xksyh 500 fexzk- 1 xksyh 0.91 1213(अ) 25.03.2020
627 isjkflVkeksy xksyh 650 fexzk- 1 xksyh 1.84 1213(अ) 25.03.202032 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
628 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 3.08 1213(अ) 25.03.2020
¼0-5 fefy-½
629 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 4.21 1213(अ) 25.03.2020
¼1 fefy-½
630 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 6.46 1213(अ) 25.03.2020
¼2 fefy-½
631 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 8.73 1213(अ) 25.03.2020
¼3 fefy-½
632 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 10.99 1213(अ) 25.03.2020
¼4 fefy-½
633 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 13.25 1213(अ) 25.03.2020
¼5 fefy-½
634 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 17.77 1213(अ) 25.03.2020
¼7 fefy-½
635 isjkflVkeksy lqIiksftVªh 170 fexzk- izfr 7.71 1213(अ) 25.03.2020
lqIiksftVªh
636 isjkflVkeksy lqIiksftVªh 80 fexzk- izfr 6.52 1213(अ) 25.03.2020
lqIiksftVªh
637 iSjkflVkeksy vksjy 100 fexzk-@fefy- ¼isMªkfVd½ 1 fefy- 1.62 1213(अ) 25.03.2020
fyD;wbMZ
638 iSXysVsM baVjQsjkWu ,YQk 2 batSD'ku 180 ,elhth izfr iSd 7932.08 1213(अ) 25.03.2020
,
639 iSXysVsM baVjQsjkWu ,YQk 2 batSD'ku 100 ,elhth izfr iSd 15682.67 1213(अ) 25.03.2020
ch
640 iSXysVsM baVjQsjkWu ,YQk 2 batSD'ku 120 ,elhth izfr iSd 14605.00 1213(अ) 25.03.2020
ch
641 iSXysVsM baVjQsjkWu ,YQk 2 batSD'ku 80 ,elhth izfr iSd 12537.85 1213(अ) 25.03.2020
ch
642 isfuflykekbu dSIlwy 250 fexzk- 1 dSIlwy 14.90 1213(अ) 25.03.2020
643 ieZFs kzhu Øhe 1% 1 xzke 1.61 1213(अ) 25.03.2020
644 ieZFs kzhu Øhe 5% 1 xzke 1.74 1213(अ) 25.03.2020
645 ieFZs kzhu tSy 5% 1 xzke 1.47 1213(अ) 25.03.2020
646 ieZFs kzhu yks'ku 1% 1 xzke 0.91 1213(अ) 25.03.2020
647 ieZFs kzhu yks'ku 5% 1 fefy- 0.98 1213(अ) 25.03.2020
648 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy-¼2 fefy- 1 fefy- 2.29 1213(अ) 25.03.2020
½
649 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy-¼10 1 fefy- 1.71 1213(अ) 25.03.2020
fefy-½
650 QsuksckjfcVksu batSD'ku 200 fexzk-@fefy- 1 fefy- 19.21 1213(अ) 25.03.2020
651 QsuksckjfcVksu xksyh 30 fexzk- 1 xksyh 1.23 1213(अ) 25.03.2020
652 QsuksckjfcVksu xksyh 60 fexzk- 1 xksyh 1.77 1213(अ) 25.03.2020
653 QsuksckjfcVksu vksjy fyD;wbZM 20 fexzk-@5 fefy- 1 fefy- 0.44 1213(अ) 25.03.2020
654 QsuhysQjhu MªksIl 10% 1 fefy- 8.10 1213(अ) 25.03.2020
655 QsuhysQjhu MªksIl 5% 1 fefy- 3.74 1213(अ) 25.03.2020
656 QsuhVksbu dSIlwy 100 fexzk- 1 dSIlwy 1.53 1213(अ) 25.03.2020
657 QsuhVksbu dSIlwy 300 fexzk- 1 dSIlwy 3.82 1213(अ) 25.03.2020
658 QsuhVksbu bZvkj dSIlwy 300 fexzk- 1 dSIlwy 3.82 1213(अ) 25.03.2020
659 QsuhVksbu batSD'ku 25 fexzk-@fefy- 1 fefy- 2.52 1213(अ) 25.03.2020
660 QsuhVksbu batSD'ku 50 fexzk-@fefy- 1 fefy- 5.39 1213(अ) 25.03.2020
661 QsuhVksbu vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 0.90 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 33
662 QsuhVksbu vksjy fyD;wbZM 30 fexzk-@5 fefy- 1 fefy- 0.31 1213(अ) 25.03.2020
663 QsuhVksbu bZvkj xksyh 300 fexzk- 1 xksyh 5.82 1213(अ) 25.03.2020
664 QsuhVksbu xksyh 100 fexzk- 1 xksyh 1.56 1213(अ) 25.03.2020
665 QsuhVksbu xksyh 300 fexzk- 1 xksyh 4.76 1213(अ) 25.03.2020
666 QsuhVksbu xksyh 50 fexzk- 1 xksyh 0.74 1213(अ) 25.03.2020
667 QkbVksesukMhvksu ¼foVkfeu batSD'ku 10 fexzk-@fefy- 1 fefy- 48.00 1213(अ) 25.03.2020
ds1½
668 QkbVksesukMhvksu ¼foVkfeu xksyh 10 fexzk- 1 xksyh 14.56 1213(अ) 25.03.2020
ds1½
669 fiyksdkjfiu MªksIl 2% 1 fefy- 10.13 1213(अ) 25.03.2020
670 fiyksdkjfiu MªksIl 4% 1 fefy- 11.71 1213(अ) 25.03.2020
671 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 1 xzke ¼,½ izfr iSd 88.61 1213(अ) 25.03.2020
$VstkscDs Ve ¼ch½ $ 125 fexzk- ¼ch½
672 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 2 xzke ¼,½ izfr iSd 209.63 1213(अ) 25.03.2020
$VstkscDs Ve ¼ch½ $ 250 fexzk- ¼ch½
673 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 4 xzke ¼,½ izfr iSd 440.35 1213(अ) 25.03.2020
$VstkscDs Ve ¼ch½ $ 500 fexzk- ¼ch½
674 iksVsf'k;e DyksjkbM batSD'ku 150 fexzk-@fefy- 1 fefy- 2.43 1213(अ) 25.03.2020
675 iksVsf'k;e DyksjkbM vksjy fyD;wbZM 500 fexzk-@5 fefy- 1 fefy- 0.29 1213(अ) 25.03.2020
676 iksVsf'k;e ijeasxusV fØLVy QkWj VkWfidy lksyq'ku 1 xzke 0.44 1213(अ) 25.03.2020
677 ikWfoMu vk;ksMhu vksbuVesaV 10% 1 xzke 5.22 1213(अ) 25.03.2020
678 ikWfoMu vk;ksMhu lksy'q ku 4% 1 fefy- 1.74 1213(अ) 25.03.2020
679 ikWfoMu vk;ksMhu lksy'q ku 7-5% 1 fefy- 0.77 1213(अ) 25.03.2020
680 ikWfoMu vk;ksMhu lksy'q ku 10% 1 fefy- 0.93 1213(अ) 25.03.2020
681 ikWfoMu vk;ksMhu lksy'q ku 5% 1 fefy- 0.39 1213(अ) 25.03.2020
682 izkfyMksDlhe DyksjkbM batSD'ku 25 fexzk-@fefy- 1 fefy- 3.74 1213(अ) 25.03.2020
¼2&ih,,e½
683 izkftD;wuVsy xksyh 600 fexzk 1 xksyh 34.82 3977(अ) 03.11.2020
684 izsMfulksyksu MªksIl 1% 1 fefy- 5.04 1213(अ) 25.03.2020
685 izsMfulksyksu batSD'ku 20 fexzk-@2 fefy- 1 fefy- 3.59 1213(अ) 25.03.2020
686 izsMfulksyksu vksjy fyD;wbZM 15 fexzk-@5 fefy- 1 fefy- 0.75 1213(अ) 25.03.2020
687 izsMfulksyksu vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.43 1213(अ) 25.03.2020
688 izsMfulksyksu xksyh 10 fexzk- 1 xksyh 0.98 1213(अ) 25.03.2020
689 izsMfulksyksu xksyh 20 fexzk- 1 xksyh 1.96 1213(अ) 25.03.2020
690 izsMfulksyksu xksyh 40 fexzk- 1 xksyh 2.82 1213(अ) 25.03.2020
691 izsMfulksyksu xksyh 5 fexzk- 1 xksyh 0.56 1213(अ) 25.03.2020
692 izsfeDl balqfyu 30%70 batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.09 1213(अ) 25.03.2020
batSD'ku ¼jsxqyj%,uih,p½
693 izhyksdus ¼,½ $ fyXuksdsu Øhe 2-5% ¼,½ $ 2-5% ¼ch½ 1 xzke 20.50 1213(अ) 25.03.2020
¼ch½
694 izhekDohu xksyh 15 fexzk- 1 xksyh 4.58 1213(अ) 25.03.2020
695 izhekDohu xksyh 2-5 fexzk- 1 xksyh 1.56 1213(अ) 25.03.2020
696 izhekDohu xksyh 7-5 fexzk- 1 xksyh 2.12 1213(अ) 25.03.2020
697 izksdkckZftu dSIlwy 50 fexzk- 1 dSIlwy 34.65 1213(अ) 25.03.2020
698 izksdkckZftu xksyh 50 fexzk- 1 xksyh 47.22 1213(अ) 25.03.202034 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
699 izksikjkdsu MªksIl 0-5% 1 fefy- 9.99 1213(अ) 25.03.2020
700 izksiksQksy batSD'ku 10 fexzk-@fefy- 1 fefy- 7.24 1213(अ) 25.03.2020
701 izksizkuksyksy dSIlwy 40 fexzk- 1 dSIlwy 3.81 1213(अ) 25.03.2020
702 izksizkuksyksy dSIlwy 80 fexzk- 1 dSIlwy 5.79 1213(अ) 25.03.2020
703 izksizkuksyksy xksyh 10 fexzk- 1 xksyh 1.17 1213(अ) 25.03.2020
704 izksizkuksyksy xksyh 40 fexzk- 1 xksyh 2.76 1213(अ) 25.03.2020
705 izksizkuksyksy xksyh 80 fexzk- 1 xksyh 5.01 1213(अ) 25.03.2020
706 izksVkekbu batSD'ku 10 fexzk-@fefy- 1 fefy- 9.27 1213(अ) 25.03.2020
707 ikbjkftukekbM vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.61 1213(अ) 25.03.2020
708 ikbjkftukekbM xksyh 1000 fexzk- 1 xksyh 9.45 1213(अ) 25.03.2020
709 ikbjkftukekbM xksyh 1500 fexzk- 1 xksyh 10.47 1213(अ) 25.03.2020
710 ikbjkftukekbM xksyh 500 fexzk- 1 xksyh 4.24 1213(अ) 25.03.2020
711 ikbjkftukekbM xksyh 750 fexzk- 1 xksyh 6.45 1213(अ) 25.03.2020
712 ikbfjMksDlhu xksyh 100 fexzk- 1 xksyh 5.60 1213(अ) 25.03.2020
713 ikbfjMksDlhu xksyh 10 fexzk- 1 xksyh 0.11 1213(अ) 25.03.2020
714 कुनेन batSD'ku 300 fexzk-@fefy- 1 fefy- 10.19 1213(अ) 25.03.2020
715 कुनेन xksyh 300 fexzk- 1 xksyh 5.74 1213(अ) 25.03.2020
716 jsfct oSDlhu izfr iSd 342.55 1213(अ) 25.03.2020
717 jkyVsxzkohj xksyh 400 fexzk- 1 xksyh 156.88 1213(अ) 25.03.2020
718 jkfeizhy dSIlwy 2-5 fexzk- 1 dSIlwy 4.75 1213(अ) 25.03.2020
719 jkfeizhy dSIlwy 5 fexzk- 1 dSIlwy 7.41 1213(अ) 25.03.2020
720 jkfeizhy xksyh 2-5 fexzk- 1 xksyh 4.99 1213(अ) 25.03.2020
721 jkfeizhy xksyh 5 fexzk- 1 xksyh 7.85 1213(अ) 25.03.2020
722 jkfufVfMu vksjy fyD;wbZM 75 fexzk-@5 fefy- 1 fefy- 0.72 1213(अ) 25.03.2020
723 jkfufVfMu xksyh 150 fexzk- 1 xksyh 0.73 1213(अ) 25.03.2020
724 jkfufVfMu batSD'ku 25 fexzk-@fefy- 1 fefy- 1.62 1213(अ) 25.03.2020
725 fjckfofju dSIlwy 200 fexzk- 1 dSIlwy 83.85 1213(अ) 25.03.2020
726 fjQkcqVhu dSIlwy 150 fexzk- 1 dSIlwy 39.76 1213(अ) 25.03.2020
727 fjQkcqVhu xksyh 150 fexzk- 1 xksyh 37.13 1213(अ) 25.03.2020
728 fjQefiflu dSIlwy 150 fexzk- 1 dSIlwy 2.01 1213(अ) 25.03.2020
729 fjQefiflu dSIlwy 300 fexzk- 1 dSIlwy 3.81 1213(अ) 25.03.2020
730 fjQefiflu dSIlwy 450 fexzk- 1 dSIlwy 4.95 1213(अ) 25.03.2020
731 fjQefiflu dSIlwy 600 fexzk- 1 dSIlwy 11.62 1213(अ) 25.03.2020
732 fjQefiflu vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.39 1213(अ) 25.03.2020
733 fjQefiflu xksyh 150 fexzk- 1 xksyh 1.62 1213(अ) 25.03.2020
734 fjQefiflu xksyh 300 fexzk- 1 xksyh 2.94 1213(अ) 25.03.2020
735 fjaxj ySDVsV batSD'ku 1000 fefy- izfr iSd 79.96 1213(अ) 25.03.2020
736 fjaxj ySDVsV batSD'ku 100 fefy- izfr iSd 20.94 1213(अ) 25.03.2020
737 fjaxj ySDVsV batSD'ku 250 fefy- izfr iSd 35.70 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 35
738 fjaxj ySDVsV batSD'ku 500 fefy- izfr iSd 45.49 1213(अ) 25.03.2020
739 fjlisfjMksu vksjy fyD;wbZM 1 fexzk-@ fefy- 1 fefy- 1.94 1213(अ) 25.03.2020
740 fjlisfjMksu xksyh 1 fexzk- 1 xksyh 3.09 1213(अ) 25.03.2020
741 fjlisfjMksu xksyh 2 fexzk- 1 xksyh 4.94 1213(अ) 25.03.2020
742 fjlisfjMksu xksyh 4 fexzk- 1 xksyh 10.02 1213(अ) 25.03.2020
743 fjVksukohj dSIlwy 100 fexzk- 1 dSIlwy 28.29 1213(अ) 25.03.2020
744 fjVksukohj xksyh 100 fexzk- 1 xksyh 29.10 1213(अ) 25.03.2020
745 fjVqDlheso batSD'ku 10 fexzk-@fefy- 1 fefy- 760.32 1213(अ) 25.03.2020
746 lsycqVkeksy dSIlwy 4 fexzk- 1 dSIlwy 0.60 1213(अ) 25.03.2020
747 lsycqVkeksy bugsy's ku ¼,eMhvkbZ@MhihvkbZ½ 100 1 Mkst 0.40 1213(अ) 25.03.2020
,elhth@Mkst
748 lsycqVkeksy vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 0.15 1213(अ) 25.03.2020
749 lsycqVkeksy jslfijsVkWjh lksyq'ku QkWj ;wt bu 1 fefy- 0.70 1213(अ) 25.03.2020
uscqykbtj 5 fexzk-@fefy-
750 lsycqVkeksy xksyh 2 fexzk- 1 xksyh 0.16 1213(अ) 25.03.2020
751 lsycqVkeksy xksyh 4 fexzk- 1 xksyh 0.18 1213(अ) 25.03.2020
752 lsyhflfyd ,flM vksbVa esaV 6% 1 xzke 1.80 1213(अ) 25.03.2020
753 lsoks¶ywjku bugsy's ku 1 fefy- 29.98 1213(अ) 25.03.2020
754 flYoj lYQkMkbftu Øhe 1% 1 xzke 0.51 1213(अ) 25.03.2020
755 LuSd osukse ,aVhlsje batSD'ku ds fy, ikmMj 10 fefy- 558.57 1213(अ) 25.03.2020
ykbvksfQykftM ikWyhosyaVs iSd
756 LuSd osukse ,aVhlsje batSD'ku izfr iSd 433.76 1213(अ) 25.03.2020
lksycq y@fyD;wbM ¼10 fefy-½
ikWyhosysVa
757 lksfM;e ckbdkcksZusV batSD'ku 7-5% 1 fefy- 1.41 1213(अ) 25.03.2020
758 lksfM;e ckbdkcksZusV batSD'ku 8-4% 1 fefy- 1.29 1213(अ) 25.03.2020
759 lksfM;e DyksjkbM batSD'ku 0-9% 1000 fefy- 59.49 1213(अ) 25.03.2020
Xykl
760 lksfM;e DyksjkbM batSD'ku 0-9% 1000 fefy- 46.92 1213(अ) 25.03.2020
ukWu Xykl
761 lksfM;e DyksjkbM batSD'ku 0-9% 100 fefy- 17.59 1213(अ) 25.03.2020
Xykl
762 lksfM;e DyksjkbM batSD'ku 0-9% 100 fefy- 15.84 1213(अ) 25.03.2020
ukWu Xykl
763 lksfM;e DyksjkbM batSD'ku 0-9% 250 fefy- 23.73 1213(अ) 25.03.2020
Xykl
764 lksfM;e DyksjkbM batSD'ku 0-9% 250 fefy- 21.30 1213(अ) 25.03.2020
ukWu Xykl
765 lksfM;e DyksjkbM batSD'ku 0-9% 500 fefy- 32.99 1213(अ) 25.03.2020
Xykl
766 lksfM;e DyksjkbM batSD'ku 0-9% 500 fefy- 28.08 1213(अ) 25.03.2020
ukWu Xykl
767 lksfM;e ukbZVªsV batSD'ku 30 fexzk-@fefy- 1 fefy- 26.05 3977(अ) 03.11.2020
768 lksfM;e ukbVªksi:lkbM batSD'ku 10 fexzk-@fefy- 1 fefy- 25.88 1213(अ) 25.03.2020
769 lksfM;e osyizks,V batSD'ku 100 fexzk-@fefy- 1 fefy- 5.78 1213(अ) 25.03.2020
770 lksfM;e osyizks,V vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 0.58 1213(अ) 25.03.2020
771 lksfM;e osyizks,V lhvkj xksyh 300 fexzk- 1 xksyh 6.31 1213(अ) 25.03.2020
772 lksfM;e osyizks,V lhvkj xksyh 500 fexzk- 1 xksyh 9.77 1213(अ) 25.03.202036 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
773 lksfM;e osyizks,V xksyh 200 fexzk- 1 xksyh 3.11 1213(अ) 25.03.2020
774 lksfM;e osyizks,V xksyh 300 fexzk- 1 xksyh 3.98 1213(अ) 25.03.2020
775 lksfM;e osyizks,V xksyh 500 fexzk- 1 xksyh 6.96 1213(अ) 25.03.2020
776 lksQkscoq hj xksyh 400 fexzk- 1 xksyh 669.09 1213(अ) 25.03.2020
777 lksekVksLVkVhu batSD'ku ds fy, ikmMj 3 fexzk- izfr iSd 1588.65 1213(अ) 25.03.2020
778 LihjksuksysDVksu xksyh 25 fexzk- 1 xksyh 1.92 1213(अ) 25.03.2020
779 LihjksuksysDVksu xksyh 50 fexzk- 1 xksyh 3.81 1213(अ) 25.03.2020
780 LVkoqfMu ¼,½ $ ykfeofqMu xksyh 30 fexzk-¼,½ $ 150 fexzk- ¼ch½ 1 xksyh 9.57 1213(अ) 25.03.2020
¼ch½
781 LVªsIVksfdukl batSD'ku 1500000 vkbZ;w izfr iSd 1794.35 1213(अ) 25.03.2020
782 LVªsIVksfdukl batSD'ku 7]50]000 vkbZ;w izfr iSd 1262.01 1213(अ) 25.03.2020
783 LVªsIVksekbflu batSD'ku ds fy, ikmMj 750 fexzk- izfr idS 8.80 1213(अ) 25.03.2020
784 LVªsIVksekbflu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 10.46 1213(अ) 25.03.2020
785 lfDluhy dksfyu batSD'ku 50 fexzk-@fefy- 1 fefy- 4.85 1213(अ) 25.03.2020
786 lqØkyQsV vksjy fyD;wbZM 1 xzke 1 fefy- 0.70 1213(अ) 25.03.2020
787 lYQklkyktkbu xksyh 500 fexzk- 1 xksyh 3.99 1213(अ) 25.03.2020
788 lqekVªhIVu xksyh 25 fexzk- 1 xksyh 33.37 1213(अ) 25.03.2020
789 lqekVªhIVu xksyh 50 fexzk- 1 xksyh 51.66 1213(अ) 25.03.2020
790 ljQsDVkaV lLis'a ku QkWj buVªkVªkpsy izfr iSd eas 67.05 1213(अ) 25.03.2020
buLVkbys'ku ¼ykblsal ds :i eas½ izfr fefy-
QksLQksfyfiM~l
791 VkØksfyeql dSIlwy 0-5 fexzk- 1 dSIlwy 22.17 1213(अ) 25.03.2020
792 VkØksfyeql dSIlwy 1 fexzk- 1 dSIlwy 39.16 1213(अ) 25.03.2020
793 VkØksfyeql dSIlwy 2 fexzk- 1 dSIlwy 76.71 1213(अ) 25.03.2020
794 VkØksfyeql xksyh 0.5 fexzk- 1 xksyh 18.78 3976(अ) 03.11.2020
795 VkØksfyeql xksyh 1 fexzk- 1 xksyh 34.49 3976(अ) 03.11.2020
796 VkØksfyeql xksyh 2 fexzk- 1 xksyh 68.13 3976(अ) 03.11.2020
797 VkeksDlhQsu xksyh 10 fexzk- 1 xksyh 2.58 1213(अ) 25.03.2020
798 VkeksDlhQsu xksyh 20 fexzk- 1 xksyh 2.92 1213(अ) 25.03.2020
799 टी डी र्ैजक्सन प्रत्सयेक 0.5 जमली. डोसेस मे: प्रत्सयेक 0.5 18.79 3976(अ) 03.11.2020
जडप्थेठरया टोक्साइड ≤ 5 एलएफ (≥ जमली. पकै
2आईय)ू
टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40
आईय)ू
800 टी डी र्ैजक्सन प्रत्सयेक 0.5 जमली. डोसेस मे: प्रत्सयेक 5 176.53 3976(अ) 03.11.2020
जडप्थेठरया टोक्साइड ≤ 5 एलएफ (≥ 2 जमली. पकै
आईय)ू
टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40
आईय)ू
801 टी डी र्ैजक्सन प्रत्सयेक 0.5 जमली. डोसेस मे: प्रत्सयेक 0.5 16.11 3976(अ) 03.11.2020
जडप्थेठरया टोक्साइड ≤ 25 एलएफ (≥ जमली. पकै
30 आईय)ू
टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40
आईय)ू
802 VsyfelkVZu xksyh 20 fexzk- 1 xksyh 3.66 1213(अ) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 37
803 VsyfelkVZu xksyh 40 fexzk- 1 xksyh 6.61 1213(अ) 25.03.2020
804 VsyfelkVZu xksyh 80 fexzk- 1 xksyh 10.07 1213(अ) 25.03.2020
805 VsekstksyksekbM dSIlwy 100 fexzk- 1 dSIlwy 2088.67 1213(अ) 25.03.2020
806 VsekstksyksekbM dSIlwy 20 fexzk- 1 dSIlwy 597.87 1213(अ) 25.03.2020
807 VsekstksyksekbM dSIlwy 250 fexzk- 1 dSIlwy 4697.81 1213(अ) 25.03.2020
808 VsekstksyksekbM xksyh 100 fexzk- 1 xksyh 1550.39 1213(अ) 25.03.2020
809 VsekstksyksekbM xksyh 20 fexzk- 1 xksyh 375.62 1213(अ) 25.03.2020
810 VsekstksyksekbM xksyh 250 fexzk- 1 xksyh 3837.37 1213(अ) 25.03.2020
811 VsuksQksohj xksyh 300 fexzk- 1 xksyh 47.30 1213(अ) 25.03.2020
812 VsuksQksohj ¼,½ $ xksyh 300 fexzk- ¼,½ $ 300 fexzk- 1 xksyh 45.00 1213(अ) 25.03.2020
ykfeoMq kbu ¼ch½ ¼ch½
813 VsuksQksohj ¼,½ $ xksyh 300 fexzk- ¼,½ $ 300 fexzk- 1 xksyh 103.32 1213(अ) 25.03.2020
ykfeoMq kbu ¼ch½ ¼ch½ $ 600 fexzk- ¼lh½
$bQkohjsat ¼lh½
814 VsVul VkWDlkbM batSD'ku izfr iSd 10.87 1213(अ) 25.03.2020
¼0-5 fefy-½
815 VsVul VkWDlkbM batSD'ku izfr iSd 23.50 1213(अ) 25.03.2020
¼5 fefy-½
816 FkkyhMksekbM dSIlwy 100 fexzk- 1 dSIlwy 61.25 1213(अ) 25.03.2020
817 FkkyhMksekbM dSIlwy 50 fexzk- 1 dSIlwy 35.38 1213(अ) 25.03.2020
818 Fkh;kekbu batSD'ku 100 fexzk-@fefy- 1 fefy- 24.86 1213(अ) 25.03.2020
819 Fkh;kekbu xksyh 100 fexzk- 1 xksyh 3.76 1213(अ) 25.03.2020
820 FkhvksisuVkWu batSD'ku ds fy, ikmMj 0-5 xzke izfr iSd 40.83 1213(अ) 25.03.2020
821 FkhvksisuVkWu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 49.54 1213(अ) 25.03.2020
822 fVeksyksy MªksIl 0-25% 1 fefy- 5.18 1213(अ) 25.03.2020
823 fVeksyksy MªksIl 0-5% 1 fefy- 11.95 1213(अ) 25.03.2020
824 fVvksVªksfi;e bugsy's ku ¼MhihvkbZ½ 9 1 Mkst 2.41 1213(अ) 25.03.2020
,elhth@Mkst
825 fVvksVªksfi;e bugsy's ku ¼,eMhvkbZ½ 18 1 Mkst 9.31 1213(अ) 25.03.2020
,elhth@Mkst
826 VªkekMksy dSIlwy 50 fexzk- 1 dSIlwy 4.52 1213(अ) 25.03.2020
827 VªkekMksy batSD'ku 50 fexzk-@fefy- ¼20 fefy- 1 fefy- 1.25 1213(अ) 25.03.2020
iSd½
828 VªkekMksy batSD'ku 50 fexzk-@fefy- ¼2 fefy- 1 fefy- 10.50 1213(अ) 25.03.2020
iSd rd½
829 VªkekMksy xksyh 100 fexzk- 1 xksyh 19.72 1213(अ) 25.03.2020
830 VªkekMksy xksyh 50 fexzk- 1 xksyh 8.08 1213(अ) 25.03.2020
831 VªkekMksy dSIlwy 100 fexzk- 1 dSIlwy 9.62 1213(अ) 25.03.2020
832 VªkusDlkfed ,flM batSD'ku 100 fexzk-@fefy- 1 fefy- 14.98 1213(अ) 25.03.2020
833 VªkusDlkfed ,flM xksyh 500 fexzk- 1 xksyh 17.41 1213(अ) 25.03.2020
834 VªkLVqtqec batSD'ku 440 fexzk-@50 fefy- izfr iSd 60298.66 1213(अ) 25.03.2020
835 VªhgsDlhQsuhMhy xksyh 2 fexzk- 1 xksyh 1.22 1213(अ) 25.03.2020
836 VªksfidkekbM vkbZ Mªksi 1% 1 fefy- 10.08 1213(अ) 25.03.2020
837 osudksekblhu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 477.07 1213(अ) 25.03.2020
838 osudksekblhu batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 222.28 1213(अ) 25.03.202038 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
839 osudksekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 286.94 1213(अ) 25.03.2020
840 osdjq ksfu;e batSD'ku ds fy, ikmMj 10 fexzk- izfr iSd 189.53 1213(अ) 25.03.2020
841 osdjq ksfu;e batSD'ku ds fy, ikmMj 4 fexzk- izfr iSd 91.47 1213(अ) 25.03.2020
842 osjkikfey batSD'ku 2-5 fexzk-@fefy- 1 fefy- 1.17 1213(अ) 25.03.2020
843 osjkikfey xksyh 40 fexzk- 1 xksyh 0.74 1213(अ) 25.03.2020
844 osjkikfey xksyh 80 fexzk- 1 xksyh 1.40 1213(अ) 25.03.2020
845 fouOykLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 20.57 1213(अ) 25.03.2020
846 fouØhLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 52.24 1213(अ) 25.03.2020
847 foVkfeu , dSIlwy 50000 vkbZ;w 1 dSIlwy 0.55 1213(अ) 25.03.2020
848 foVkfeu , batSD'ku 50000 vkbZ;w@fefy- 1 fefy- 1.92 1213(अ) 25.03.2020
849 foVkfeu , xksyh 50000 vkbZ;w 1 xksyh 0.70 1213(अ) 25.03.2020
850 okjQfju xksyh 1 fexzk- 1 xksyh 2.42 1213(अ) 25.03.2020
851 okjQfju xksyh 2 fexzk- 1 xksyh 2.67 1213(अ) 25.03.2020
852 okjQfju xksyh 3 fexzk- 1 xksyh 3.13 1213(अ) 25.03.2020
853 okjQfju xksyh 5 fexzk- 1 xksyh 2.36 1213(अ) 25.03.2020
854 okVj QkWj batSD'ku batSD'ku izfr iSd 2.33 1213(अ) 25.03.2020
¼10 fefy-½
855 okVj QkWj batSD'ku batSD'ku izfr iSd 2.25 1213(अ) 25.03.2020
¼5 fefy-½
856 okbV iSVªksfy;e tsyh 100% 1 xzke 0.09 1213(अ) 25.03.2020
857 ,DlhyksesVktksykbu usty MªksIl 0-05% 1 fefy- 3.94 1213(अ) 25.03.2020
858 ,DlhyksesVktksykbu usty MªksIl 0-1% 1 fefy- 5.22 1213(अ) 25.03.2020
859 ftMksoqMkbu dSIlwy 300 fexzk- 1 dSIlwy 2.07 1213(अ) 25.03.2020
860 ftMksoqMkbu xksyh 300 fexzk- 1 xksyh 14.29 1213(अ) 25.03.2020
861 ftMksoqMkbu ¼,½ $ xksyh 300 fexzk- ¼,½ $ 150 fexzk- 1 xksyh 20.20 1213(अ) 25.03.2020
ykfeoMq kbu ¼ch½ $ ¼ch½ $ 200 fexzk- ¼lh½
usfojkikbu ¼lh½
862 ftad lYQsV fMLizsflcy xksyh 20 fexzk- 1 xksyh 3.15 1213(अ) 25.03.2020
863 tksyMs ªksfud ,flM batSD'ku ds fy, ikmMj 4 fexzk- izfr iSd 4211.34 1213(अ) 25.03.2020
864 tksyfiMse dSIlwy 5 fexzk- 1 dSIlwy 7.37 1213(अ) 25.03.2020
865 tksyfiMse xksyh 10 fexzk- 1 xksyh 8.47 1213(अ) 25.03.2020
866 tksyfiMse xksyh 5 fexzk- 1 xksyh 5.40 1213(अ) 25.03.2020
-
( 0.53638
)
11(3)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 39
(5)
13(2) .
(5)
V
(4)
u II I
II III
II IV
ड जब तक ददनांक लागू ह ैतब तक हेपठरन इंजेक्िन आईय/ू एमएल और हेपठरन इंजेक्िन आईय ू/ एमएल
की जो उपयिुव ताजलका म ेक्रम संख्या और के कॉलम ( में जनर्ददष्ट ह]ै लाग ूनहीं होगा
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदिे क
ORDER
New Delhi, the 25th March, 2021
S.O. 1330(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the
Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government
of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India
in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date
specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority,
hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and
services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in
column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding
entries in columns (3) and (4) thereof:40 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
TABLE
Price Revision as per Annual Wholesale Price Index (WPI) @ 0.53638% increase.
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
1 5-aminosalicylic Acid Suppository 500 mg 1 Suppository 16.95 1213(E) 25.03.2020
Retention Enema
2 5-aminosalicylic Acid Tablet 400 mg 1 Tablet 7.49 1213(E) 25.03.2020
3 5-Fluorouracil Injection 250 mg/5 ml 1 ml 2.34 1213(E) 25.03.2020
4 6-Mercaptopurine Tablet 50mg 1 Tablet 6.47 1213(E) 25.03.2020
5 Abacavir Tablet 300 mg 1 Tablet 47.27 1213(E) 25.03.2020
6 Abacavir (A) + Lamivudine Tablet 60 mg(A) + 30 1 Tablet 20.13 1213(E) 25.03.2020
(B) mg(B)
7 Abacavir (A) + Lamivudine Tablet 600 mg(A)+ 300 1 Tablet 91.35 1213(E) 25.03.2020
(B) mg(B)
8 Acetazolamide Capsule 250 mg 1 Capsule 4.53 1213(E) 25.03.2020
9 Acetazolamide Tablet 250 mg 1 Tablet 3.67 1213(E) 25.03.2020
10 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 0.18 1213(E) 25.03.2020
Enteric coated Tablet 100
mg
11 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 1.21 1213(E) 25.03.2020
Enteric coated Tablet 150
mg
12 Acetylsalicylic acid Effervescent/ Dispersible/ 1 Tablet 1.23 1213(E) 25.03.2020
Enteric coated Tablet 75 mg
13 Acetylsalicylic acid Tablet 100 mg 1 Tablet 0.17 1213(E) 25.03.2020
14 Acetylsalicylic acid Tablet 150 mg 1 Tablet 0.41 1213(E) 25.03.2020
15 Acetylsalicylic acid Tablet 325mg 1 Tablet 0.55 1213(E) 25.03.2020
16 Acetylsalicylic acid Tablet 350mg 1 Tablet 0.31 1213(E) 25.03.2020
17 Acetylsalicylic acid Tablet 75 mg 1 Tablet 0.31 1213(E) 25.03.2020
18 Actinomycin D Powder for Injection 0.5mg Each Pack 317.90 1213(E) 25.03.2020
19 Acyclovir Ointment 3% 1 gm 10.44 1213(E) 25.03.2020
20 Acyclovir Oral Liquid 400 mg/5ml 1 ml 1.27 1213(E) 25.03.2020
21 Acyclovir Tablet 200 mg 1 Tablet 6.79 1213(E) 25.03.2020
22 Acyclovir Tablet 400 mg 1 Tablet 12.34 1213(E) 25.03.2020
23 Acyclovir Powder for Injection 250 mg Each Pack 356.17 1213(E) 25.03.2020
24 Acyclovir Powder for Injection 500 mg Each Pack 460.03 1213(E) 25.03.2020
25 Adenosine Injection 3mg/ml 1 ml 98.70 1213(E) 25.03.2020
26 Adrenaline Injection 1 mg/ml 1 ml 15.69 1213(E) 25.03.2020
27 Albendazole Oral Liquid 200 mg/5ml 1 ml 1.60 1213(E) 25.03.2020
28 Albendazole Tablet 400 mg 1 Tablet 7.72 1213(E) 25.03.2020
29 Allopurinol Tablet 100 mg 1 Tablet 1.91 1213(E) 25.03.2020
30 Allopurinol Tablet 300 mg 1 Tablet 7.50 1213(E) 25.03.2020
31 All-trans Retinoic Acid Capsule 10 mg 1 Capsule 82.00 1213(E) 25.03.2020
32 Alprostadil Injection 0.5 mg/ml 1 ml 5676.93 1213(E) 25.03.2020
33 Alteplase Powder for Injection 20 mg Each Pack 19040.03 1213(E) 25.03.2020
34 Alteplase Powder for Injection 50 mg Each Pack 39753.72 1213(E) 25.03.2020
35 Amiodarone Injection 50 mg/ml 1 ml 22.36 1213(E) 25.03.2020
36 Amiodarone Tablet 100 mg 1 Tablet 5.73 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 41
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
37 Amiodarone Tablet 200 mg 1 Tablet 11.35 1213(E) 25.03.2020
38 Amitriptyline Tablet 10 mg 1 Tablet 2.29 1213(E) 25.03.2020
39 Amitriptyline Tablet 25 mg 1 Tablet 2.26 1213(E) 25.03.2020
40 Amitriptyline Tablet 50 mg 1 Tablet 5.82 1213(E) 25.03.2020
41 Amitriptyline Tablet 75 mg 1 Tablet 5.62 1213(E) 25.03.2020
42 Amlodipine Tablet 10 mg 1 Tablet 5.08 1213(E) 25.03.2020
43 Amlodipine Tablet 2.5 mg 1 Tablet 1.66 1213(E) 25.03.2020
44 Amlodipine Tablet 5mg 1 Tablet 2.61 1213(E) 25.03.2020
45 Amoxicillin Capsule 250 mg 1 Capsule 2.21 1213(E) 25.03.2020
46 Amoxicillin Oral Liquid 250 mg/5ml 1 ml 1.35 1213(E) 25.03.2020
47 Amoxicillin Capsule 500mg 1 Capsule 6.47 1213(E) 25.03.2020
48 Amoxicillin (A) + Dry Syrup 125 mg(A) + 1 ml 2.17 1213(E) 25.03.2020
Clavulanic acid (B) 31.25 (B)/5 ml
49 Amoxicillin (A) + Oral Liquid 200 mg(A) + 1 ml 1.81 1213(E) 25.03.2020
Clavulanic acid (B) 28.5 mg(B)/5ml
50 Amoxicillin (A) + Powder for Injection 500 Each Pack 90.24 1213(E) 25.03.2020
Clavulanic acid (B) mg(A) + 100 mg(B)
51 Amoxicillin (A) Tablet 500mg(A) 1 Tablet 18.01 1213(E) 25.03.2020
+Clavulanic acid (B) +125mg(B)
52 Amoxicillin (A) Powder for Injection 1g (A) Each Pack 125.89 1213(E) 25.03.2020
+Clavulanic acid (B) +200mg(B)
53 Amphotericin B (Lipid) Powder for Injection 50 mg Each Pack 3213.07 1213(E) 25.03.2020
54 Amphotericin B Powder for Injection 50 mg 7484.24 1213(E) 25.03.2020
(Liposomal) Each Pack
55 Amphotericin B – Powder for Injection 50 mg Each Pack 310.48 1213(E) 25.03.2020
Conventional
56 Ampicillin Powder for Injection 1 gm Each Pack 21.39 1213(E) 25.03.2020
57 Ampicillin Powder for Injection 500 mg Each Pack 13.18 1213(E) 25.03.2020
58 Anti-D immunoglobulin Injection 300mcg Each Pack 2139.67 1213(E) 25.03.2020
59 Anti-D Immunoglobulin Injection 150mcg Each Vial 1667.80 1213(E) 25.03.2020
60 Anti-rabies immunoglobulin Injection 150 IU/ml 1 ml 2781.05 1213(E) 25.03.2020
61 Anti-rabies immunoglobulin Injection 300 IU/ml 1 ml 98.04 1213(E) 25.03.2020
62 Anti-tetanus 250IU Each Pack 1113.99 1213(E) 25.03.2020
immunoglobulin
63 Arsenic Trioxide Injection 1mg/ml 1 ml 54.43 1213(E) 25.03.2020
64 Artemether (A) + Oral Liquid 80 mg(A) +480 1 ml 4.04 1213(E) 25.03.2020
Lumefantrine (B) mg(B) /5ml
65 Artemether (A) + Tablet 20 mg(A) + 120 1 Tablet 12.55 1213(E) 25.03.2020
Lumefantrine (B) mg(B)
66 Artemether (A) + Tablet 40 mg(A) + 240 1 Tablet 16.18 1213(E) 25.03.2020
Lumefantrine (B) mg(B)
67 Artemether (A) + Tablet 80 mg(A) + 480 1 Tablet 23.22 1213(E) 25.03.2020
Lumefantrine (B) mg(B)
68 Artesunate Powder for Injection 120 mg Each Pack 417.13 1213(E) 25.03.2020
69 Artesunate Powder for Injection 60 mg Each Pack 219.10 1213(E) 25.03.2020
70 Artesunate (A) + Tablet 100 mg(A) + 1 Tablet Combi pack 29.57 1213(E) 25.03.2020
Sulphadoxine - (750 mg+ 37.5 mg) (B)
Pyrimethamine (B)42 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
71 Artesunate (A) + Tablet 150 mg(A) + 2 Tablet Combi pack 40.14 1213(E) 25.03.2020
Sulphadoxine - (500 mg+ 25 mg) (B)
Pyrimethamine (B)
72 Artesunate (A) + Tablet 200 mg(A) + 2 Tablet Combi pack 36.60 1213(E) 25.03.2020
Sulphadoxine - (750 mg+ 37.5 mg) (B)
Pyrimethamine (B)
73 Artesunate (A) + Tablet 25 mg(A) + 1 Tablet Combi pack 19.71 1213(E) 25.03.2020
Sulphadoxine - (250 mg+ 12.5 mg) (B)
Pyrimethamine (B)
74 Artesunate (A) + 1 Tablet 50 mg(A) + 1 Combi Pack 21.27 1213(E) 25.03.2020
Sulphadoxine - Tablet (500 mg+ 25 mg) (B)
Pyrimethamine (B)
75 Ascorbic Acid (Vitamin C) Tablet 100mg 1 Tablet 0.19 1213(E) 25.03.2020
76 Ascorbic Acid (Vitamin C) Tablet 500 mg 1 Tablet 1.38 1213(E) 25.03.2020
77 Atazanavir (A) + Ritonavir Tablet 300 mg(A) + 100 1 Tablet 98.96 1213(E) 25.03.2020
(B) mg(B)
78 Atenolol Tablet 100 mg 1 Tablet 3.49 1213(E) 25.03.2020
79 Atenolol Tablet 50 mg 1 Tablet 1.79 1213(E) 25.03.2020
80 Atorvastatin Tablet 10 mg 1 Tablet 5.50 1213(E) 25.03.2020
81 Atorvastatin Tablet 20 mg 1 Tablet 13.32 1213(E) 25.03.2020
82 Atorvastatin Tablet 40 mg 1 Tablet 19.34 1213(E) 25.03.2020
83 Atracurium Injection 10 mg/ml Each Pack 52.55 1213(E) 25.03.2020
84 Atropine Ointment 1% 1 gm 3.79 1213(E) 25.03.2020
85 Atropine Injection 0.6 mg/ml 1 ml 4.20 1213(E) 25.03.2020
86 Atropine Drops 1% 1 ml 3.44 1213(E) 25.03.2020
87 Azathioprine Tablet 50 mg 1 Tablet 10.17 1213(E) 25.03.2020
88 Azithromycin Capsule 250 mg 1 Capsule 10.53 1213(E) 25.03.2020
89 Azithromycin Capsule 500 mg 1 Capsule 16.62 1213(E) 25.03.2020
90 Azithromycin Oral Liquid 200 mg/5ml 1 ml 3.09 1213(E) 25.03.2020
91 Azithromycin Tablet 250mg 1 Tablet 10.58 1213(E) 25.03.2020
92 Azithromycin Tablet 500mg 1 Tablet 21.34 1213(E) 25.03.2020
93 Azithromycin Powder for Injection 500mg Each Pack 192.73 1213(E) 25.03.2020
94 Baclofen Tablet 10 mg 1 Tablet 10.78 1213(E) 25.03.2020
95 Baclofen Tablet 20 mg 1 Tablet 14.83 1213(E) 25.03.2020
96 Baclofen Tablet 5 mg 1 Tablet 5.55 1213(E) 25.03.2020
97 BCG vaccine Each Dose 8.96 1213(E) 25.03.2020
98 Benzathine benzylpenicillin Powder for Injection 12 lac Each Pack 18.28 1213(E) 25.03.2020
units
99 Benzathine benzylpenicillin Powder for Injection 6 lac Each Pack 12.09 1213(E) 25.03.2020
units
100 Benzoyl Peroxide Cream 2.5% 1 gm 2.34 1213(E) 25.03.2020
101 Benzoyl Peroxide Gel 2.5% 1 gm 3.76 1213(E) 25.03.2020
102 Benzyl penicillin Powder for Injection 10 Lac Each Pack 7.82 1213(E) 25.03.2020
Units
103 Betamethasone Cream 0.05% 1 gm 0.58 1213(E) 25.03.2020
104 Betamethasone Cream 0.1% 1 gm 0.84 1213(E) 25.03.2020
105 Betamethasone Gel 0.05% 1 gm 0.53 1213(E) 25.03.2020
106 Betamethasone Lotion 0.1% 1 ml 0.82 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 43
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
107 Betamethasone Lotion 0.5% 1 ml 0.53 1213(E) 25.03.2020
108 Betamethasone Injection 4 mg/ml 1 ml 4.21 1213(E) 25.03.2020
109 Bicalutamide Tablet 50 mg 1 Tablet 68.78 1213(E) 25.03.2020
110 Bisacodyl Suppository 5 mg 1 Suppository 8.46 1213(E) 25.03.2020
111 Bisacodyl Tablet 5 mg 1 Tablet 1.01 1213(E) 25.03.2020
112 Bleomycin Powder for Injection 15 Each Pack 622.26 1213(E) 25.03.2020
Units
113 Bortezomib Powder for Injection 2 mg Each Pack 12328.88 1213(E) 25.03.2020
114 Budesonide Nasal Spray 100 mcg/dose 1 Dose 0.91 1213(E) 25.03.2020
115 Budesonide Nasal Spray 50 mcg/dose 1 Dose 1.02 1213(E) 25.03.2020
116 Budesonide Respiratory Solution for use 1 ml 10.74 1213(E) 25.03.2020
in Nebulizer 0.5 mg/ml
117 Budesonide Respiratory Solution for use 1 ml 12.95 1213(E) 25.03.2020
in Nebulizer 1 mg/ml
118 Budesonide Inhalation (MDI) 100 Per Metered 1.27 1213(E) 25.03.2020
mcg/dose Dose
119 Budesonide Inhalation (MDI) 200 Per metered 1.77 2292(E) 10.07.2020
mcg/dose Dose
120 Budesonide Inhalation (DPI) 100 Per Dose 2.00 1213(E) 25.03.2020
mcg/dose
121 Budesonide Inhalation (DPI) 200 Per Dose 2.90 1213(E) 25.03.2020
mcg/dose
122 Budesonide (A)+ Inhalation (MDI) 100 mcg Per Metered 1.89 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B) Dose
123 Budesonide (A)+ Inhalation (MDI) 200 mcg Per Metered 2.68 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B) Dose
124 Budesonide (A)+ Inhalation (MDI) 400 mcg Per Metered 3.06 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B) Dose
125 Budesonide (A)+ Inhalation (DPI) 100 mcg Per Dose 3.80 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B)
126 Budesonide (A)+ Inhalation (DPI) 200 mcg Per Dose 5.05 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B)
127 Budesonide (A)+ Inhalation (DPI) 400 mcg Per Dose 6.45 1213(E) 25.03.2020
Formoterol (B) (A) + 6 mcg (B)
128 Bupivacaine Injection 0.25% 1 ml 2.46 1213(E) 25.03.2020
129 Bupivacaine Injection 0.5% with 7.5% 1 ml 6.22 1213(E) 25.03.2020
glucose
130 Bupivacaine Injection 0.50% 1 ml 3.93 1213(E) 25.03.2020
131 Caffeine Injection 20 mg/ml 1 ml 251.61 1213(E) 25.03.2020
132 Caffeine Oral Liquid 20 mg/ml 1 ml 213.70 1213(E) 25.03.2020
133 Calamine Lotion (As per IP) 1 ml 0.85 1213(E) 25.03.2020
134 Calcium Carbonate Tablet 500mg 1 Tablet 1.73 1213(E) 25.03.2020
135 Calcium folinate Tablet 15 mg 1 Tablet 40.89 1213(E) 25.03.2020
136 Calcium gluconate Injection 100 mg/ml 1 ml 0.55 1213(E) 25.03.2020
137 Capecitabine Tablet 500 mg 1 Tablet 126.69 1213(E) 25.03.2020
138 Capreomycin Powder for Injection 1 gm Each Pack 347.22 1213(E) 25.03.2020
139 Carbamazepine Oral Liquid 100 mg/5ml 1 ml 0.19 1213(E) 25.03.2020
140 Carbamazepine CR Tablet 200 mg 1 Tablet 1.56 1213(E) 25.03.202044 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
141 Carbamazepine CR Tablet 400 mg 1 Tablet 3.07 1213(E) 25.03.2020
142 Carbamazepine Tablet 100 mg 1 Tablet 0.68 1213(E) 25.03.2020
143 Carbamazepine Tablet 200 mg 1 Tablet 1.40 1213(E) 25.03.2020
144 Carbamazepine Tablet 400 mg 1 Tablet 3.31 1213(E) 25.03.2020
145 Carbimazole Tablet 10 mg 1 Tablet 3.71 1213(E) 25.03.2020
146 Carbimazole Tablet 5 mg 1 Tablet 1.91 1213(E) 25.03.2020
147 Carboplatin Injection 10 mg/ml 1 ml 53.34 1213(E) 25.03.2020
148 Carboxymethylcellulose Drops 0.5% 1 ml 12.81 1213(E) 25.03.2020
149 Carboxymethylcellulose Drops 1% 1 ml 17.75 1213(E) 25.03.2020
150 Cefadroxil Capsule 500 mg 1 Capsule 7.17 1213(E) 25.03.2020
151 Cefadroxil Oral Liquid 125 mg/5ml 1 ml 0.63 1213(E) 25.03.2020
152 Cefadroxil Tablet 1 gm 1 Tablet 6.30 1213(E) 25.03.2020
153 Cefadroxil Tablet 500 mg 1 Tablet 4.04 1213(E) 25.03.2020
154 Cefazolin Powder for Injection 1 gm Each Pack 24.61 1213(E) 25.03.2020
155 Cefazolin Powder for Injection 500 mg Each Pack 15.60 1213(E) 25.03.2020
156 Cefixime Capsule 200 mg 1 Capsule 14.47 1213(E) 25.03.2020
157 Cefixime Capsule 400 mg 1 Capsule 29.31 1213(E) 25.03.2020
158 Cefixime Oral Liquid 100 mg/5ml 1 ml 2.16 1213(E) 25.03.2020
159 Cefixime Oral Liquid 50 mg/5ml 1 ml 1.46 1213(E) 25.03.2020
160 Cefixime Tablet 400 mg 1 Tablet 22.12 1213(E) 25.03.2020
161 Cefixime Tablet 200mg 1 Tablet 9.62 1213(E) 25.03.2020
162 Cefotaxime Powder for Injection 1 gm Each Pack 34.40 1213(E) 25.03.2020
163 Cefotaxime Powder for Injection 250 mg Each Pack 15.64 1213(E) 25.03.2020
164 Cefotaxime Powder for Injection 500 mg Each Pack 20.57 1213(E) 25.03.2020
165 Ceftazidime Powder for Injection 1 gm Each Pack 209.80 1213(E) 25.03.2020
166 Ceftazidime Powder for Injection 250 mg Each Pack 65.25 1213(E) 25.03.2020
167 Ceftriaxone Powder for Injection 1gm Each Pack 54.04 1213(E) 25.03.2020
168 Ceftriaxone Powder for Injection 2 gm Each Pack 128.46 1213(E) 25.03.2020
169 Ceftriaxone Powder for Injection 250 mg Each Pack 24.74 1213(E) 25.03.2020
170 Ceftriaxone Powder for Injection 500 mg Each Pack 45.19 1213(E) 25.03.2020
171 Cetirizine Capsule 10 mg 1 Capsule 2.38 1213(E) 25.03.2020
172 Cetirizine Oral Liquid 5 mg/5ml 1 ml 0.59 1213(E) 25.03.2020
173 Cetirizine Tablet 10 mg 1 Tablet 1.66 1213(E) 25.03.2020
174 Cetrimide Solution 20% (concentrate 1 ml 0.32 1213(E) 25.03.2020
for dilution)
175 Chlorambucil Tablet 2 mg 1 Tablet 37.00 1213(E) 25.03.2020
176 Chlorambucil Tablet 5 mg 1 Tablet 83.14 1213(E) 25.03.2020
177 Chlorhexidine Solution 5% (Concentrate 1 ml 0.15 1213(E) 25.03.2020
for dilution)
178 Chloroquine Oral Liquid 50 mg/5ml 1 ml 0.30 1213(E) 25.03.2020
179 Chloroquine Tablet 150mg 1 Tablet 1.19 1213(E) 25.03.2020
180 Chlorpheniramine Tablet 4 mg 1 Tablet 0.09 1213(E) 25.03.2020
181 Cholecalciferol Capsule 1000 IU 1 Capsule 4.79 1213(E) 25.03.2020
182 Cholecalciferol Capsule 60000 IU 1 Capsule 29.60 1213(E) 25.03.2020
183 Cholecalciferol Oral Liquid 400 IU/ml 1 ml 2.35 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 45
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
184 Cholecalciferol Tablet 1000 IU 1 Tablet 3.76 1213(E) 25.03.2020
185 Cholecalciferol Tablet 60000 IU 1 Tablet 24.31 1213(E) 25.03.2020
186 Ciprofloxacin Ointment 0.3% 1 gm 1.14 1213(E) 25.03.2020
187 Ciprofloxacin Drops 0.30% 1 ml 1.53 1213(E) 25.03.2020
188 Ciprofloxacin Injection 200 mg/100ml 1 ml 0.17 1213(E) 25.03.2020
189 Ciprofloxacin Oral Liquid 250 mg/5ml 1 ml 0.63 1213(E) 25.03.2020
190 Ciprofloxacin Tablet 250mg 1 Tablet 2.08 1213(E) 25.03.2020
191 Ciprofloxacin Tablet 500mg 1 Tablet 3.66 1213(E) 25.03.2020
192 Cisplatin Injection 1 mg/ml 1 ml 6.91 1213(E) 25.03.2020
193 Clarithromycin Oral Liquid 125 mg/5ml 1 ml 4.32 1213(E) 25.03.2020
194 Clarithromycin Tablet 250 mg 1 Tablet 28.07 1213(E) 25.03.2020
195 Clarithromycin Tablet 500 mg 1 Tablet 49.47 1213(E) 25.03.2020
196 Clindamycin Capsule 150 mg 1 Capsule 14.51 1213(E) 25.03.2020
197 Clindamycin Capsule 300 mg 1 Capsule 23.69 1213(E) 25.03.2020
198 Clindamycin Tablet 300 mg 1 Tablet 15.28 1213(E) 25.03.2020
199 Clobazam Tablet 10 mg 1 Tablet 9.06 1213(E) 25.03.2020
200 Clobazam Tablet 5 mg 1 Tablet 5.15 1213(E) 25.03.2020
201 Clofazimine Capsule 100 mg 1 Capsule 3.72 1213(E) 25.03.2020
202 Clofazimine Capsule 50 mg 1 Capsule 2.18 1213(E) 25.03.2020
203 Clomiphene Capsule 100 mg 1 Capsule 55.80 1213(E) 25.03.2020
204 Clomiphene Capsule 50 mg 1 Capsule 30.69 1213(E) 25.03.2020
205 Clomiphene Tablet 100mg 1 Tablet 12.25 1213(E) 25.03.2020
206 Clomiphene Tablet 50mg 1 Tablet 8.34 1213(E) 25.03.2020
207 Clomipramine Tablet 10 mg 1 Tablet 2.52 1213(E) 25.03.2020
208 Clomipramine Tablet 25 mg 1 Tablet 5.56 1213(E) 25.03.2020
209 Clomipramine Tablet 75 mg 1 Tablet 14.38 1213(E) 25.03.2020
210 Clonazepam Tablet 0.25 mg 1 Tablet 1.83 1213(E) 25.03.2020
211 Clonazepam Tablet 0.5 mg 1 Tablet 3.12 1213(E) 25.03.2020
212 Clonazepam Tablet 1 mg 1 Tablet 4.24 1213(E) 25.03.2020
213 Clopidogrel Tablet 75 mg 1 Tablet 6.97 1213(E) 25.03.2020
214 Clotrimazole Cream 1% 1 gm 2.92 1213(E) 25.03.2020
215 Clotrimazole Drops 1% 1 ml 3.04 1213(E) 25.03.2020
216 Clotrimazole Lotion 1% 1 ml 3.59 1213(E) 25.03.2020
217 Clotrimazole Pessary 100 mg 1 Pessary 8.71 1213(E) 25.03.2020
218 Cloxacillin Capsule 250mg 1 Capsule 1.14 1213(E) 25.03.2020
219 Cloxacillin Capsule 500mg 1 Capsule 1.91 1213(E) 25.03.2020
220 Cloxacillin Tablet 250mg 1 Tablet 1.73 1213(E) 25.03.2020
221 Cloxacillin Powder for Injection250mg Each Pack 4.45 1213(E) 25.03.2020
222 Clozapine Tablet 100 mg 1 Tablet 7.76 1213(E) 25.03.2020
223 Clozapine Tablet 25 mg 1 Tablet 2.52 1213(E) 25.03.2020
224 Clozapine Tablet 50 mg 1 Tablet 4.82 1213(E) 25.03.2020
225 Coagulation factor IX Powder for Injection 600 IU Each Pack 12350.88 1213(E) 25.03.2020
226 Coagulation factor VIII Powder for Injection 250 IU Each pack 3744.09 1213(E) 25.03.2020
227 Coagulation factor VIII Powder for Injection 500 IU Each Pack 9187.72 1213(E) 25.03.202046 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
228 Colchicine Tablet 0.5 mg 1 Tablet 3.12 1213(E) 25.03.2020
229 Co-trimoxazole Oral Liquid 200 mg(A)+40 1 ml 0.33 1213(E) 25.03.2020
(Sulphamethoxazole mg(B)/5ml
(A)+Trimethoprim (B)]
230 Co-trimoxazole Tablet 400 mg(A)+80 1 Tablet 0.78 1213(E) 25.03.2020
(Sulphamethoxazole mg(B)
(A)+Trimethoprim (B)]
231 Co-trimoxazole Tablet 800 mg(A)+160 1 Tablet 2.03 1213(E) 25.03.2020
(Sulphamethoxazole mg(B)
(A)+Trimethoprim (B)]
232 Cyclophosphamide Tablet 50 mg 1 Tablet 4.06 1213(E) 25.03.2020
233 Cyclophosphamide Powder for Injection 500 mg Each Pack 80.01 1213(E) 25.03.2020
234 Cycloserine Capsule 250 mg 1 Capsule 54.42 1213(E) 25.03.2020
235 Cycloserine Tablet 250 mg 1 Tablet 46.79 1213(E) 25.03.2020
236 Cyclosporine Capsule 100 mg 1 Capsule 102.75 1213(E) 25.03.2020
237 Cyclosporine Capsule 25 mg 1 Capsule 27.58 1213(E) 25.03.2020
238 Cyclosporine Capsule 50 mg 1 Capsule 52.77 1213(E) 25.03.2020
239 Cyclosporine Injection 50 mg/ml 1 ml 270.37 1213(E) 25.03.2020
240 Cyclosporine Oral Liquid 100 mg/ml 1 ml 94.75 1213(E) 25.03.2020
241 Cytosine arabinoside Injection 100 mg/ml Each Pack 199.15 1213(E) 25.03.2020
242 Cytosine arabinoside Powder for Injection 1000 Each Pack 1074.14 1213(E) 25.03.2020
mg
243 Cytosine arabinoside Powder for Injection 500 mg Each Pack 513.39 1213(E) 25.03.2020
244 Dacarbazine Powder for Injection 200 mg Each Pack 440.38 1213(E) 25.03.2020
245 Dacarbazine Powder for Injection 500 mg Each Pack 993.45 1213(E) 25.03.2020
246 Dapsone Tablet 100 mg 1 Tablet 0.36 1213(E) 25.03.2020
247 Darunavir Tablet 600 mg 1 Tablet 167.32 1213(E) 25.03.2020
248 Daunarubicin Powder for I.V. Injection 20 Each pack 243.77 1213(E) 25.03.2020
mg (5 mg/ml)
249 Desferrioxamine Powder for Injection 500mg Each pack 161.20 1213(E) 25.03.2020
250 Dexamethasone Tablet 0.5 mg 1 Tablet 0.19 1213(E) 25.03.2020
251 Dexamethasone Injection 4 mg/ml Each Pack 13.80 1213(E) 25.03.2020
(10 ml)
252 Dexamethasone Injection 4 mg/ml Each Pack (2 9.34 1213(E) 25.03.2020
ml)
253 Dexamethasone Injection 4 mg/ml Each Pack 26.46 1213(E) 25.03.2020
(20 ml)
254 Dexamethasone Injection 4 mg/ml Each Pack 35.36 1213(E) 25.03.2020
(30 ml)
255 Dextran-40 Injection 10% 1 ml 0.85 1213(E) 25.03.2020
256 Diazepam Injection 5 mg/ml 1 ml 6.07 1213(E) 25.03.2020
257 Diazepam Oral Liquid 2 mg/5ml 1 ml 2.74 1213(E) 25.03.2020
258 Diazepam Suppository 5 mg 1 Suppository 5.99 1213(E) 25.03.2020
259 Diazepam Tablet 2 mg 1 Tablet 1.51 1213(E) 25.03.2020
260 Diazepam Tablet 5 mg 1 Tablet 1.43 1213(E) 25.03.2020
261 Diclofenac Capsule 50 mg 1 Capsule 0.61 1213(E) 25.03.2020
262 Diclofenac Injection 25 mg/ml 1 ml 1.47 1213(E) 25.03.2020
263 Diclofenac Tablet 50 mg 1 Tablet 1.92 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 47
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
264 Dicyclomine Injection 10 mg/ml (10ml & 1 ml 2.06 1213(E) 25.03.2020
30ml Pack)
265 Dicyclomine Injection 10 mg/ml (1ml & 1 ml 3.20 1213(E) 25.03.2020
2ml Pack)
266 Dicyclomine Oral Solution 10mg/5ml 1 ml 0.16 1213(E) 25.03.2020
267 Dicyclomine Tablet 10mg 1 Tablet 0.11 1213(E) 25.03.2020
268 Diethylcarbamazine Oral Liquid 120 mg/5ml 1 ml 0.49 1213(E) 25.03.2020
269 Diethylcarbamazine Tablet 100 mg 1 Tablet 1.42 1213(E) 25.03.2020
270 Diethylcarbamazine Tablet 50 mg 1 Tablet 0.56 1213(E) 25.03.2020
271 Digoxin Injection 0.25 mg/ml 1 ml 3.34 1213(E) 25.03.2020
272 Digoxin Oral liquid 0.05 mg/ml 1 ml 1.27 1213(E) 25.03.2020
273 Digoxin Tablet 0.25 mg 1 Tablet 1.20 1213(E) 25.03.2020
274 Diloxanide furoate Tablet 500mg 1 Tablet 1.06 1213(E) 25.03.2020
275 Diltiazem Capsule 90 mg 1 Capsule 9.63 1213(E) 25.03.2020
276 Diltiazem Injection 5 mg/ml 1 ml 3.17 1213(E) 25.03.2020
277 Diltiazem SR Tablet 90 mg 1 Tablet 9.35 1213(E) 25.03.2020
278 Diltiazem Tablet 30 mg 1 Tablet 2.40 1213(E) 25.03.2020
279 Diltiazem Tablet 60 mg 1 Tablet 4.90 1213(E) 25.03.2020
280 Dimercaprol Injection 50 mg/ml 1 ml 200.62 1213(E) 25.03.2020
281 Dinoprostone Gel 0.5 mg 1 gm 81.26 1213(E) 25.03.2020
282 Dinoprostone Tablet 0.5mg 1 Tablet 50.17 1213(E) 25.03.2020
283 Diphtheria antitoxin 10000 IU Each Pack 1313.77 1213(E) 25.03.2020
284 Dobutamine Injection 50 mg/ml Each Pack 37.59 1213(E) 25.03.2020
285 Docetaxel Powder for Injection 20 mg Each Pack 3000.60 1213(E) 25.03.2020
286 Docetaxel Powder for Injection 80 mg Each Pack 11408.49 1213(E) 25.03.2020
287 Domperidone Oral Liquid 1 mg/ml 1 ml 1.08 1213(E) 25.03.2020
288 Domperidone Tablet 10 mg 1 Tablet 2.42 1213(E) 25.03.2020
289 Donepezil Tablet 10 mg 1 Tablet 16.09 1213(E) 25.03.2020
290 Donepezil Tablet 5 mg 1 Tablet 11.27 1213(E) 25.03.2020
291 Dopamine Injection 40 mg/ml 1 ml 5.66 1213(E) 25.03.2020
292 Doxorubicin Injection 2 mg/ml 1 ml 35.99 1213(E) 25.03.2020
293 Doxycycline Capsule 100 mg 1 Capsule 2.51 1213(E) 25.03.2020
294 Doxycycline Tablet 100 mg 1 Tablet 0.98 1213(E) 25.03.2020
295 DPT + Hib + Hep B vaccine Per 0.1 ml 80.51 1213(E) 25.03.2020
296 DPT vaccine Per 0.5 ml 14.20 1213(E) 25.03.2020
297 Efavirenz Capsule 200 mg 1 Capsule 24.13 1213(E) 25.03.2020
298 Efavirenz Capsule 600 mg 1 Capsule 62.88 1213(E) 25.03.2020
299 Efavirenz Tablet 200 mg 1 Tablet 22.73 1213(E) 25.03.2020
300 Efavirenz Tablet 600 mg 1 Tablet 71.19 1213(E) 25.03.2020
301 Enalapril Tablet 2.5 mg 1 Tablet 1.94 1213(E) 25.03.2020
302 Enalapril Tablet 5 mg 1 Tablet 3.22 1213(E) 25.03.2020
303 Enoxaparin Injection 40 mg/0.4ml 0.1 ml 101.89 1213(E) 25.03.2020
304 Enoxaparin Injection 60 mg/0.6ml 0.1 ml 101.89 1213(E) 25.03.2020
305 Entecavir Tablet 0.5 mg 1 Tablet 79.98 1213(E) 25.03.2020
306 Entecavir Tablet 1 mg 1 Tablet 127.08 1213(E) 25.03.202048 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
307 Erythropoietin Injection 10000 IU/ml Each pack 2607.78 1213(E) 25.03.2020
308 Erythropoietin Injection 2000 IU/ml Each pack 617.66 1213(E) 25.03.2020
309 Escitalopram Tablet 10 mg 1 Tablet 8.12 1213(E) 25.03.2020
310 Escitalopram Tablet 20 mg 1 Tablet 12.83 1213(E) 25.03.2020
311 Escitalopram Tablet 5 mg 1 Tablet 4.57 1213(E) 25.03.2020
312 Esmolol Injection 10mg/ml 1 ml 21.72 1213(E) 25.03.2020
313 Ethambutol Tablet 200 mg 1 Tablet 1.06 1213(E) 25.03.2020
314 Ethambutol Tablet 400 mg 1 Tablet 2.40 1213(E) 25.03.2020
315 Ethambutol Tablet 600 mg 1 Tablet 3.55 1213(E) 25.03.2020
316 Ethambutol Tablet 800 mg 1 Tablet 4.24 1213(E) 25.03.2020
317 Ethinylestradiol Tablet 0.01 mg 1 Tablet 2.35 1213(E) 25.03.2020
318 Ethinylestradiol Tablet 0.05 mg 1 Tablet 3.76 1213(E) 25.03.2020
319 Ethinylestradiol (A) + Tablet 0.03 mg(A) + 0.15 1 Tablet 3.46 1213(E) 25.03.2020
Levonorgestrel (B) mg(B)
320 Ethionamide Tablet 250 mg 1 Tablet 15.82 1213(E) 25.03.2020
321 Ethyl Alcohol (Denatured) Solution 70% 1 ml 0.42 1213(E) 25.03.2020
322 Etoposide Capsule 50 mg 1 Capsule 54.50 1213(E) 25.03.2020
323 Etoposide Injection 20 mg/ml 1 ml 35.94 1213(E) 25.03.2020
324 Fentanyl Injection 50mcg/ml 1 ml 22.76 1213(E) 25.03.2020
325 Ferrous Salt (A) + Folic Tablet 100mg elemental iron 1 Tablet 0.23 1213(E) 25.03.2020
Acid (B) (A) + 500mcg (B)
326 Filgrastim Injection 300 mcg Each pack 1375.63 1213(E) 25.03.2020
327 Fluconazole Capsule 100 mg 1 Capsule 25.33 1213(E) 25.03.2020
328 Fluconazole Capsule 150 mg 1 Capsule 18.59 1213(E) 25.03.2020
329 Fluconazole Capsule 200 mg 1 Capsule 36.60 1213(E) 25.03.2020
330 Fluconazole Oral Liquid 50mg/5ml 1 ml 2.62 1213(E) 25.03.2020
331 Fluconazole Tablet 100 mg 1 Tablet 8.00 1213(E) 25.03.2020
332 Fluconazole Tablet 150 mg 1 Tablet 11.87 1213(E) 25.03.2020
333 Fluconazole Tablet 200 mg 1 Tablet 18.83 1213(E) 25.03.2020
334 Fluconazole Tablet 400 mg 1 Tablet 31.32 1213(E) 25.03.2020
335 Fluconazole Injection 200 mg/100 ml Each Pack 106.68 1213(E) 25.03.2020
336 Flunarizine Tablet 10 mg 1 Tablet 4.75 1213(E) 25.03.2020
337 Flunarizine Tablet 5 mg 1 Tablet 2.76 1213(E) 25.03.2020
338 Fluoxetine Capsule 10 mg 1 Capsule 2.98 1213(E) 25.03.2020
339 Fluoxetine Capsule 20 mg 1 Capsule 3.66 1213(E) 25.03.2020
340 Fluoxetine Capsule 40 mg 1 Capsule 5.55 1213(E) 25.03.2020
341 Fluoxetine Capsule 60 mg 1 Capsule 9.81 1213(E) 25.03.2020
342 Fluoxetine Tablet 10 mg 1 Tablet 2.50 1213(E) 25.03.2020
343 Fluoxetine Tablet 20 mg 1 Tablet 3.97 1213(E) 25.03.2020
344 Fluoxetine Tablet 40 mg 1 Tablet 5.35 1213(E) 25.03.2020
345 Fluoxetine Tablet 60 mg 1 Tablet 7.42 1213(E) 25.03.2020
346 Fluphenazine Depot Injection 25 mg/ml 1 ml 50.15 1213(E) 25.03.2020
347 Folic Acid Capsule 5 mg 1 Capsule 5.65 1213(E) 25.03.2020
348 Folic Acid Tablet 5 mg 1 Tablet 1.40 1213(E) 25.03.2020
349 Furosemide Oral liquid 10 mg/ml 1 ml 2.77 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 49
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
350 Furosemide Tablet 40 mg 1 Tablet 0.75 1213(E) 25.03.2020
351 Furosemide Injection 10mg/ml 1 ml 2.49 1213(E) 25.03.2020
352 Fusidic acid Cream 2% 1 gm 9.15 1213(E) 25.03.2020
353 Gadobenate Injection 529 mg/ml 1 ml 109.25 1213(E) 25.03.2020
354 Ganciclovir Capsule 250 mg 1 Capsule 120.51 1213(E) 25.03.2020
355 Ganciclovir Powder for Injection 500 mg Each Pack 1691.68 1213(E) 25.03.2020
356 Gefitinib Tablet 250 mg 1 Tablet 429.64 1213(E) 25.03.2020
357 Gemcitabine Powder for Injection 1 gm Each Pack 5318.10 1213(E) 25.03.2020
358 Gemcitabine Powder for Injection 200mg Each Pack 1174.50 1213(E) 25.03.2020
359 Gentamicin Drops 0.3% 1 ml 0.91 1213(E) 25.03.2020
360 Gentamicin Injection 10 mg/ml 1 ml 3.19 1213(E) 25.03.2020
361 Gentamicin Injection 40 mg/ml Each Pack 18.01 1213(E) 25.03.2020
(10 ml)
362 Gentamicin Injection 40 mg/ml Each Pack (2 8.44 1213(E) 25.03.2020
ml)
363 Gentamicin Injection 40 mg/ml Each Pack 27.30 1213(E) 25.03.2020
(20 ml)
364 Gentamicin Injection 40 mg/ml Each Pack 29.88 1213(E) 25.03.2020
(30 ml)
365 Glimepiride Tablet 1 mg 1 Tablet 3.60 1213(E) 25.03.2020
366 Glimepiride Tablet 2 mg 1 Tablet 5.72 1213(E) 25.03.2020
367 Glucose Injection 25% 1 ml 0.17 1213(E) 25.03.2020
368 Glucose Injection 50% 1 ml 0.49 1213(E) 25.03.2020
369 Glucose Injection 5% 1000ml Glass 64.38 1213(E) 25.03.2020
370 Glucose Injection 5% 1000ml Non- 51.97 1213(E) 25.03.2020
Glass
371 Glucose Injection 5% 100ml Glass 18.07 1213(E) 25.03.2020
372 Glucose Injection 5% 100ml Non- 16.36 1213(E) 25.03.2020
Glass
373 Glucose Injection 5% 250ml Glass 24.97 1213(E) 25.03.2020
374 Glucose Injection 5% 250ml Non- 22.56 1213(E) 25.03.2020
Glass
375 Glucose Injection 5% 500ml Glass 35.44 1213(E) 25.03.2020
376 Glucose Injection 5% 500ml Non- 30.58 1213(E) 25.03.2020
Glass
377 Glucose Injection 10% Each Pack 25.89 1213(E) 25.03.2020
(1000 ml)
378 Glucose Injection 10% Each Pack 28.16 1213(E) 25.03.2020
(500 ml)
379 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 1000ml Glass 64.80 1213(E) 25.03.2020
Chloride (B)
380 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 1000ml Non- 52.36 1213(E) 25.03.2020
Chloride (B) Glass
381 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 100ml Glass 18.12 1213(E) 25.03.2020
Chloride (B)
382 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 100ml Non- 16.38 1213(E) 25.03.2020
Chloride (B) Glass
383 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 250ml Glass 25.07 1213(E) 25.03.2020
Chloride (B)50 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
384 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 250ml Non- 22.64 1213(E) 25.03.2020
Chloride (B) Glass
385 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 500ml Glass 35.62 1213(E) 25.03.2020
Chloride (B)
386 Glucose (A) + Sodium Injection 5% (A) + 0.9% (B) 500ml Non- 30.77 1213(E) 25.03.2020
Chloride (B) Glass
387 Glutaraldehyde Solution 2% 1 ml 0.06 1213(E) 25.03.2020
388 Glycerin Oral Liquid 1 ml 0.15 1213(E) 25.03.2020
389 Glyceryl Trinitrate Injection 5 mg/ml 1 ml 6.58 1213(E) 25.03.2020
390 Glyceryl Trinitrate Sublingual Tablet 0.5 mg 1 Tablet 1.81 1213(E) 25.03.2020
391 Glycopyrrolate Injection 0.2 mg/ml 1 ml 12.32 1213(E) 25.03.2020
392 Griseofulvin Tablet 125mg 1 Tablet 0.82 1213(E) 25.03.2020
393 Griseofulvin Tablet 250 mg 1 Tablet 1.60 1213(E) 25.03.2020
394 Griseofulvin Tablet 375 mg 1 Tablet 4.31 1213(E) 25.03.2020
395 Haemodialysis fluid As license 1 ml 0.04 1213(E) 25.03.2020
396 Haloperidol Injection 5 mg/ml 1 ml 5.84 1213(E) 25.03.2020
397 Haloperidol Oral Liquid 2 mg/ 5ml 1 ml 2.06 1213(E) 25.03.2020
398 Haloperidol Tablet 1.5 mg 1 Tablet 1.66 1213(E) 25.03.2020
399 Haloperidol Tablet 10 mg 1 Tablet 4.42 1213(E) 25.03.2020
400 Haloperidol Tablet 20 mg 1 Tablet 4.94 1213(E) 25.03.2020
401 Haloperidol Tablet 5 mg 1 Tablet 3.45 1213(E) 25.03.2020
402 Halothane Inhalation 1 ml 5.87 1213(E) 25.03.2020
403 Heparin Injection 1000 IU/ml 1 ml 16.35 1213(E) 25.03.2020
404 Heparin Injection 5000 IU/ml 1 ml 40.58 1213(E) 25.03.2020
405 Hepatitis B immunoglobulin Each Pack 5521.66 1213(E) 25.03.2020
406 Hepatitis B vaccine 1 ml 78.50 1213(E) 25.03.2020
407 Homatropine Drops 2% 1 ml 6.22 1213(E) 25.03.2020
408 Hormone releasing IUD Contains 52 mgof 1 IUD 3877.55 1213(E) 25.03.2020
Levonorgestrel
409 Human chorionic Injection 1000 IU Each Pack 213.04 1213(E) 25.03.2020
Gonadotropin
410 Human chorionic Injection 5000 IU Each Pack 418.37 1213(E) 25.03.2020
Gonadotropin
411 Human Normal Solution for infusion 5% 1 ml 154.65 1213(E) 25.03.2020
Immunoglobulin
412 Human Normal Solution for infusion 10% 1 ml 209.38 1213(E) 25.03.2020
Immunoglobulin
413 Human Normal Solution for infusion 16.5% 1 ml 381.87 1241(E) 03.04.2020
Immunoglobulin
414 Hydrochlorothiazide Tablet 12.5 mg 1 Tablet 0.99 1213(E) 25.03.2020
415 Hydrochlorothiazide Tablet 25 mg 1 Tablet 1.69 1213(E) 25.03.2020
416 Hydrochlorothiazide Tablet 50 mg 1 Tablet 0.08 1213(E) 25.03.2020
417 Hydrocortisone Tablet 10 mg 1 Tablet 5.90 1213(E) 25.03.2020
418 Hydrocortisone Tablet 5 mg 1 Tablet 3.04 1213(E) 25.03.2020
419 Hydrocortisone Injection 100 mg Each Pack 39.01 1213(E) 25.03.2020
420 Hydrocortisone Injection 200 mg Each Pack 60.14 1213(E) 25.03.2020
421 Hydrocortisone Powder for Injection 100 mg Each Pack 39.01 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 51
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
422 Hydrogen peroxide Solution 6% 1 ml 0.04 1213(E) 25.03.2020
423 Hydroxychloroquine Tablet 200 mg 1 Tablet 5.94 1213(E) 25.03.2020
424 Hydroxychloroquine Tablet 400 mg 1 Tablet 11.97 1213(E) 25.03.2020
425 Hydroxypropyl Injection 2% 1 ml 37.59 1213(E) 25.03.2020
methylcellulose
426 Hydroxyurea Capsule 500 mg 1 Capsule 12.85 1213(E) 25.03.2020
427 Hyoscine butylbromide Injection 20 mg/ml 1 ml 10.46 1213(E) 25.03.2020
428 Hyoscine Butylbromide Tablet 10 mg 1 Tablet 2.98 1213(E) 25.03.2020
429 Ibuprofen Capsule 400 mg 1 Capsule 1.06 1213(E) 25.03.2020
430 Ibuprofen Capsule 200 mg 1 soft gelatin 2.68 1213(E) 25.03.2020
capsule
431 Ibuprofen Tablet 200 mg 1 Tablet 0.39 1213(E) 25.03.2020
432 Ibuprofen Tablet 400 mg 1 Tablet 0.69 1213(E) 25.03.2020
433 Ibuprofen Oral Liquid 100mg/5ml 1 ml 0.19 1213(E) 25.03.2020
434 Ifosfamide Powder for Injection 1g Each Pack 362.72 1213(E) 25.03.2020
435 Ifosfamide Powder for Injection 2g Each Pack 952.09 1213(E) 25.03.2020
436 Imatinib Capsule 100 mg 1 Capsule 77.82 1213(E) 25.03.2020
437 Imatinib Capsule 400 mg 1 Capsule 256.04 1213(E) 25.03.2020
438 Imatinib Tablet 100 mg 1 Tablet 79.61 1213(E) 25.03.2020
439 Imatinib Tablet 400 mg 1 Tablet 230.47 1213(E) 25.03.2020
440 Insulin (Soluble) Injection 40 IU/ml 1 ml 15.09 1213(E) 25.03.2020
441 Intermediate Acting (NPH) Injection 40 IU/ml 1 ml 15.09 1213(E) 25.03.2020
Insulin
442 Iohexol Injection 300mgiodine/ml 1 ml 16.67 1213(E) 25.03.2020
443 Ipratropium Inhalation (MDI/DPI) 20 1 Dose 0.61 1213(E) 25.03.2020
mcg/dose
444 Ipratropium Respirator solution for use 1 ml 2.54 1213(E) 25.03.2020
in Nebulizer 250 mcg/ml
445 Iron sucrose Injection 20 mg/ml 1 ml 53.88 1213(E) 25.03.2020
446 Isoflurane Inhalation 1 ml 10.48 1213(E) 25.03.2020
447 Isoniazid Tablet 100mg 1 Tablet 0.68 1213(E) 25.03.2020
448 Isoniazid Tablet 300mg 1 Tablet 1.20 1213(E) 25.03.2020
449 Isosorbide 5 Mononitrate Tablet 20 mg 1 Tablet 3.29 1213(E) 25.03.2020
450 Isosorbide dinitrate Tablet 10 mg 1 Tablet 0.73 1213(E) 25.03.2020
451 Isosorbide dinitrate Tablet 5 mg 1 Tablet 0.75 1213(E) 25.03.2020
452 Isosorbide-5-mononitrate SR Capsule 30 mg 1 Capsule 3.51 1213(E) 25.03.2020
453 Isosorbide-5-mononitrate SR Capsule 60 mg 1 Capsule 3.49 1213(E) 25.03.2020
454 Isosorbide-5-mononitrate SR Tablet 30 mg 1 Tablet 4.91 1213(E) 25.03.2020
455 Isosorbide-5-mononitrate SR Tablet 60 mg 1 Tablet 6.40 1213(E) 25.03.2020
456 Isosorbide-5-mononitrate Tablet 10 mg 1 Tablet 1.97 1213(E) 25.03.2020
457 Ispaghula Granules/ Husk/ Powder 1 gm 0.77 1213(E) 25.03.2020
458 IUD containing Copper As licensed 1 IUD 288.19 1213(E) 25.03.2020
459 Japanese Encephalitis 4mcg to 6mcg Each Pack 699.24 1213(E) 25.03.2020
Vaccine
460 Japanese Encephalitis up to 3mcg Each Pack 532.72 1213(E) 25.03.2020
Vaccine52 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
461 Kanamycin Powder for Injection 1 gm Each Pack 39.20 1213(E) 25.03.2020
462 Kanamycin Powder for Injection 500 mg Each Pack 21.38 1213(E) 25.03.2020
463 Kanamycin Powder for Injection 750 mg Each Pack 36.53 1213(E) 25.03.2020
464 Ketamine Injection 10 mg/ml 1 ml 10.62 1213(E) 25.03.2020
465 Ketamine Injection 50 mg/ml 1 ml 10.48 1213(E) 25.03.2020
466 Labetalol Injection 5 mg/ml 1 ml 50.81 1213(E) 25.03.2020
467 Lactulose Oral Liquid 10 g/15 ml 1 ml 1.10 1213(E) 25.03.2020
468 Lamivudine (A) + Tablet 150 mg(A) + 200 1 Tablet 15.64 1213(E) 25.03.2020
Nevirapine (B) + Stavudine mg(B) + 30 mg(C)
(C)
469 Lamivudine (A) + Tablet 150 mg(A) + 300 1 Tablet 20.11 1213(E) 25.03.2020
Zidovudine (B) mg(B)
470 Lamivudine (A)+ Dispersible Tablet 30 mg(A) 1 Tablet 4.96 1213(E) 25.03.2020
Nevirapine (B) + Stavudine + 50 mg(B) + 6 mg(C)
(C)
471 L-Asparaginase Powder for Injection 10000 Each Pack 1609.22 1213(E) 25.03.2020
KU
472 L-Asparaginase Powder for Injection Each Pack 1038.73 1213(E) 25.03.2020
5000KU
473 Leflunomide Tablet 10 mg 1 Tablet 10.03 1213(E) 25.03.2020
474 Leflunomide Tablet 20 mg 1 Tablet 19.58 1213(E) 25.03.2020
475 Letrozole Tablet 2.5 mg 1 Tablet 40.87 1213(E) 25.03.2020
476 Levetiracetam Injection 100 mg/ml 1 ml 21.87 1213(E) 25.03.2020
477 Levetiracetam ER Tablet 750 mg 1 Tablet 17.43 1213(E) 25.03.2020
478 Levetiracetam Tablet 250 mg 1 Tablet 5.86 1213(E) 25.03.2020
479 Levetiracetam Tablet 500 mg 1 Tablet 11.85 1213(E) 25.03.2020
480 Levetiracetam Tablet 750 mg 1 Tablet 18.23 1213(E) 25.03.2020
481 Levetiracetam Oral Liquid 100 mg/ml 1 ml 3.66 1213(E) 25.03.2020
482 Levodopa (A) + Carbidopa CR Tablet 100 mg(A) + 25 1 Tablet 3.34 1213(E) 25.03.2020
(B) mg(B)
483 Levodopa (A) + Carbidopa Tablet 100 mg(A) + 10 1 Tablet 1.56 1213(E) 25.03.2020
(B) mg(B)
484 Levodopa (A) + Carbidopa Tablet 100 mg(A) + 25 1 Tablet 2.26 1213(E) 25.03.2020
(B) mg(B)
485 Levodopa (A) + Carbidopa Tablet 250 mg(A) + 25 1 Tablet 3.75 1213(E) 25.03.2020
(B) mg(B)
486 Levodopa (A) + Carbidopa CR Tablet 200 mg(A) + 50 1 Tablet 4.12 1213(E) 25.03.2020
(B) mg(B)
487 Levofloxacin Tablet 250 mg 1 Tablet 4.42 1213(E) 25.03.2020
488 Levofloxacin Tablet 750 mg 1 Tablet 10.96 1213(E) 25.03.2020
489 Levofloxacin Tablet 500mg 1 Tablet 8.08 1213(E) 25.03.2020
490 Levonorgestrel Tablet 0.75 mg 1 Tablet 23.07 1213(E) 25.03.2020
491 Levothyroxine Tablet 100 mcg 1 Tablet 1.20 1213(E) 25.03.2020
492 Levothyroxine Tablet 112mcg 1 Tablet 1.44 1213(E) 25.03.2020
493 Levothyroxine Tablet 12.5 mcg 1 Tablet 1.35 1213(E) 25.03.2020
494 Levothyroxine Tablet 125 mcg 1 Tablet 1.54 1213(E) 25.03.2020
495 Levothyroxine Tablet 150 mcg 1 Tablet 1.55 1213(E) 25.03.2020
496 Levothyroxine Tablet 25 mcg 1 Tablet 1.31 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 53
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
497 Levothyroxine Tablet 50 mcg 1 Tablet 0.99 1213(E) 25.03.2020
498 Levothyroxine Tablet 62.5mcg 1 Tablet 1.41 1213(E) 25.03.2020
499 Levothyroxine Tablet 75 mcg 1 Tablet 1.30 1213(E) 25.03.2020
500 Levothyroxine Tablet 88 mcg 1 Tablet 1.54 1213(E) 25.03.2020
501 Lignocaine Injection 2% 1 ml 0.99 1213(E) 25.03.2020
502 Lignocaine Injection 2%(Preservative 1 ml 0.98 1213(E) 25.03.2020
free for IV use)
503 Lignocaine Injection 1% Each Pack 7.96 1213(E) 25.03.2020
504 Lignocaine Topical Forms 2-5% 1 gm or 1 ml 1.08 1213(E) 25.03.2020
505 Lignocaine Injection 5% with 7.5% 1 ml 3.69 1213(E) 25.03.2020
Glucose
506 Lignocaine (A) + Injection 1% (A) + 1 ml 0.45 1213(E) 25.03.2020
Adrenaline (B) 1:200000 (5 mcg/ml) (B)
507 Lignocaine (A) + Injection 2% (A) + 1 ml 0.92 1213(E) 25.03.2020
Adrenaline (B) 1:200000 (5mcg/ml) (B)
508 Linezolid Tablet 600 mg 1 Tablet 33.12 1213(E) 25.03.2020
509 Lithium Tablet 300 mg 1 Tablet 1.47 1213(E) 25.03.2020
510 Loperamide Capsule 2 mg 1 Capsule 3.59 1213(E) 25.03.2020
511 Loperamide Tablet 2 mg 1 Tablet 1.98 1213(E) 25.03.2020
512 Lopinavir (A) + Ritonavir Tablet 100 mg(A) + 25 1 Tablet 23.57 1213(E) 25.03.2020
(B) mg(B)
513 Lopinavir (A) + Ritonavir Tablet 200 mg(A) + 50 1 Tablet 45.67 1213(E) 25.03.2020
(B) mg(B)
514 Lorazepam injection 2 mg/ml 1 ml 7.79 1213(E) 25.03.2020
515 Lorazepam Tablet 1 mg 1 Tablet 2.07 1213(E) 25.03.2020
516 Lorazepam Tablet 2 mg 1 Tablet 2.52 1213(E) 25.03.2020
517 Magnesium Sulphate Injection 500 mg/ml 1 ml 4.79 1213(E) 25.03.2020
518 Mannitol Injection 10% 1 ml 0.16 1213(E) 25.03.2020
519 Mannitol Injection 20% 1 ml 0.30 1213(E) 25.03.2020
520 Measles Rubbela Vaccine Each Pack 88.62 1213(E) 25.03.2020
(0.5ml)
521 Measles vaccine Vaccine Each Pack 51.11 1213(E) 25.03.2020
(0.5ml)
522 Mebendazole Oral Liquid 100 mg/5ml 1 ml 0.77 1213(E) 25.03.2020
523 Mebendazole Tablet 100 mg 1 Tablet 2.94 1213(E) 25.03.2020
524 Medroxyprogesteroneacetate Tablet 10 mg 1 Tablet 5.40 1213(E) 25.03.2020
525 Mefenamic acid Oral Liquid 100 mg/5ml 1 ml 0.52 1213(E) 25.03.2020
526 Mefenamic acid Tablet 250 mg 1 Tablet 1.94 1213(E) 25.03.2020
527 Mefenamic acid Tablet 500 mg 1 Tablet 2.46 1213(E) 25.03.2020
528 Mefloquine Tablet 250 mg 1 Tablet 51.10 1213(E) 25.03.2020
529 Meglumine Diatrizoate Injection 60%w/v 1 ml 8.28 1213(E) 25.03.2020
530 Meglumine Diatrizoate Injection 76%w/v 1 ml 9.57 1213(E) 25.03.2020
531 Melphalan Tablet 2 mg 1 Tablet 98.34 1213(E) 25.03.2020
532 Melphalan Tablet 5 mg 1 Tablet 168.67 1213(E) 25.03.2020
533 Mesna Injection 100 mg/ml 1 ml 16.81 1213(E) 25.03.2020
534 Metformin Immediate Release Tablet 1 Tablet 1.51 1213(E) 25.03.2020
500 mg54 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
535 Metformin Controlled Release Tablet 1 Tablet 3.66 1213(E) 25.03.2020
1000 mg
536 Metformin Controlled Release Tablet 1 Tablet 1.92 1213(E) 25.03.2020
500 mg
537 Metformin controlled Released Tablet 1 Tablet 2.40 1213(E) 25.03.2020
750 mg
538 Metformin Immediate Release Tablet 1 Tablet 3.61 1213(E) 25.03.2020
1000 mg
539 Metformin Immediate Release Tablet 1 Tablet 3.05 1213(E) 25.03.2020
750 mg
540 Methotrexate Injection 25 mg/ml 1 ml 48.22 1213(E) 25.03.2020
541 Methotrexate Injection 50 mg/ml 1 ml 40.15 1213(E) 25.03.2020
542 Methotrexate Tablet 10 mg 1 Tablet 12.17 1213(E) 25.03.2020
543 Methotrexate Tablet 2.5 mg 1 Tablet 4.80 1213(E) 25.03.2020
544 Methotrexate Tablet 7.5 mg 1 Tablet 11.61 1213(E) 25.03.2020
545 Methotrexate Tablet 5 mg 1 Tablet 8.39 1213(E) 25.03.2020
546 Methyldopa Tablet 250 mg 1 Tablet 2.45 1213(E) 25.03.2020
547 Methyldopa Tablet 500 mg 1 Tablet 4.70 1213(E) 25.03.2020
548 Methylergometrine Injection 0.2 mg/ml 1 ml 14.31 1213(E) 25.03.2020
549 Methylergometrine Tablet 0.125 mg 1 Tablet 7.94 1213(E) 25.03.2020
550 Methylprednisolone Tablet 16 mg 1 Tablet 8.94 1213(E) 25.03.2020
551 Methylprednisolone Tablet 8 mg 1 Tablet 5.11 1213(E) 25.03.2020
552 Methylprednisolone Injection 40mg/ml 1 ml 54.10 1213(E) 25.03.2020
553 Methylrosanilinium chloride Paint 1% 1 ml 0.08549 4334(E) 03.12.2020
(Gentian Violet)
554 Metoclopramide Injection 5 mg/ml (10 ml 1 ml 1.43 1213(E) 25.03.2020
Pack)
555 Metoclopramide Injection 5 mg/ml (2 ml 1 ml 2.34 1213(E) 25.03.2020
Pack)
556 Metoclopramide Oral Liquid 5 mg/5ml 1 ml 0.44 1213(E) 25.03.2020
557 Metoclopramide Tablet 10 mg 1 Tablet 1.17 1213(E) 25.03.2020
558 Metoprolol Capsule 25 mg 1 Capsule 4.24 1213(E) 25.03.2020
559 Metoprolol Capsule 50 mg 1 Capsule 6.46 1213(E) 25.03.2020
560 Metoprolol SR Tablet 25 mg 1 Tablet 4.04 1213(E) 25.03.2020
561 Metoprolol SR Tablet 50 mg 1 Tablet 5.79 1213(E) 25.03.2020
562 Metoprolol Tablet 25 mg 1 Tablet 3.12 1213(E) 25.03.2020
563 Metoprolol Tablet 50 mg 1 Tablet 4.73 1213(E) 25.03.2020
564 Metronidazole Injection 500mg/100ml 1 ml 0.20 1213(E) 25.03.2020
565 Metronidazole Oral Liquid 200 mg/5ml 1 ml 0.45 1213(E) 25.03.2020
566 Metronidazole Tablet 200 mg 1 Tablet 0.69 1213(E) 25.03.2020
567 Metronidazole Tablet 400 mg 1 Tablet 1.28 1213(E) 25.03.2020
568 Midazolam Injection 1 mg/ml 1 ml 5.92 1213(E) 25.03.2020
569 Midazolam Injection 5 mg/ml 1 ml 14.55 1213(E) 25.03.2020
570 Midazolam Tablet 7.5mg 1 Tablet 22.50 1213(E) 25.03.2020
571 Mifepristone Tablet 200 mg 1 Tablet 322.49 1213(E) 25.03.2020
572 Misoprostol Tablet 100 mcg 1 Tablet 8.73 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 55
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
573 Misoprostol Tablet 200 mcg 1 Tablet 16.74 1213(E) 25.03.2020
574 Morphine Injection 10 mg/ml 1 ml 23.81 1213(E) 25.03.2020
575 Morphine Injection 15 mg/ml 1 ml 29.71 1213(E) 25.03.2020
576 Morphine SR Tablet 30 mg 1 Tablet 5.46 1213(E) 25.03.2020
577 Morphine Tablet 10 mg 1 Tablet 5.34 1213(E) 25.03.2020
578 Moxifloxacin Tablet 400 mg 1 Tablet 25.40 1213(E) 25.03.2020
579 Mycophenolate mofetil Tablet 250 mg 1 Tablet 41.62 1213(E) 25.03.2020
580 Mycophenolate mofetil Tablet 500 mg 1 Tablet 82.33 1213(E) 25.03.2020
581 N-acetylcysteine Injection 200 mg/ml 1 ml 22.46 1213(E) 25.03.2020
582 N-acetylcysteine Sachet 200mg 1 gm 9.02 1213(E) 25.03.2020
583 Naloxone injection 0.4 mg/ml 1 ml 86.96 1213(E) 25.03.2020
584 Natamycin Drops 5% 1 ml 22.86 1213(E) 25.03.2020
585 Neostigmine injection 0.5 mg/ml 1 ml 4.36 1213(E) 25.03.2020
586 Neostigmine Tablet 15 mg 1 Tablet 4.68 1213(E) 25.03.2020
587 Nevirapine Oral Liquid 50 mg/5ml 1 ml 0.84 1213(E) 25.03.2020
588 Nevirapine Tablet 200 mg 1 Tablet 14.35 1213(E) 25.03.2020
589 Nifedipine Capsule 10 mg 1 Capsule 0.86 1213(E) 25.03.2020
590 Nifedipine Tablet 10 mg 1 Tablet 1.24 1213(E) 25.03.2020
591 Nitrofurantoin Oral Liquid 25 mg/5ml 1 ml 0.82 1213(E) 25.03.2020
592 Nitrofurantoin Tablet 100 mg 1 Tablet 7.25 1213(E) 25.03.2020
593 Nitrofurantoin Capsule 100mg 1 Capsule 7.87 1213(E) 25.03.2020
594 Nitrous Oxide Inhalation Cubic Meter 234.21 1213(E) 25.03.2020
595 Noradrenaline Injection 2 mg/ml 1 ml 25.83 1213(E) 25.03.2020
596 Norethisterone Tablet 5 mg 1 Tablet 5.12 1213(E) 25.03.2020
597 Omeprazole Capsule 10 mg 1 Capsule 2.12 1213(E) 25.03.2020
598 Omeprazole Capsule 20 mg 1 Capsule 2.50 1213(E) 25.03.2020
599 Omeprazole Capsule 40 mg 1 Capsule 4.95 1213(E) 25.03.2020
600 Omeprazole Powder for oral Liquid 20 1 gm 1.23 1213(E) 25.03.2020
mg
601 Omeprazole Tablet 10 mg 1 Tablet 4.44 1213(E) 25.03.2020
602 Omeprazole Tablet 20 mg 1 Tablet 4.94 1213(E) 25.03.2020
603 Omeprazole Tablet 40 mg 1 Tablet 8.35 1213(E) 25.03.2020
604 Ondansetron Injection 2 mg/ml 1 ml 5.86 1213(E) 25.03.2020
605 Ondansetron Oral Liquid 2 mg/5ml 1 ml 1.14 1213(E) 25.03.2020
606 Ondansetron Tablet 4 mg 1 Tablet 4.72 1213(E) 25.03.2020
607 Ondansetron Tablet 8 mg 1 Tablet 9.78 1213(E) 25.03.2020
608 Oral poliomyelitis vaccine 1 ml 102.79 4335(E) 03.12.2020
609 Oral Rehydration Salts As Licensed 1 gm 0.89 1213(E) 25.03.2020
610 Oral Rehydration Salts As Licensed 1 ml 0.14 1213(E) 25.03.2020
611 Oxaliplatin Injection 100mg(as licensed) Each Pack 4479.80 1213(E) 25.03.2020
612 Oxaliplatin Injection 50mg(as licensed) Each Pack 2605.35 1213(E) 25.03.2020
613 Oxytocin Injection 10 IU/ml 1 ml 39.49 1213(E) 25.03.2020
614 Oxytocin Injection 5IU/ml 1 ml 17.69 1213(E) 25.03.2020
615 Paclitaxel Injection 100 mg/16.7 ml 1 ml 206.14 1242(E) 03.04.202056 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
616 Paclitaxel Injection 30 mg/ 5ml 1 ml 206.14 1242(E) 03.04.2020
617 Pantoprazole Injection 40 mg Each Pack 44.63 1213(E) 25.03.2020
618 Para-aminosalicylic acid Granules (As licensed) 1 gm 2.85 1213(E) 25.03.2020
619 Paracetamol Oral Liquid 100 mg/5ml 1 ml 0.51 1213(E) 25.03.2020
620 Paracetamol Oral Liquid 120 mg/5ml 1 ml 0.53 1213(E) 25.03.2020
621 Paracetamol Oral Liquid 125 mg/5ml 1 ml 0.34 1213(E) 25.03.2020
622 Paracetamol Oral Liquid 150 mg/5ml 1 ml 0.58 1213(E) 25.03.2020
623 Paracetamol Oral Liquid 250 mg/5ml 1 ml 0.60 1213(E) 25.03.2020
624 Paracetamol Oral Liquid 500 mg/5ml 1 ml 0.64 1213(E) 25.03.2020
625 Paracetamol Oral Liquid 650 mg/5ml 1 ml 0.52 1213(E) 25.03.2020
626 Paracetamol Tablet 500 mg 1 Tablet 0.91 1213(E) 25.03.2020
627 Paracetamol Tablet 650 mg 1 Tablet 1.84 1213(E) 25.03.2020
628 Paracetamol Injection 150 mg/ml Each Pack ( 3.08 1213(E) 25.03.2020
0.5 ml)
629 Paracetamol Injection 150 mg/ml Each Pack (1 4.21 1213(E) 25.03.2020
ml)
630 Paracetamol Injection 150 mg/ml Each Pack (2 6.46 1213(E) 25.03.2020
ml)
631 Paracetamol Injection 150 mg/ml Each Pack (3 8.73 1213(E) 25.03.2020
ml)
632 Paracetamol Injection 150 mg/ml Each Pack (4 10.99 1213(E) 25.03.2020
ml)
633 Paracetamol Injection 150 mg/ml Each Pack (5 13.25 1213(E) 25.03.2020
ml)
634 Paracetamol Injection 150 mg/ml Each Pack (7 17.77 1213(E) 25.03.2020
ml)
635 Paracetamol Suppository 170 mg Each 7.71 1213(E) 25.03.2020
Suppository
636 Paracetamol Suppository 80 mg Each 6.52 1213(E) 25.03.2020
Suppository
637 Paracetamol Oral Liquid 100 mg/ml (pediatric) 1 ml 1.62 1213(E) 25.03.2020
638 Pegylated interferon alfa 2a Injection 180mcg Each Pack 7932.08 1213(E) 25.03.2020
639 Pegylated interferon alfa 2b Injection 100mcg Each Pack 15682.67 1213(E) 25.03.2020
640 Pegylated interferon alfa 2b Injection 120mcg Each Pack 14605.00 1213(E) 25.03.2020
641 Pegylated interferon alfa 2b Injection 80mcg Each Pack 12537.85 1213(E) 25.03.2020
642 Penicillamine Capsule 250 mg 1 Capsule 14.90 1213(E) 25.03.2020
643 Permethrin Cream 1% 1 gm 1.61 1213(E) 25.03.2020
644 Permethrin Cream 5% 1 gm 1.74 1213(E) 25.03.2020
645 Permethrin Gel 5% 1 gm 1.47 1213(E) 25.03.2020
646 Permethrin Lotion 1% 1 gm 0.91 1213(E) 25.03.2020
647 Permethrin Lotion 5% 1 ml 0.98 1213(E) 25.03.2020
648 Pheniramine Injection 22.75 mg/ml (2ml) 1 ml 2.29 1213(E) 25.03.2020
649 Pheniramine Injection 22.75 1 ml 1.71 1213(E) 25.03.2020
mg/ml(10ml)
650 Phenobarbitone Injection 200 mg/ml 1 ml 19.21 1213(E) 25.03.2020
651 Phenobarbitone Tablet 30 mg 1 Tablet 1.23 1213(E) 25.03.2020
652 Phenobarbitone Tablet 60 mg 1 Tablet 1.77 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 57
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
653 Phenobarbitone Oral liquid 20 mg/5 ml 1 ml 0.44 1213(E) 25.03.2020
654 Phenylephrine Drop 10% 1 ml 8.10 1213(E) 25.03.2020
655 Phenylephrine Drops 5% 1 ml 3.74 1213(E) 25.03.2020
656 Phenytoin Capsule 100 mg 1 Capsule 1.53 1213(E) 25.03.2020
657 Phenytoin Capsule 300 mg 1 Capsule 3.82 1213(E) 25.03.2020
658 Phenytoin ERCapsule 300 mg 1 Capsule 3.82 1213(E) 25.03.2020
659 Phenytoin injection 25 mg/ml 1 ml 2.52 1213(E) 25.03.2020
660 Phenytoin Injection 50 mg/ml 1 ml 5.39 1213(E) 25.03.2020
661 Phenytoin Oral Liquid 125 mg/5ml 1 ml 0.90 1213(E) 25.03.2020
662 Phenytoin Oral Liquid 30 mg/5ml 1 ml 0.31 1213(E) 25.03.2020
663 Phenytoin ER Tablet 300 mg 1 Tablet 5.82 1213(E) 25.03.2020
664 Phenytoin Tablet 100 mg 1 Tablet 1.56 1213(E) 25.03.2020
665 Phenytoin Tablet 300 mg 1 Tablet 4.76 1213(E) 25.03.2020
666 Phenytoin Tablet 50 mg 1 Tablet 0.74 1213(E) 25.03.2020
667 Phytomenadione (Vitamin Injection 10mg/ml 1 ml 48.00 1213(E) 25.03.2020
K1)
668 Phytomenadione (Vitamin Tablet 10mg 1 Tablet 14.56 1213(E) 25.03.2020
K1)
669 Pilocarpine Drops 2% 1 ml 10.13 1213(E) 25.03.2020
670 Pilocarpine Drops 4% 1 ml 11.71 1213(E) 25.03.2020
671 Piperacillin (A) + Powder for Injection 1 g (A) Each Pack 88.61 1213(E) 25.03.2020
Tazobactam (B) + 125 mg(B)
672 Piperacillin (A) + Powder for Injection 2 g (A) Each Pack 209.63 1213(E) 25.03.2020
Tazobactam (B) + 250 mg(B)
673 Piperacillin (A) + Powder for Injection 4 g (A) Each Pack 440.35 1213(E) 25.03.2020
Tazobactam (B) + 500 mg(B)
674 Potassium chloride Injection 150 mg/ml 1 ml 2.43 1213(E) 25.03.2020
675 Potassium chloride Oral Liquid 500 mg/5ml 1 ml 0.29 1213(E) 25.03.2020
676 Potassium permanganate Crystals for topical solution 1 gm 0.44 1213(E) 25.03.2020
677 Povidone iodine Ointment 10% 1 gm 5.22 1213(E) 25.03.2020
678 Povidone iodine Solution 4% 1 ml 1.74 1213(E) 25.03.2020
679 Povidone iodine Solution 7.5% 1 ml 0.77 1213(E) 25.03.2020
680 Povidone Iodine Solution 10% 1 ml 0.93 1213(E) 25.03.2020
681 Povidone Iodine Solution 5% 1 ml 0.39 1213(E) 25.03.2020
682 Pralidoxime chloride (2- Injection 25 mg/ml 1 ml 3.74 1213(E) 25.03.2020
PAM)
683 Praziquantel Tablet 600 mg 1 tablet 34.82 3977(E) 03.11.2020
684 Prednisolone Drops 1% 1 ml 5.04 1213(E) 25.03.2020
685 Prednisolone Injection 20 mg/2ml 1 ml 3.59 1213(E) 25.03.2020
686 Prednisolone Oral Liquid 15 mg/ 5ml 1 ml 0.75 1213(E) 25.03.2020
687 Prednisolone Oral Liquid 5 mg/ 5ml 1 ml 0.43 1213(E) 25.03.2020
688 Prednisolone Tablet 10 mg 1 Tablet 0.98 1213(E) 25.03.2020
689 Prednisolone Tablet 20 mg 1 Tablet 1.96 1213(E) 25.03.2020
690 Prednisolone Tablet 40 mg 1 Tablet 2.82 1213(E) 25.03.2020
691 Prednisolone Tablet 5 mg 1 Tablet 0.56 1213(E) 25.03.2020
692 Premix Insulin 30:70 Injection 40 IU /ml 1 ml 15.09 1213(E) 25.03.202058 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
Injection (Regular:NPH)
693 Prilocaine (A) + Lignocaine Cream 2.5% (A) + 2.5% (B 1 gm 20.50 1213(E) 25.03.2020
(B) )
694 Primaquine Tablet 15 mg 1 Tablet 4.58 1213(E) 25.03.2020
695 Primaquine Tablet 2.5 mg 1 Tablet 1.56 1213(E) 25.03.2020
696 Primaquine Tablet 7.5 mg 1 Tablet 2.12 1213(E) 25.03.2020
697 Procarbazine Capsule 50 mg 1 Capsule 34.65 1213(E) 25.03.2020
698 Procarbazine Tablet 50 mg 1 Tablet 47.22 1213(E) 25.03.2020
699 Proparacaine Drops 0.5% 1 ml 9.99 1213(E) 25.03.2020
700 Propofol Injection 10 mg/ml 1 ml 7.24 1213(E) 25.03.2020
701 Propranolol Capsule 40 mg 1 Capsule 3.81 1213(E) 25.03.2020
702 Propranolol Capsule 80 mg 1 Capsule 5.79 1213(E) 25.03.2020
703 Propranolol Tablet 10 mg 1 Tablet 1.17 1213(E) 25.03.2020
704 Propranolol Tablet 40 mg 1 Tablet 2.76 1213(E) 25.03.2020
705 Propranolol Tablet 80 mg 1 Tablet 5.01 1213(E) 25.03.2020
706 Protamine Injection 10 mg/ml 1 ml 9.27 1213(E) 25.03.2020
707 Pyrazinamide Oral Liquid 250 mg/5ml 1 ml 0.61 1213(E) 25.03.2020
708 Pyrazinamide Tablet 1000 mg 1 Tablet 9.45 1213(E) 25.03.2020
709 Pyrazinamide Tablet 1500 mg 1 Tablet 10.47 1213(E) 25.03.2020
710 Pyrazinamide Tablet 500 mg 1 Tablet 4.24 1213(E) 25.03.2020
711 Pyrazinamide Tablet 750 mg 1 Tablet 6.45 1213(E) 25.03.2020
712 Pyridoxine Tablet 100 mg 1 Tablet 5.60 1213(E) 25.03.2020
713 Pyridoxine Tablet 10mg 1 Tablet 0.11 1213(E) 25.03.2020
714 Quinine Injection 300 mg/ml 1 ml 10.19 1213(E) 25.03.2020
715 Quinine Tablet 300 mg 1 Tablet 5.74 1213(E) 25.03.2020
716 Rabies Vaccine Each Pack 342.55 1213(E) 25.03.2020
717 Raltegravir Tablet 400 mg 1 Tablet 156.88 1213(E) 25.03.2020
718 Ramipril Capsule 2.5 mg 1 Capsule 4.75 1213(E) 25.03.2020
719 Ramipril Capsule 5 mg 1 Capsule 7.41 1213(E) 25.03.2020
720 Ramipril Tablet 2.5 mg 1 Tablet 4.99 1213(E) 25.03.2020
721 Ramipril Tablet 5 mg 1 Tablet 7.85 1213(E) 25.03.2020
722 Ranitidine Oral Liquid 75 mg/5ml 1 ml 0.72 1213(E) 25.03.2020
723 Ranitidine Tablet 150 mg 1 Tablet 0.73 1213(E) 25.03.2020
724 Ranitidine Injection 25mg/ml 1 ml 1.62 1213(E) 25.03.2020
725 Ribavirin Capsule 200 mg 1 Capsule 83.85 1213(E) 25.03.2020
726 Rifabutin Capsule 150mg 1 Capsule 39.76 1213(E) 25.03.2020
727 Rifabutin Tablet 150mg 1 Tablet 37.13 1213(E) 25.03.2020
728 Rifampicin Capsule 150 mg 1 Capsule 2.01 1213(E) 25.03.2020
729 Rifampicin Capsule 300 mg 1 Capsule 3.81 1213(E) 25.03.2020
730 Rifampicin Capsule 450 mg 1 Capsule 4.95 1213(E) 25.03.2020
731 Rifampicin Capsule 600 mg 1 Capsule 11.62 1213(E) 25.03.2020
732 Rifampicin Oral Liquid 100 mg/5ml 1 ml 0.39 1213(E) 25.03.2020
733 Rifampicin Tablet 150 mg 1 Tablet 1.62 1213(E) 25.03.2020
734 Rifampicin Tablet 300 mg 1 Tablet 2.94 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 59
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
735 Ringer Lactate Injection 1000ml Each Pack 79.96 1213(E) 25.03.2020
736 Ringer Lactate Injection 100ml Each Pack 20.94 1213(E) 25.03.2020
737 Ringer Lactate Injection 250ml Each Pack 35.70 1213(E) 25.03.2020
738 Ringer Lactate Injection 500ml Each Pack 45.49 1213(E) 25.03.2020
739 Risperidone Oral Liquid 1 mg/ml 1 ml 1.94 1213(E) 25.03.2020
740 Risperidone Tablet 1 mg 1 Tablet 3.09 1213(E) 25.03.2020
741 Risperidone Tablet 2 mg 1 Tablet 4.94 1213(E) 25.03.2020
742 Risperidone Tablet 4 mg 1 Tablet 10.02 1213(E) 25.03.2020
743 Ritonavir Capsule 100 mg 1 Capsule 28.29 1213(E) 25.03.2020
744 Ritonavir Tablet 100 mg 1 Tablet 29.10 1213(E) 25.03.2020
745 Rituximab Injection 10 mg/ml 1 ml 760.32 1213(E) 25.03.2020
746 Salbutamol Capsule 4 mg 1 Capsule 0.60 1213(E) 25.03.2020
747 Salbutamol Inhalation (MDI/DPI) 100 1 Dose 0.40 1213(E) 25.03.2020
mcg/dose
748 Salbutamol Oral Liquid 2 mg/5ml 1 ml 0.15 1213(E) 25.03.2020
749 Salbutamol Respirator solution for use 1 ml 0.70 1213(E) 25.03.2020
in Nebulizer 5 mg/ml
750 Salbutamol Tablet 2 mg 1 Tablet 0.16 1213(E) 25.03.2020
751 Salbutamol Tablet 4 mg 1 Tablet 0.18 1213(E) 25.03.2020
752 Salicylic acid Ointment 6% 1 gm 1.80 1213(E) 25.03.2020
753 Sevoflurane Inhalation 1 ml 29.98 1213(E) 25.03.2020
754 Silver Sulphadiazine Cream 1% 1 gm 0.51 1213(E) 25.03.2020
755 Snake venom antiserum- Powder for Injection 10 ml Pack 558.57 1213(E) 25.03.2020
Lyophilized polyvalent
756 Snake Venom Antiserum- Injection Each Pack 433.76 1213(E) 25.03.2020
Soluble/ Liquid Polyvalent (10 ML)
757 Sodium Bicarbonate Injection 7.5% 1 ml 1.41 1213(E) 25.03.2020
758 Sodium Bicarbonate Injection 8.4% 1 ml 1.29 1213(E) 25.03.2020
759 Sodium Chloride Injection 0.9% 1000ml Glass 59.49 1213(E) 25.03.2020
760 Sodium Chloride Injection 0.9% 1000ml Non- 46.92 1213(E) 25.03.2020
Glass
761 Sodium Chloride Injection 0.9% 100ml Glass 17.59 1213(E) 25.03.2020
762 Sodium Chloride Injection 0.9% 100ml Non- 15.84 1213(E) 25.03.2020
Glass
763 Sodium Chloride Injection 0.9% 250ml Glass 23.73 1213(E) 25.03.2020
764 Sodium Chloride Injection 0.9% 250ml Non- 21.30 1213(E) 25.03.2020
Glass
765 Sodium Chloride Injection 0.9% 500ml Glass 32.99 1213(E) 25.03.2020
766 Sodium Chloride Injection 0.9% 500ml Non- 28.08 1213(E) 25.03.2020
Glass
767 Sodium nitrite Injection 30 mg/ml 1 ml 26.05 3977(E) 03.11.2020
768 Sodium Nitroprusside Injection 10 mg/ml 1 ml 25.88 1213(E) 25.03.2020
769 Sodium Valproate Injection 100 mg/ml 1 ml 5.78 1213(E) 25.03.2020
770 Sodium Valproate Oral Liquid 200 mg/5ml 1 ml 0.58 1213(E) 25.03.2020
771 Sodium Valproate CR Tablets 300mg 1 Tablet 6.31 1213(E) 25.03.2020
772 Sodium Valproate CR Tablets 500mg 1 Tablet 9.77 1213(E) 25.03.202060 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
773 Sodium Valproate Tablet 200 mg 1 Tablet 3.11 1213(E) 25.03.2020
774 Sodium Valproate Tablet 300 mg 1 Tablet 3.98 1213(E) 25.03.2020
775 Sodium Valproate Tablet 500 mg 1 Tablet 6.96 1213(E) 25.03.2020
776 Sofosbuvir Tablet 400 mg 1 Tablet 669.09 1213(E) 25.03.2020
777 Somatostatin Powder for Injection 3 mg Each pack 1588.65 1213(E) 25.03.2020
778 Spironolactone Tablet 25 mg 1 Tablet 1.92 1213(E) 25.03.2020
779 Spironolactone Tablet 50 mg 1 Tablet 3.81 1213(E) 25.03.2020
780 Stavudine (A) + Lamivudine Tablet 30 mg(A) +150 1 Tablet 9.57 1213(E) 25.03.2020
(B) mg(B)
781 Streptokinase Injection 15,00,000 IU Each Pack 1794.35 1213(E) 25.03.2020
782 Streptokinase Injection 7,50,000 IU Each Pack 1262.01 1213(E) 25.03.2020
783 Streptomycin Powder for Injection 750 mg Each Pack 8.80 1213(E) 25.03.2020
784 Streptomycin Powder for Injection 1 gm Each Pack 10.46 1213(E) 25.03.2020
785 Succinyl Choline Injection 50 mg/ml 1 ml 4.85 1213(E) 25.03.2020
786 Sucralfate Oral Liquid 1 g 1 ml 0.70 1213(E) 25.03.2020
787 Sulfasalazine Tablet 500 mg 1 Tablet 3.99 1213(E) 25.03.2020
788 Sumatriptan Tablet 25mg 1 Tablet 33.37 1213(E) 25.03.2020
789 Sumatriptan Tablet 50mg 1 Tablet 51.66 1213(E) 25.03.2020
790 Surfactant Suspension for intratracheal Per mg of 67.05 1213(E) 25.03.2020
instillation (As liensed) Phospholipids
in the pack
791 Tacrolimus Capsule 0.5 mg 1 Capsule 22.17 1213(E) 25.03.2020
792 Tacrolimus Capsule 1 mg 1 Capsule 39.16 1213(E) 25.03.2020
793 Tacrolimus Capsule 2 mg 1 Capsule 76.71 1213(E) 25.03.2020
794 Tacrolimus Tablet 0.5 mg 1 Tablet 18.78 3976(E) 03.11.2020
795 Tacrolimus Tablet 1 mg 1 Tablet 34.49 3976(E) 03.11.2020
796 Tacrolimus Tablet 2 mg 1 Tablet 68.13 3976(E) 03.11.2020
797 Tamoxifen Tablet 10 mg 1 Tablet 2.58 1213(E) 25.03.2020
798 Tamoxifen Tablet 20 mg 1 Tablet 2.92 1213(E) 25.03.2020
799 TD Vaccine Each dose of 0.5ml contains: Each 0.5ml 18.79 3976(E) 03.11.2020
Diphtheria Toxoid ≤5Lf (≥ Pack
2IU)
Tetanus Toxoid ≥ 5Lf (≥
40IU)
800 TD Vaccine Each dose of 0.5ml contains: Each 5ml 176.53 3976(E) 03.11.2020
Diphtheria Toxoid ≤5Lf (≥ Pack
2IU)
Tetanus Toxoid ≥ 5Lf (≥
40IU)
801 TD Vaccine Each dose of 0.5ml contains: Each 0.5ml 16.11 3976(E) 03.11.2020
Diphtheria Toxoid ≤25Lf (≥ Pack
30IU) Tetanus Toxoid ≥ 5Lf
(≥ 40IU)
802 Telmisartan Tablet 20 mg 1 Tablet 3.66 1213(E) 25.03.2020
803 Telmisartan Tablet 40 mg 1 Tablet 6.61 1213(E) 25.03.2020
804 Telmisartan Tablet 80 mg 1 Tablet 10.07 1213(E) 25.03.2020
805 Temozolomide Capsule 100 mg 1 Capsule 2088.67 1213(E) 25.03.2020
806 Temozolomide Capsule 20 mg 1 Capsule 597.87 1213(E) 25.03.2020[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 61
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
807 Temozolomide Capsule 250 mg 1 Capsule 4697.81 1213(E) 25.03.2020
808 Temozolomide Tablet 100 mg 1 Tablet 1550.39 1213(E) 25.03.2020
809 Temozolomide Tablet 20 mg 1 Tablet 375.62 1213(E) 25.03.2020
810 Temozolomide Tablet 250 mg 1 Tablet 3837.37 1213(E) 25.03.2020
811 Tenofovir Tablet 300 mg 1 Tablet 47.30 1213(E) 25.03.2020
812 Tenofovir (A) + Lamivudine Tablet 300 mg(A) + 300 1 Tablet 45.00 1213(E) 25.03.2020
(B) mg(B)
813 Tenofovir (A) + Lamivudine Tablet 300 mg(A) + 300 1 Tablet 103.32 1213(E) 25.03.2020
(B) + Efavirenz (C) mg(B) + 600 mg(C)
814 Tetanus Toxoid Injection Each Pack 10.87 1213(E) 25.03.2020
(0.5ml)
815 Tetanus Toxoid Injection Each Pack (5 23.50 1213(E) 25.03.2020
ml)
816 Thalidomide Capsule 100 mg 1 Capsule 61.25 1213(E) 25.03.2020
817 Thalidomide Capsule 50 mg 1 Capsule 35.38 1213(E) 25.03.2020
818 Thiamine Injection 100 mg/ml 1 ml 24.86 1213(E) 25.03.2020
819 Thiamine Tablet 100 mg 1 Tablet 3.76 1213(E) 25.03.2020
820 Thiopentone Powder for Injection 0.5 gm Each Pack 40.83 1213(E) 25.03.2020
821 Thiopentone Powder for Injection 1 gm Each Pack 49.54 1213(E) 25.03.2020
822 Timolol Drops 0.25% 1 ml 5.18 1213(E) 25.03.2020
823 Timolol Drops 0.5% 1 ml 11.95 1213(E) 25.03.2020
824 Tiotropium Inhalation (MDI) 9 Per Metered 2.41 1213(E) 25.03.2020
mcg/dose Dose
825 Tiotropium Inhalation (DPI) 18 Per Dose 9.31 1213(E) 25.03.2020
mcg/dose
826 Tramadol Capsule 50 mg 1 Capsule 4.52 1213(E) 25.03.2020
827 Tramadol Injection 50 mg/ml (20 ml 1 ml 1.25 1213(E) 25.03.2020
Pack)
828 Tramadol Injection 50 mg/ml (upto 2 1 ml 10.50 1213(E) 25.03.2020
ml Pack)
829 Tramadol Tablet 100 mg 1 Tablet 19.72 1213(E) 25.03.2020
830 Tramadol Tablet 50 mg 1 Tablet 8.08 1213(E) 25.03.2020
831 Tramadol Capsule 100 mg 1 Capsule 9.62 1213(E) 25.03.2020
832 Tranexamic acid Injection 100 mg/ml 1 ml 14.98 1213(E) 25.03.2020
833 Tranexamic acid Tablet 500 mg 1 Tablet 17.41 1213(E) 25.03.2020
834 Trastuzumab Injection 440 mg/50 ml Each Pack 60298.66 1213(E) 25.03.2020
835 Trihexyphenidyl Tablet 2 mg 1 Tablet 1.22 1213(E) 25.03.2020
836 Tropicamide Eye Drop 1% 1 ml 10.08 1213(E) 25.03.2020
837 Vancomycin Powder for Injection 1 gm Each Pack 477.07 1213(E) 25.03.2020
838 Vancomycin Powder for Injection 250 mg Each Pack 222.28 1213(E) 25.03.2020
839 Vancomycin Powder for Injection 500 mg Each Pack 286.94 1213(E) 25.03.2020
840 Vecuronium Powder for Injection 10 mg Each Pack 189.53 1213(E) 25.03.2020
841 Vecuronium Powder for Injection 4 mg Each Pack 91.47 1213(E) 25.03.2020
842 Verapamil Injection 2.5 mg/ml 1 ml 1.17 1213(E) 25.03.2020
843 Verapamil Tablet 40 mg 1 Tablet 0.74 1213(E) 25.03.2020
844 Verapamil Tablet 80 mg 1 Tablet 1.40 1213(E) 25.03.202062 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Medicines Dosage form and Strength Unit Ceiling price Existing S.O. No. &
No (wef 1.4.2021 Date
with WPI @
0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
845 Vinblastine Injection 1mg/ml 1 ml 20.57 1213(E) 25.03.2020
846 Vincristine Injection 1 mg/ml 1 ml 52.24 1213(E) 25.03.2020
847 Vitamin A Capsule 50000 IU 1 Capsule 0.55 1213(E) 25.03.2020
848 Vitamin A Injection 50000 IU/ml 1 ml 1.92 1213(E) 25.03.2020
849 Vitamin A Tablet 50000 IU 1 Tablet 0.70 1213(E) 25.03.2020
850 Warfarin Tablet 1 mg 1 Tablet 2.42 1213(E) 25.03.2020
851 Warfarin Tablet 2 mg 1 Tablet 2.67 1213(E) 25.03.2020
852 Warfarin Tablet 3 mg 1 Tablet 3.13 1213(E) 25.03.2020
853 Warfarin Tablet 5 mg 1 Tablet 2.36 1213(E) 25.03.2020
854 Water for Injection Injection Each Pack 2.33 1213(E) 25.03.2020
(10 ml)
855 Water for Injection Injection Each Pack (5 2.25 1213(E) 25.03.2020
ml)
856 White Petrolatum Jelly 100% 1 gm 0.09 1213(E) 25.03.2020
857 Xylometazoline Nasal Drops 0.05% 1 ml 3.94 1213(E) 25.03.2020
858 Xylometazoline Nasal Drops 0.1% 1 ml 5.22 1213(E) 25.03.2020
859 Zidovudine Capsule 300 mg 1 Capsule 2.07 1213(E) 25.03.2020
860 Zidovudine Tablet 300 mg 1 Tablet 14.29 1213(E) 25.03.2020
861 Zidovudine (A) + Tablet 300 mg(A) + 150 1 Tablet 20.20 1213(E) 25.03.2020
Lamivudine (B) + mg(B) + 200 mg(C)
Nevirapine (C)
862 Zinc sulphate Dispersible Tablet 20mg 1 Tablet 3.15 1213(E) 25.03.2020
863 Zoledronic Acid Powder for Injection 4 mg Each Pack 4211.34 1213(E) 25.03.2020
864 Zolpidem Capsule 5 mg 1 Capsule 7.37 1213(E) 25.03.2020
865 Zolpidem Tablet 10 mg 1 Tablet 8.47 1213(E) 25.03.2020
866 Zolpidem Tablet 5 mg 1 Tablet 5.40 1213(E) 25.03.2020
Notes:-
(a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale
Price Index (WPI) @0.53638% for the year 2020 over 2019).
(b) In respect of formulation where pack wise ceiling price is notified, for any other pack size manufactured,
the manufacturer shall approach NPPA under para 11(3) of DPCO, 2013 for specific price approval for
its formulations. The formulation of Sodium Valproate includes combination of Sodium Valproate and
Valproic Acid both together corresponding to Sodium Valproate of the stated strength.
(c) In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the
manufacturer shall approach NPPA for specific price approval for its formulations.
(d) All manufacturers of scheduled formulations, selling branded or generic or both the versions of
scheduled formulations at price higher than the ceiling price (plus Goods and Services Taxes as
applicable) so fixed and notified by the Government, shall revise the prices of all such formulations
downward not exceeding the ceiling price specified in column (5) in the above table plus Goods and
Services Taxes as applicable, if any.
(e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the
ceiling price specified in column (5) in the above table (plus Goods and Services Taxes as applicable, if
any), may revise the existing MRP of their formulations, on the basis of WPI @ 0.53638% for year 2020
in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 63
(f) The manufacturers may add Goods and Services Taxes only if they have paid actually or if it is payable
to the Government on the ceiling price mentioned in column (5) of the above said table.
(g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (5) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall
issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA
through IPDMS and submit a copy to State Drug Controller and dealers.
(h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he
carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in
the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing
manufacturer shall apply for prior price approval of such new drug to NPPA in Form I as specified under
Schedule-II of the DPCO, 2013.
(j) The manufacturers of above said scheduled formulations shall furnish quarterly return to NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the
DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said
scheduled formulation shall furnish information to NPPA, in respect of discontinuation of production
and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six
months prior to the intended date of discontinuation.
(k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable
to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
(l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above
table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above
said date of notification, stand(s) superseded.
(m) The ceiling price of Heparin Injection 1000IU/ml specified in col. (5) of Sl. No. 403 of the Table above
and the ceiling price of Heparin Injection 5000IU/ml specified in col. (5) of Sl. No. 404 of the Table
above would not be applicable till the time SO. 1236(E) dated 17.03.2021 is in force.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
आदेि
नई ददल्ली, 25 माचव, 2021
का.आ. 1331(अ).—
4, 6, 10, 11, 14, 61 ,61 ,4 18
a b
@ (0.53638%)
0.53638%
(1) (2) (3) (4) (5) 6(a) 6(b)
1 ,lhVkby lkfyflfyd xksyh 300 fexzk 1214 ¼v½ 25.03.2020
1 xksyh
,flM 0.22687
2 dSfY'k;e dkcksZusV xksyh 250 fexzk 1 xksyh 1.96 1214 ¼v½ 25.03.2020
3 daMksel 1 daMkse 9.15 1214 ¼v½ 25.03.2020
4 Msilksu xksyh 50 fexzk 1 xksyh 0.23656 1214 ¼v½ 25.03.202064 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
5 bVksikslkbM dSIlwy 100 fexzk- 1 dSIlwy 60.69 1214 ¼v½ 25.03.2020
6 ÝkekblsVhu lYQsV Øhe 0-50% 1 xzke 0.87467 1214 ¼v½ 25.03.2020
7 vkbZlksfutkbM flji 100 fexzk-@5 1214 ¼v½ 25.03.2020
1 fefy-
fefy- 0.2591
8 eMs ªksDlh izksxsLVsjksu xksyh 5 fexzk 1214 ¼v½ 25.03.2020
1 xksyh
,flVsV 3.00
9 fjQefiflu xksyh 450 fexzk 1 xksyh 4.44 1214 ¼v½ 25.03.2020
-
(
0.53638 )
(5)
13(2)
.
घ (5)
ङ
V
च (4)
u
II I
ज
II III
II IV
झ
ञ
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदिे क[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 65
ORDER
New Delhi, the 25th March, 2021
S.O. 1331(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the
Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government
of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India
in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date
specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority,
hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and
services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column
(2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in
columns (3) and (4) thereof:
TABLE
Price Revision as per Annual Wholesale Price Index (WPI) @ 0.53638% increase.
Sl No Medicines Dosage form and Unit Ceiling price (wef Existing S.O. No. &
Strength 01.04.2021 with Date
WPI @ 0.53638%)
(1) (2) (3) (4) (5) 6(a) 6(b)
1 Acetyl Salicylic Tablet 300mg 1 Tablet 1214 (E) 25.03.2020
Acid 0.22687
2 Calcium Tablet 250 mg 1 Tablet 1214 (E) 25.03.2020
carbonate 1.96
3 Condoms 1 1214 (E) 25.03.2020
Condom 9.15
4 Dapsone Tablet 50 mg 1 Tablet 0.23656 1214 (E) 25.03.2020
5 Etoposide Capsules 100 mg 1 1214 (E) 25.03.2020
Capsule 60.69
6 Framycetin Cream 0.50% 1 GM 1214 (E) 25.03.2020
Sulphate 0.87467
7 Isoniazid Syrup 100 1 ML 1214 (E) 25.03.2020
mg/5ml 0.2591
8 Medroxy Tablet 5mg 1 Tablet 1214 (E) 25.03.2020
Progesterone
Acetate 3.00
9 Rifampicin Tablet 450mg 1 Tablet 4.44 1214 (E) 25.03.2020
Notes:-
(a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale
Price Index (WPI) @0.53638% for the year 2020 over 2019).
(b) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of
scheduled formulations at a price higher than the ceiling price (plus goods and services taxes as
applicable) so fixed and notified by the Government, shall revise the prices of all such formulations
downward not exceeding the ceiling price specified in column (5) in the above table plus goods and
services taxes as applicable, if any.
(c) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the
ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if
any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 0.53638% for year
2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.
(d) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to
the Government on the ceiling price mentioned in column (5) of the above said table.66 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(e) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (5) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall
issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA
through IPDMS and submit a copy to State Drug Controller and dealers.
(f) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he
carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(g) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in
the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing
manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified
under Schedule-II of the DPCO, 2013.
(h) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the
DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said
scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production
and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six
months prior to the intended date of discontinuation.
(i) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable
to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
(j) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above
table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above
said date of notification, stand(s) superseded.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
आदिे
नई ददल्ली, 25 माच,व 2021
का.आ. 1332(अ).—Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj
dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 11 ds mi iSjk ¼3½ vkSj ¼4½ vkSj
iSjk 14 }kjk iznRr “kfDr;ks a dk iz;ksx djrs gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k
izkf/kdj.k½ ds “kqf)&i= vkns“k dk-vk- 1215¼v½ fnukad 25 ekpZ] 2020, dk-vk- 2823¼v½ fnukad 20 vxLr] 2020, dk-vk- 3320¼v½
fnukad 25 flrEcj] 2020, dk-vk- 3974¼v½ fnukad 3 uoEcj] 2020 vkSj dk-vk- 522¼v½ fnukad 04 Qjojh] 2021 vkns“k ds vf/kØe.k
es a tgk¡ rd mldk lEcU/k uhps dh lkj.kh ^d* e sa fofufeZr iSdksa ds fo“ks"k fo“ks"krkvks a lfgr xSj&dk¡p ds :i es a ¼dk-vk- 1993¼v½
fnukad 3 twu] 2016 ea s xSj&ihohlh ds #i e sa ;Fkk of.kZr½] l“akks/ku fd;k] uhps nh xbZ lkj.kh [k es a fofufnZ"V fuekZrk ds fo“ks"k mRikn
,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djrs gq, ftUgs a ,sls vf/kØe.k ds iwo Z fd;k x;k gS ;k djus dk yksi fd;k x;k gS]
jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2020 ij vk/kkfjr la“kks/ku djrk gS] tSlk fd uhps
dh lkj.kh ^d* ds LrHak ¼5½ es a fofufn"ZV gS] vf/kdre dher dks mDr lkj.kh ds LrHak ¼3½ vkSj ¼4½ es a dh xbZ Øe“k% rRLFkkuh izfof"V;ks a
es a fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ esa dh xb Z rRLFkkuh izfof"V esa
fofufnZ"V vulq fwpr fofufeZfr;ksa es a l s izR;sd dh oLrq ,oa los k dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i es a fu;r djrh
gSA
@ 0.53638%
@ 0.53638%
(1) (2) (3) (4) (5)
1 Xydw kst batsD'ku 5% 1000 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 76.58
2 Xydw kts batsD'ku 5% 500 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 66.25[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 67
3 Xydw kts ¼,½$lksfM;e DyksjkbM ¼ch½ batsD'ku 5% ¼,½$0-9% ¼ch½ 1000 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 80.47
4 Xydw kts ¼,½$lksfM;e DyksjkbM ¼ch½ batsD'ku 5% ¼,½$ 0-9% ¼ch½ 500 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 68.86
5 lkfsM;e Dykjs kbM batsD'ku 0-9% 100 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 33.86
6 lkfsM;e Dykjs kbM batsD'ku 0-9% 250 fefy xSj&dk¡p fo'ks"k
fo'ks‖krkvkas lfgr 50.01
7 lkfsM;e Dykjs kbM batsD'ku 0-9% 500 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 70.81
8 lkfsM;e Dykjs kbM batsD'ku 0-9% 1000 fefy xSj&dk¡p fo'ks"k
fo'ks’krkvks a lfgr 79.31
मसै सव अक्सा पैरेंटल्स जलजमटेड यूरोहडे के साथ स्ट्टेरी जड्रप बोतल
मसै सव श्री कृष्णा केिर् लेबोरेटरीज जलजमटेड यूरोहडे के साथ ईज़ीपोटव बोतल
मसै सव रुसोमा लेबोरेटरीज प्रा०जलजमटेड प् यूराड्रीप
मसै सव आर. के. लेबोरेटरीज प्रा०जलजमटेड यूरोहडे बाटल
मसै सव यूरोलाइफ हल्े थकेयर प्रा०जलजमटेड लाइफ पोटव
मसै सव ठरयलकेड लाईफसाइंस प्रा०जलजमटेड यूरोहडे बाटल
मसै सव पुजनस्ट्का हल्े थकेयर प्रा०जलजमटेड नोन पीर्ीसी बेग
0.53638%
के 5, 6, 7 और 8 मे दिावई गई कीमते केर्ल मैससव पुजनस्ट्का हल्े थकेयर प्रा०जलजमटेड पर लागू
होंगी.
(5)
0.53638%
(5)68 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
i ii iii
V
(4)
u
II I
II III
II IV
ड
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदिे क
ORDER
New Delhi, the 25th March, 2021
S.O. 1332(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and
paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O.
1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in
supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National
Pharmaceutical Pricing Authority) No. SO. 1215(E) dated 25.03.2020, SO. 2823(E) dated 20.08.2020, SO. 3320(E)
dated 25.09.2020, S.O. 3974(E) dated 03.11.2020 and SO. 522(E) dated 04.02.2021, in so far as they relate to
formulation packs of Non-Glass with special features (mentioned as Non-PVC in S.O. 1993(E) dated 3rd June 2016)
mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified
products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National
Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2020 as specified
in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if
any in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with
the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3)
and (4) thereof:[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 69
TABLE-A
Price Revision as per Annual Wholesale Price Index (WPI) @ 0.53638% increase.
Sl. No. Medicines Dosage form and Unit Ceiling price (wef
Strength 01.04.2021 with WPI @
0.53638%)
(1) (2) (3) (4) (5)
1 Glucose Injection 5% 1000ml Non Glass
with special features 76.58
2 Glucose Injection 5% 500ml Non Glass with
special features 66.25
3 Glucose (A) + Sodium Injection 5% (A) + 1000ml Non Glass
Chloride (B) 0.9% (B) with special features 80.47
4 Glucose (A) + Sodium Injection 5% (A) + 500ml Non Glass with
Chloride (B) 0.9% (B) special features 68.86
5 Sodium Chloride Injection 0.9% 100ml Non Glass with
special features 33.86
6 Sodium Chloride Injection 0.9% 250ml Non Glass with
special features 50.01
7 Sodium Chloride Injection 0.9% 500ml Non Glass with
special features 70.81
8 Sodium Chloride Injection 0.9% 1000ml Non Glass
with special features 79.31
TABLE ‗B‘
Sl. No. Name of Manufacturer Product /Brand Name
(1) (2) (3)
1 M/s. B.Braun Medical (I) Pvt Ltd. Ecoflac Plus bottle with Eurohead
2 M/s. Amanta Healthcare Ltd. Steriport bottle
3 M/s. Aculife Healthcare Pvt Ltd. Aculife bottle with Eurohead
4 M/s. Albert David Limited Albert David bottle with Eurohead
5 M/s. Denis Chem Limited Aquapulse with Eurohead
6 M/s. Claris Life Sciences Limited Claris bottle with Eurohead
7 M/s. Fresenius Kabi India Pvt Limited Freeflex bags
8 M/s. Otsuka Pharmaceutical India Private Ltd. Unibag
(previously known as Claris Otsuka Private Limited)
9 M/s. Aishwarya Lifesciences Lifusion Eurohead bottle
10 M/s. Baxter (India) Pvt. Ltd. Viaflex bags
11 M/s. Otsuka Pharmaceutical India Private Ltd. Eurohead bottle
(previously known as Claris Otsuka Private Limited)
12 M/s. Fresenius Kabi India Pvt Limited Eurohead bottle
13 M/s. Axa Parenterals Ltd Steri Drip bottle with Eurohead
14 M/s. Shree Krishna Keshav Laboratories Ltd Easyport bottle with Eurohead
15 M/s. Rusoma Laboratories Pvt. Ltd. Puradrip
16 M/s. R. K. Laboratories Pvt. Ltd. Eurohead bottle
17 M/s. Eurolife Healthcare Pvt. Ltd. Life port
18 M/s. Realcade Lifescience Pvt. Ltd. Euro head bottle
19 M/s. Puniska Healthcare Pvt. Ltd [Note (b) below] Non –PVC bag70 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Notes:-
(a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale
Price Index (WPI) @0.53638% for the year 2020 over 2019).
(b) In case of M/s Puniska Healthcare Pvt. Ltd. only the prices of the formulations specified in Sl. No. 5, 6, 7
& 8 of Table A are applicable.
(c) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled
formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and
notified by the Government, shall revise the prices of all such formulations downward not exceeding the
ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
(d) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price
specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise
the existing M.R.P. of their formulations, on the basis of WPI @ 0.53638% for year 2020 in accordance
with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.
(e) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the
Government on the ceiling price mentioned in column (5) of the above said table.
(f) Any other manufacturer claiming separate ceiling price for Non-Glass with special feature shall apply to
NPPA for separate ceiling price approval with details and demonstrate, that such pack has all of the
features as (i) self collapsibility and self-sealability (ii) not having air-vent; and (iii) there is no chance of
contamination during manufacture/ infusion/ admixing levels alongwith documentation and
demonstration.
(g) For other special features claimed or any other pack size manufactured, the manufacturer shall approach
the NPPA for specific price approval for its formulation
(h) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (5) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall
issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA
through IPDMS and submit a copy to State Drug Controller and dealers.
(i) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries
on business in a manner so as to be easily accessible to any person wishing to consult the same.
(j) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in
the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer
shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II
of the DPCO, 2013.
(k) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO,
2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled
formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or
import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to
the intended date of discontinuation.
(l) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
(m) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table
in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said
date of notification, stand(s) superseded.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 71
आदिे
नई ददल्ली, 25 माच,व 2021
का.आ. 1333(अ).—Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013
vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi iSjk ¼3½
vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh;
vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds vkn's k dk- vk- 1216¼v½ fnukad 25 ekpZ] 2020, dk-vk- 2824¼v½ fnukad 20 अगस्ट्त]
2020, dk-vk- 3321¼v½ fnukad 25 जसतम्बर] 2020, dk-vk- 3975¼v½ fnukad
03
नर्ेम्बर] 2020 vkSj dk-vk- 521¼v½ fnukad 04
फरर्री] 2021, vkns'k ds vf/kØe.k eas tgk¡ rd, जिसमें अब तक यह पैक में ररिंगर लैक्टेट इिंिेक्शन से सिंबिंजित है, जिसमें जिशेष सुजििाएँ हैं
िैसे (i) स्व-सिंप्रेषणीयता और स्व-सीलजबजलटी (ii) एयर-िेंट नही िं होना और (iii) जनमााण/िलसेक/प्रिेश स्तर के दौरान सिंदूषण का कोई उपाय
नही िंहै, uhp s nh xbZ lkj.kh [k eas fofufnZ"V fuekZrk ds fo'ks"k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq,
ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k djus dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk]
Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2020 ij vk/kkfjr la'kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ es a
fofufnZ"V gS] vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es a dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V
[kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LrHa k ¼2½ eas dh xbZ rRLFkkuh izfof"V es a fofufnZ"V
vuqlwfpr fofufeZfr;ks a eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i eas fu;r djrh
gSA
@ 0.53638%
@ 0.53638%
(1) (2) (3) (4) (5)
1 ररगर लैक्टेट इंजेक्िन 100 जमली प्रत्सयेक 100 जमलीलीटर पकै म ें 24.08
जर्िेष जर्िषे ताएं ह ैं
2 ररगर लैक्टेट इंजेक्िन 250 जमली प्रत्सयेक 250 जमलीलीटर पैक में 41.06
जर्िेष जर्िषे ताएं ह ैं
3 ररगर लैक्टेट इंजेक्िन 500 जमली प्रत्सयेक 500 जमलीलीटर पैक में 52.31
जर्िेष जर्िषे ताएं ह ैं
4 ररगर लैक्टेट इंजेक्िन 1000 जमली प्रत्सयेक 1000 जमलीलीटर पैक में 91.95
जर्िेष जर्िषे ताएं ह ैं
(1) (2)
1 मैससव अल्बटव डेजर्ड जल.
2 मैसस वएक्यूलाइफ हेल्थकेयर प्रा. जलजमटेड
3 मैससव बी। ब्ौन मेजडकल (इंजडया) प्रा. जलजमटेड
4 मैससव फ्रेसेजनयस काबी इंजडया प्रा. जलजमटेड
5 मैससव ओस्ट्तुका फामावस्ट्यूठटकल्स इंजडया प्रा. जलजमटेड
6 मैससव डेजनस केम लेब जलजमटेड
7 मैससव अमान्ता हेल्थकेयर जलजमटेड
8 मैससव श्री कृष्णा केिर् लेबोरेटरीज जलजमटेड
9 मैससव अक्सा पैरेंटल्स जलजमटेड
10 मैससव रुसोमा लेबोरेटरीज जलजमटेड
11 मैससव आर. के. लेबोरेटरीज प्रा० जलजमटेड
12 मैससव ठरयलकेड लाईफसाइंस प्रा० जलजमटेड72 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
0.53638%
(5)
0.53638%
(5)
कोई अन्य जिजनमााता िो जिशेष सुजििाओ िं िाले पैके िो िं में ररिंगर लैक्टेट इिंिेक्शन में िैसे (i) स्व-सिंप्रेषणीयता और स्व-
सीलजबजलटी (ii) में एयर-िेंट नही िंहोने और (iii) जनमााण/िलसेक/प्रिेश के स्तर के दौरान सिंदूषण का कोई उपाय नही िंहै, के जलए
अलग अजिकतम मूल्य का दािा करता है तो िह अलग अजिकतम मूल्य अनुमोदन के जलए एनपीपीए को आिेदन
करेगा।
V
(4)
u
II I
II III
II IV
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
प्रसेनजीत दास, उप जनदिे क[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 73
ORDER
New Delhi, the 25th March, 2021
S.O. 1333(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 of the Drugs
(Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016
issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the
Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No.
S.O 1216(E) dated 25.03.2020, SO. 2824(E) dated 20.08.2020, SO. 3321(E) dated 25.09.2020, SO. 3975(E) dated
03.11.2020 and SO. 521(E) dated 04.02.2021, in so far as it relates to ringer lactate injection in pack having special
features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of
contamination during manufacture/ infusion/ admixing levels, manufactured by the manufacturers specified in Table
B for specified products and pack-sizes, except in respect of things done or omitted to be done before such
supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index
(WPI) of 2020 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and
services tax applicable, if any in respect of the scheduled formulations specified in the corresponding entry in column
(2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding
entries in columns (3) and (4) thereof:
Table A
Price Revision as per Annual Wholesale Price Index (WPI) @ 0.53638% increase.
Sl No Medicines Dosage form and Unit Ceiling price (w.e.f.
Strength 01.04.2021 with WPI
@ 0.53638%)
(1) (2) (3) (4) (5)
1 Ringer lactate Injection100 ml Each 100 ml pack having 24.08
special features
2 Ringer lactate Injection 250 ml Each 250 ml pack having 41.06
special features
3 Ringer lactate Injection 500 ml Each 500 ml pack having 52.31
special features
4 Ringer lactate Injection 1000 ml Each 1000 ml pack 91.95
having special features
TABLE ‘B’
Sl. No. Name of Manufacturer
(1) (2)
1 M/s. Albert David Ltd.
2 M/s. Aculife Healthcare Pvt. Ltd.
3 M/s. B. Braun Medical (India) Pvt. Ltd.
4 M/s. Fresenius Kabi India Pvt. Ltd.
5 M/s. Ostuka Pharmaceuticals India Pvt. Ltd.
6 M/s. Denis Chem lab Ltd.
7 M/s. Amanta Healthcare Ltd.
8 M/s. Shree Krishna Keshav Laboratories Ltd.
9 M/s. Axa Parenterals Ltd.
10 M/s. Rusoma Laboratories Pvt. Ltd.
11 M/s. R. K. Laboratories Pvt. Ltd.
12 M/s. Realcade Lifescience Pvt. Ltd.
Notes:-
(a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale
Price Index (WPI) @0.53638% for the year 2020 over 2019).74 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled
formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and
notified by the Government, shall revise the prices of all such formulations downward not exceeding the
ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
(c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price
specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise
the existing M.R.P. of their formulations, on the basis of WPI @ 0.53638% for year 2020 in accordance
with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.
(d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the
Government on the ceiling price mentioned in column (5) of the above said table.
(e) Any other manufacturer claiming separate ceiling price for ringer lactate injection in pack having special
features like (i) self collapsibility and self-sealability (ii) not having air-ventt and (iii) there is no chance of
contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling
price approval.
(f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach
the NPPA for specific price approval for its formulation
(g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (5) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall
issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA
through IPDMS and submit a copy to State Drug Controller and dealers.
(h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries
on business in a manner so as to be easily accessible to any person wishing to consult the same.
(i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in
the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer
shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II
of the DPCO, 2013.
(j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO,
2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled
formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or
import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to
the intended date of discontinuation.
(k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
(l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table
in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said
date of notification, stand(s) superseded.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
आदिे
नई ददल्ली, 25 माच,व 2021
का.आ. 1334(अ).—
,
. .
.
,[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 75
,
I
8462
30811
-
13(2)
.
(4)
[का. सं. /216/84/2021/एफ/फा. सं. 8(84)/2021/डीपी/एनपीपीए-जडर्ी-II]
आलोक रंजन, सहायक जनदिे क
ORDER
New Delhi, the 25th March, 2021
S.O. 1334(E).—In continuation of the notifications issued by National Pharmaceutical Pricing Authority,
Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018,
S.O. 1464(E) dated 02.04.2018, S.O. 1488(E) dated 29.03.2019 and SO. 1217(E) dated 25.03.2020 regarding the
fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after
considering the Wholesale Price Index (WPI) @ 0.53638 percent for the year 2020 over 2019, it has been decided
to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods
and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2021, as under:
TABLE
Sl. No. Coronary Stents Unit Ceiling Price
( Sl No. 31 in Schedule-I of the DPCO, 2013) (in Number) (in Rs.)
(1) (2) (3) (4)
1 Bare Metal Stents 1 8462
Drug Eluting Stents (DES) including metallic DES and
2 1
Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents 30811
Notes:-76 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price
specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may
revise the existing MRP of Coronary Stent, on the basis of WPI @ 0.53638% for the year 2020 in
accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
(b) The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have
paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the
aforesaid table.
(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where
he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to
deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices
Control) Order, 2013 read with Essential Commodities Act, 1955.
[PN/216/84/2021/F/F. No. 8(84)/2021/DP/NPPA-Div.-II]
ALOK RANJAN, Asstt. Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.
            

Continue your research

Get AI Summary & Executive Breakdown

Chat with this Document

Search across full 480K+ policy library

Government of India in the Ministry of Chemicals and Fertilizers the National Pharmaceutical Pricing Authority

Executive Summary & Key Takeaways

Key Entities Referenced

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers